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Abstract 
 
Cancer is the leading contributor to the disease burden in Australia, accounting for 
almost one-fifth of the total burden. Broad geographical inequalities in cancer 
outcomes were known to exist within Australia, but few small-area cancer analyses 
had been conducted, and none within Queensland. Challenges include the small 
population dispersed over vast distances, yet Bayesian hierarchical models are able 
to accommodate sparse numbers while allowing for spatial correlation between small 
areas.  
 
This research aims to develop and apply Bayesian hierarchical models to facilitate an 
investigation of the spatial and temporal associations for diagnostic and survival 
outcomes for Queenslanders diagnosed with cancer. The key objectives are to 
document and quantify the importance of spatial inequalities, explore factors 
influencing these inequalities, and investigate how spatial inequalities change over 
time.  
 
Data on all primary invasive cancers diagnosed from 1996 onwards were obtained 
from the Queensland Cancer Registry. Patient residence at diagnosis was provided as 
one of 478 Statistical Local Areas (median population of 6,390 in 2011). All models 
allowed for local and global smoothing via spatially structured and uncorrelated 
heterogeneity components, respectively. Spatial smoothing in all analyses used an 
intrinsic conditional autoregressive prior based on first-order contiguity. 
 
The first objective, and the foundation for further analyses, was to identify cancers 
with evidence of spatial inequalities. Cancers tending to have higher incidence rates 
in more urban areas included breast, prostate, non-Hodgkin lymphoma, male kidney 
and bladder. In contrast, cervical, male lung and male oesophageal cancers had 
higher incidence rates in more remote areas. For survival spatial inequalities, a 
consistent pattern of lower survival among remote areas and higher survival among 
urban areas was observed for non-Hodgkin lymphoma, lung, colorectal, female 
breast, male leukaemia, male stomach and prostate cancers.  
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Next, the influence on diagnostic spatial patterns by area-level factors such as 
remoteness, socioeconomic disadvantage and Indigenous proportion of the 
population was considered. Due to the complex interplay between these influences, a 
classification and regression tree analysis was applied to Bayesian modelled 
incidence estimates. The remoteness of an area was found to be a key influence on 
spatial incidence inequalities for several cancers, while Indigenous ethnicity was an 
important influence only for cervical cancer. Socioeconomic disadvantage interacted 
with remoteness for melanoma, breast (females), cervical, lung and prostate cancers. 
 
Small-area changes over time were investigated for lung cancer incidence and a 
modelled estimate of its risk factors via a spatio-temporal shared component model. 
The modelled shared component appeared to reflect past trends in tobacco smoking, 
and found consistent changes across time over all small areas. This suggests that 
spatial inequalities have largely remained consistent, with the same areas remaining 
at higher risk. Limitations of survey-based data meant it had not been possible to 
look at small-area tobacco smoking prevalence changes over time previously.  
 
Small-area survival inequalities were also further investigated. The influence of 
tumour stage at diagnosis is an important prognostic influence, so was included in 
the Bayesian additive risk model with piecewise constant hazards examining spatial 
relative survival inequalities for breast and colorectal cancers.  Much of the lower 
survival observed for breast cancer patients residing in remote areas resulted from a 
greater proportion of advanced tumours diagnosed in these areas. An estimated 640 
breast and colorectal cancer deaths resulted from spatial inequalities in cancer 
survival in Queensland during 1998-2007. 
 
When survival was predicted by cancer stage, localised breast cancer had quite 
similar survival across all statistical local areas. However, 5-year relative survival 
varied between areas by up to 7% for advanced breast cancer, with more remote 
areas tending to have poorer survival. In contrast, even localised colorectal cancers 
showed maximum differences in predicted survival of almost 5% between areas, and 
up to 14% for advanced tumours, with survival generally decreasing as remoteness 
increased. 
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Spatio-temporal changes in breast and colorectal cancer survival by tumour stage 
were also examined. Larger survival improvements were observed between 2002-
2006 and 2007-2011, than between 1997-2001 and 2002-2006. Nonetheless, during 
the entire time period of 1997-2011 all small areas showed improvements in survival 
for both localised and advanced cancers, with the median 5-year relative survival 
improvement ranging from 2% for localised breast cancer to 8% for advanced 
colorectal cancer. 
 
Important methodological contributions resulted from this project. A fully Bayesian 
approach to quantify premature deaths from spatially structured variation in cancer 
survival inequalities was developed. The advantages of this include obtaining 
measures of uncertainty, the ability to adjust for prognostic influences, and excluding 
deaths considered to result from random variation. 
 
A spatial flexible parametric relative survival model was also introduced, and further 
expanded to provide the first spatio-temporal flexible parametric relative survival 
model. Benefits over previous spatial relative survival models include the ability to 
predict smooth survival functions, the ease of including continuous variables, and the 
capacity to use individual-level input data.  
 
Practical benefits for Queenslanders diagnosed with cancer also directly resulted 
from this project. The Patient Travel Subsidy Scheme, which offsets some of the 
costs associated with travelling for medical treatment, was increased after lobbying 
using our results.  Additional Cancer Council Queensland regional support staff 
positions were created in response to the demonstrated survival inequalities. Results 
were used by Queensland Health to formulate cancer health service strategies for the 
next decade, with a focus on reducing variations in cancer outcomes throughout the 
state.  
 
This detailed and comprehensive analysis of small-area inequalities in cancer 
outcomes clearly demonstrated the versatility of Bayesian hierarchical models in 
cancer control. Existing Bayesian hierarchical models were refined, new models and 
methods developed, and tangible benefits obtained for cancer patients in Queensland. 
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CHAPTER 1 
 
Introduction 
 
1.1 Motivation 
 
In 1996, cancer was declared a national health priority area in Australia (Australian 
Institute of Health and Welfare & Department of Health and Family Services, 1997). 
Mandatory notification of every cancer diagnosis (excluding only the common skin 
cancers) to a cancer registry had been introduced earlier, making cancer one of the 
few diseases with almost complete incidence data. By 2010, more than 116,000 
Australians were being diagnosed with a primary invasive cancer, while more than 
42,000 died (Australian Institute of Health and Welfare, 2014a). Cancer is the 
leading contributor to the disease burden in Australia, accounting for an estimated 
19% of the total burden (Australian Institute of Health and Welfare & Australasian 
Association of Cancer Registries, 2012). 
 
Evidence abounds for geographical inequalities in cancer outcomes. Socioeconomic 
status, ethnicity and remoteness have been associated with cancer outcome 
inequalities in many different countries, including Australia (Australian Institute of 
Health and Welfare, 2012b; Obertova et al., 2012; de Vries et al., 2014; Jemal et al., 
2014). Often these investigations have relied on standard statistical methods, which, 
to provide satisfactory results, are restricted to relatively large areas (Hegarty and 
Barry, 2008). Since aggregating data to broad regions can mask important real 
differences, this limits their usefulness for public health analyses. 
 
In the Australian state of Queensland, there was evidence of broad area inequalities 
in cancer incidence and survival (Baade et al., 2005). Queensland has the highest 
cancer incidence of any Australian state, due largely to melanomas, and the most 
dispersed population across remoteness categories (Australian Bureau of Statistics, 
2008a; Australian Institute of Health and Welfare & Australasian Association of 
Cancer Registries, 2012). This seemed an ideal location to further investigate small-
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area cancer inequalities, but techniques were required that would enable robust and 
reliable results in small areas. 
 
Bayesian methods are one of the options that meet these criteria. Bayesian 
hierarchical models are a natural way to model spatial effects, and have the capacity 
to include local and global features of outcomes over space and time, as well as 
accommodating data-specific features such as sparse numbers due to rare outcomes, 
missing values, known biases, misclassifications and measurement error (Besag et 
al., 1995; Carlin and Xia, 1999a; Louis and Shen, 1999; Dunson, 2001; Greco et al., 
2005; Thompson et al., 2007). Because information is ‘borrowed’ between 
components, valid and efficient results are possible, even when data are sparse 
(Louis and Shen, 1999). Output from Bayesian models is in the form of a posterior 
distribution, providing information on estimate uncertainty, which aids the decision 
making process (Carlin and Xia, 1999a).  
 
We sought to investigate and quantify spatial and spatio-temporal differences in 
cancer incidence and survival in Queensland, Australia, through applying Bayesian 
methods.  
 
1.2 Research Aim & Objectives 
 
This research will develop and apply Bayesian hierarchical models to facilitate an 
investigation of the spatial and temporal associations for diagnostic and survival 
outcomes for Queenslanders diagnosed with cancer. 
 
Identifying and quantifying spatial and spatio-temporal inequalities is a prerequisite 
to addressing them effectively.  In this thesis, spatial inequalities refer to substantive 
differences between areas. The following objectives will enable this to be achieved: 
 
(i) Document cancers with evidence of spatial inequalities in incidence 
and/or survival 
(ii) Explore factors influencing the spatial inequalities in cancer incidence 
Chapter 1: Introduction 
 
 3 
 
(iii) Explore spatio-temporal inequalities in cancer incidence/risk factors 
(iv) Quantify the importance of cancer survival spatial inequalities, and 
consider factors influencing this 
(v) Investigate changes in survival inequalities over time 
 
The first objective provides the foundation for subsequent objectives. Successive 
investigations will focus on the cancers with identified spatial inequalities.  
 
These objectives are addressed from two different perspectives: application and 
methodology. The objectives and interactions with each other are illustrated in 
Figure 1.1. 
 
Figure 1.1 Summary of thesis objectives 
 
Notes:  Objective numbers are provided in brackets. 
Thesis chapter numbers are provided on the right hand side, with colour shading indicating 
whether it has an applied or methodological focus.  
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This project is focused on modelling data from the Queensland Cancer Registry 
(QCR), so contributes to the data analysis side of the cancer data control cycle 
(Figure 1.2). The activities of this project are shown as the explanatory components 
of analysing data, interpreting information and communicating evidence, with the 
hope that the resulting knowledge would influence decisions made. 
 
Figure 1.2 The cancer data cycle highlighting project activities and scope 
 
Notes:  Modified from the WHO health information framework (World Health Organization, 2008) 
and the AIHW cancer data cycle (Australian Institute of Health and Welfare, 2012b). 
Project activities have an orange border. 
 
1.3 Research Data 
 
The Queensland Cancer Registry is the primary data source for this project. To 
ensure the greatest accuracy and completeness, the data collected by the QCR is 
constantly being revised. Updated data are usually released annually, when an 
additional year of data has been collated and checked. At the start of this project, data 
were available to 2006, and this had increased to 2012 by project completion.   
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Although the Queensland Cancer Registry started data collection in 1982, patient 
address at diagnosis was only available from 1996 onwards. Initially, patient’s 
suburb and postcode were matched to the 2006 boundaries for statistical local areas 
using an algorithm. Starting from the 2009 data release, patient addresses were 
geocoded to provide a latitude longitude coordinate that was matched to the SLA 
boundaries.     
 
Estimated resident population data were obtained from the Australian Bureau of 
Statistics. To enhance the timeliness of data release, three versions are released: 
preliminary, revised and final estimates. At the start of this project, final data for 
1996 to 2006 were obtained. Following the 2011 census, an unprecedented revision 
of previously final population estimates back to 1991 was implemented. Throughout 
this thesis, the most recent population estimates available at the time were used, so 
the population numbers reported for 2006 differ between chapters.  
 
1.4 Research Contribution 
 
This is the first study to investigate both spatial and spatio-temporal inequalities 
across a range of cancers in Queensland. Results from this study are expected to have 
direct implications for Queenslanders, by guiding the development of strategies and 
health policies aimed at reducing spatial and temporal inequalities for people 
diagnosed with cancer. This project is also expected to advance the field of Bayesian 
statistics by enhancing current models and developing new models. As such, both 
Application and Methodology contributions are considered. 
 
1.4.1 Contribution to Application 
 
Bayesian methods have been increasingly used to analyse spatial and spatio-temporal 
disease patterns, particularly for incidence, in recent decades.  Well-established 
methods in disease mapping, such as the Besag, York and Mollie model (Besag et 
al., 1991), as well as more recently developed methods, such as the spatial Poisson 
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relative survival model (Fairley et al., 2008), are used in the initial analyses for 
Objective 1, and are application focused. 
 
Previously developed models (Classification and Regression Tree (CART) analysis 
(Breiman et al., 1984) and shared latent component models (Richardson et al., 
2004)) are also able to be applied in innovative ways to fulfil Objectives 2 and 3. 
 
1.4.2 Contribution to Methodology 
 
In contrast to the spatial modelling of cancer incidence, modelling relative survival 
spatial inequalities was comparatively underdeveloped. Objectives 4 and 5 thus 
provide the greatest scope for methodological development. For Objective 4, firstly a 
fully Bayesian approach is proposed to quantify the number of premature deaths 
resulting from spatial inequalities. Also as part of this objective, a new spatial 
flexible parametric relative survival model is developed to enable smooth predictions 
of the survival function for each small area. 
 
For Objective 5, the newly proposed spatial flexible parametric relative survival 
model is extended to the spatio-temporal context. 
 
1.5 Research Scope 
 
The utility of applying Bayesian methods to routinely collected data are investigated 
in this thesis. Spatial epidemiology does not exclusively require a Bayesian 
framework, but these are becoming the preferred approach due to their many 
advantages in this context (Lawson, 2013). 
 
The case study analyses Queensland Cancer Registry data from 1996 onwards. The 
residential location was provided as a statistical local area, so methods considered are 
those that relate to areal analyses. Geostatistical methods appropriate for point data, 
such as kriging (point level spatial prediction, (Chilès and Delfiner, 2012)) or 
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tolerance contours used to classify regions of risk (Kelsall and Diggle, 1998), are not 
further considered in this thesis.  
 
Small-area studies can include disease mapping, geographic correlation, assessing 
risk in relation to a hazard source, and cluster detection (Wakefield and Elliott, 
1999). Our focus is on summarising spatial and spatio-temporal variation in cancer 
outcomes (disease mapping), with some overlap of investigating aetiology 
(geographic correlation). A popular and practical choice in Bayesian disease 
mapping is the use of the intrinsic conditional autoregressive (CAR) prior (Besag et 
al., 1991), and all the models presented incorporate this prior to locally smooth 
spatial data. 
 
Computation was consistently conducted using Markov chain Monte Carlo 
algorithms. Approximate Bayesian computational methods such as R-INLA (Rue et 
al., 2009) are possible for many of the analyses presented here, but were not 
investigated. 
 
1.6 Thesis Structure 
 
This thesis is presented by publication, as the research objectives were met by six 
papers written for journals. Chapters 3 to 8 are presented in the form they were 
submitted or accepted apart from minor editing for consistency, such as updating 
online first references. Additional details for some chapters are presented as 
appendices, and marked as unpublished when not included in the original paper. 
Some table footnotes are also more detailed than in the published papers. As each 
paper was required to be self-contained, there is necessarily some repetitiveness and 
overlap between chapters, particularly regarding descriptions of the data. Each 
chapter includes an overview of the relevant literature and a bibliography. A detailed 
literature review is provided in Chapter 2, focusing on approaches suitable for areal 
analyses. All references are compiled into a comprehensive bibliography that is 
located at the end of the thesis. 
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Chapter 3 addresses Objective 1, focusing on the rationale behind decisions made 
and explaining the models used to document cancers with evidence of spatial 
inequalities in incidence or survival. 
 
Chapter 4 focuses on exploring the interactions between remoteness, area-level 
socioeconomic status, and population ethnicity in relation to spatial inequalities in 
cancer incidence for the NHPA cancers. Classification and Regression Tree analyses 
were applied to fulfil Objective 2. 
 
Chapter 5 addresses Objective 3, exploring spatio-temporal inequalities in lung 
cancer incidence, focusing on detecting the underlying risk component via a spatio-
temporal shared component model. 
 
Chapter 6 is part of Objective 4, exploring the influence of cancer stage at diagnosis, 
distance to treatment and area-level socioeconomic disadvantage for breast and 
colorectal cancers. Here a generalised linear model with piecewise hazards was used 
to model relative survival. Methodology was developed to enable quantification of 
the number of deaths due to spatial inequalities.  
 
Chapter 7 continues the focus on Objective 4 by developing a new method to 
examine spatial variation in relative survival – the spatial flexible parametric relative 
survival model. Predicting smooth survival functions is one of the advantages of this 
approach, and these were predicted for each geographic area by cancer stage at 
diagnosis. 
 
Chapter 8 addresses Objective 5 by extending the newly developed spatial flexible 
parametric relative survival model to the spatio-temporal context. The influence of 
early diagnosis on survival improvements is considered. 
 
In Chapter 9 the main findings of each chapter are restated along with the appropriate 
objective addressed. The current impact of this research as well as potential future 
areas of research are discussed. 
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CHAPTER 2 
 
Literature Review 
 
2.1 Introduction 
 
This literature review provides the context for the areal models used in this project. 
Geostatistical methods suitable for point-level data are outside the project scope and 
not considered.   
 
Key concepts in spatial epidemiology are described, and Bayesian approaches and 
computational methods discussed. Bayesian spatial and spatio-temporal models 
currently used in small-area estimation for cancer incidence and survival are then 
reviewed before concluding remarks. 
 
2.2 Spatial Epidemiology 
 
Small-area analyses are part of the relatively new discipline of spatial epidemiology, 
which aims to quantify and explain geographic variation in diseases and their 
relationship with environmental factors (Lope et al., 2006). As such, disease 
mapping is an integral component of spatial epidemiology (Elliott and Wartenberg, 
2004).  
 
Two distinguishing properties of spatial data include spatial heterogeneity and spatial 
correlation (Demsar et al., 2013). Spatial heterogeneity means processes may vary 
locally and may differ between locations, that is, geographic nonstationarity (Demsar 
et al., 2013). Spatial correlation suggests areas closer together are more similar than 
those further apart. Where these are present, the assumptions that data are 
independent and identically distributed underlying most traditional regression 
analyses are violated (Demsar et al., 2013). Ignoring these spatial properties can lead 
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to spurious conclusions (Wakefield and Elliott, 1999; Choo and Walker, 2008). 
Additional challenges in small-area analyses include sparse data, often with a large 
number of event-free areas, overdispersion, and measurement of errors in numerators 
and denominators (Prieto et al., 2007).  
 
When conducted appropriately, benefits of small-area analyses include decreased 
ecologic bias, improved result interpretation and the ability to detect local effects 
linked to environmental problems (Richardson et al., 2004; Lope et al., 2006). Often 
models incorporate smoothing of the data between areas, and this can remove any 
artefactual variation introduced by the data aggregation into geo-political boundaries 
that are unrelated to the disease of interest (Langford et al., 1999). 
 
2.3 Bayesian approach 
 
Bayesian methods are an increasingly popular choice for small-area analyses. In 
contrast to other statistical methods, Bayesian models assume the vector of unknown 
parameters to be estimated is random, rather than fixed, and vary according to some 
‘prior’ distribution (Carlin and Xia, 1999a). This prior distribution 𝜋 often aims to 
represent any available information before the analysis. This information, combined 
with the observed data 𝒚 given the parameters 𝜽 (in the form of the likelihood, 𝑓), 
produces the posterior distribution using Bayes’ theorem: 
 
𝑝(𝜽|𝒚, 𝜆) =
𝑓(𝒚|𝜽)𝜋(𝜽|𝜆) 
𝑝(𝒚|𝜆)
=
𝑓(𝒚|𝜽)𝜋(𝜽|𝜆) 
∫ 𝑓(𝒚|𝜽)𝜋(𝜽|𝜆)𝑑𝜃
 ∝ 𝑓(𝒚|𝜽)𝜋(𝜽|𝜆)                    (2.1) 
 
where 𝜆 represents the prior parameters and is assumed to be known. The likelihood 
can be expressed as the product of individual contributions, as follows: 
𝑓(𝒚|𝜽) = ∏ 𝑓(𝑦𝑖|𝜽)
𝑛
𝑖=1
 
 
In practice, 𝜆 is unknown, and the method of dealing with this determines the type of 
Bayesian approach. Empirical Bayes replace 𝜆 in (2.1) with ?̂?, estimating the 
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unknown information on the prior and conditional distributions using the marginal 
distributions of the observations (Devine et al., 1994; Ghosh et al., 1999). However, 
the variance of empirical Bayes rate estimators are prone to being too small, as they 
do not account for the additional variability in estimating the parameter values 
(Devine et al., 1994; Lahiri and Rao, 1995; Maiti, 1998; Louis and Shen, 1999). 
Although there are methods available to adjust the variance estimates (Devine et al., 
1994; Meza, 2003), fully Bayesian methods are preferable to guarantee an adequate 
representation of the distribution of underlying rates (Louis and Shen, 1999).  
 
2.3.1  Bayesian hierarchical models 
 
The alternative approach for the unknown prior parameter 𝜆 is to use an additional 
stage, known as a hyperprior ℎ(𝜆|𝑥), distribution, which has hyperparameters 𝑥 and 
replaces (2.1) with the following fully Bayesian approach (Banerjee et al., 2004): 
 
𝑝(𝜽|𝒚) =
∫ 𝑓(𝒚|𝜽)𝜋(𝜽|𝜆)ℎ(𝜆|𝑥)𝑑𝜆 
∫ 𝑓(𝒚|𝜽)𝜋(𝜽|𝜆)ℎ(𝜆|𝑥)𝑑𝜃𝑑𝜆
                                  (2.2) 
 
By nature, all Bayesian models are hierarchical (Ntzoufras, 2009), and likewise (2.2) 
meets the definition of a hierarchical model, as it specifies a series of conditional 
models (Wikle et al., 1998). The first stage is the likelihood, the second stage the 
priors, and the third stage the hyperpriors (Figure 2.1). 
 
Figure 2.1 Hierarchical structure expressed as a directed acyclic graph (DAG)  
 
 
 
 
 
Note: Oval nodes represent stochastic components, rectangular nodes represent constant parameters. 
 
Bayesian hierarchical models are able to accommodate very complicated structures 
from a succession of relatively simple components, enabling greater flexibility 
     𝑥          𝜆             𝜃      𝑦 
           ℎ(𝜆|𝑥)            𝜋(𝜃|𝜆)     𝑓(𝑦|𝜃) 
Hyperparameters       Hyperprior   Prior            Data likelihood 
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(Mugglin et al., 2002; Ntzoufras, 2009). Other advantages include good performance 
as well as ease of implementation (Carlin and Xia, 1999a; Louis and Shen, 1999; 
Dunson, 2001; Thompson et al., 2007). They are also a natural approach to model 
spatially misaligned data, as occurs when the exposure and response are measured at 
different levels of aggregation (Greco et al., 2005).  
 
A wide range of inferences can be obtained from a Bayesian posterior distribution 
(Carlin and Xia, 1999a; Thompson et al., 2007), although some, such as posterior 
probabilities, may be rather sensitive to the choice of priors (Tenan et al., 2014). 
Because information is shared between components, results are often more valid and 
efficient than those obtained under other statistical approaches  (Louis and Shen, 
1999). 
 
2.3.2  Gaussian Markov Random field models 
 
Of all the Bayesian hierarchical models, the most widely used in spatial 
epidemiology, particularly for disease maps, are the Gaussian Markov random field 
(GMRF) models (Carlin and Perez, 2000; Ferreira and De Oliveira, 2007; Ocana-
Riola, 2007; Escaramis et al., 2008). A Markov chain is a sequence of random 
elements where the conditional distribution of 𝑋𝑛+1 given 𝑋1, … , 𝑋𝑛 depends on 𝑋𝑛 
only (Brooks et al., 2011). Generalising this to two or more dimensions produces a 
Markov random field, which conditions area 𝑖 on the neighbourhood 𝒩𝑖  (Fieguth, 
2011).  
 
The neighbourhood must meet the following criteria (Fieguth, 2011): 
1. An area 𝑖 is not its own neighbour: 𝑖 ∉ 𝒩𝑖 
2. The neighbourhood is reciprocal: 𝑖 ∈ 𝒩𝑗 ⇔ 𝑗 ∈ 𝒩𝑖 where 𝑖 ≠ 𝑗 
 
Although other forms of smoothing are possible, GMRFs generally seem to perform 
well for areal data (Best et al., 2005; Hennerfeind et al., 2008a).  
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2.3.2.1  Conditional autoregressive (CAR) prior 
 
The seminal work of Besag (1974, 1975) showed the conditional auto-regressive 
(CAR) prior distribution is a Gaussian Markov random field. This prior is commonly 
applied on the spatially structured component (𝑢𝑖) within a Bayesian hierarchical 
model. 
 
The intrinsic Gaussian CAR (Besag et al., 1991) defines conditional moments using 
simple functions of the neighbouring values and number of neighbours, 𝑛𝒩𝑖, which 
equates to the following conditional distribution (Lawson, 2013): 
𝑢𝑖|𝐮−𝐢~N (?̅?𝑖 ,
𝜎𝑢
2
𝑛𝒩𝑖
) 
where ?̅?𝑖 =
1
𝑛𝒩𝑖
∑ 𝑢𝑗𝑗∈𝒩𝑖  and is the average over neighbouring regions, and 𝜎𝑢
2 is the 
variance of 𝑢. Although all full conditionals are proper, the joint distribution is 
improper due to the pairwise difference joint specification, so the intrinsic CAR 
distribution is restricted to specifying prior distributions.  
A key advantage of the intrinsic CAR formulation is the computational ease (Gelfand 
and Vounatsou, 2003; Waller and Carlin, 2010). 
 
2.3.3  Computation 
 
The integration required to obtain posteriors such as (2.2) largely prohibited the use 
of Bayesian hierarchical models until Markov chain Monte Carlo (MCMC) and 
modern computing power enabled calculation (Carlin and Xia, 1999a; Gelfand, 
2000). Given a sequence of draws from a stationary Markov chain, the desired 
summary of the posterior is approximated by MCMC, which are simulated random 
processes conditional on the previous value.  
 
Although MCMC was originally developed in the 1950s, it wasn’t until 1990 that 
this became widely applied in statistics (Brooks et al., 2011), dramatically expanding 
the potential scope of statistical models (Gelfand, 2000). Spatial statistics were 
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instrumental in implementing and developing the use of MCMC in Bayesian 
inference (Besag and Green, 1993). 
 
MCMC methods are not without controversy, including concerns over assessing 
convergence, selecting starting values, and the length (and necessity) of burn-in 
periods (Geyer, 2011). Although theoretically the simulated chain/s will converge to 
the required distribution, careful checking is required. A range of quantitative 
methods are available to assess different aspects of convergence, including those 
based on spectral analysis (Geweke, 1992), discretisation (two-state Markov chain 
theory (Raftery and Lewis, 1992)), within-between variance comparison (Gelman 
and Rubin, 1992; Brooks and Gelman, 1998), Riemann sums (Philippe and Robert, 
2001), and the Spearman test (Robert et al., 1999) among others, however, none are 
infallible. Visual assessment of trace and density plots are crude but useful 
(Mengersen et al., 1999b). More sophisticated graphical approaches can be used to 
evaluate the mixing speed of the chain, such as via CUSUM (cumulative sum control 
chart (Yu and Mykland, 1998)) or autocorrelation (Box and Jenkins, 1970) plots. 
Nonetheless, often it is not feasible to visually examine and subjectively assess the 
hundreds (or more) of parameters of interest. A pragmatic approach involves a 
combination of methods coupled with common sense and experience (Mengersen et 
al., 1999a). 
 
MCMC methods remain computationally intensive (Escaramis et al., 2008; 
Goovaerts and Gebreab, 2008), and this is perhaps their greatest disadvantage, with 
alternative methods seeking to provide good approximations in a drastically reduced 
timeframe (Taylor and Diggle, 2013). However, their ability to directly approximate 
probabilities (Besag et al., 1995), and answer a broad range of questions (Haran, 
2011), means they remain a valid and useful means of inference.  
 
2.3.3.1  Metropolis-Hastings algorithm 
 
The Metropolis algorithm was the first MCMC algorithm developed (Metropolis et 
al., 1953). This was subsequently modified by Hastings (1970) to not require 
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symmetry in the proposal function. The algorithm is an acceptance-rejection method 
that proceeds as follows, given a starting value 𝜃(0): 
1. Draw 𝜃∗ from the candidate density 𝑞(∙ |𝜃(𝑡−1)) 
2. Compute the acceptance ratio 𝑟 =
𝑚(𝜃∗) 𝑞(𝜃(𝑡−1)|𝜃∗)
𝑚(𝜃(𝑡−1))𝑞(𝜃∗|𝜃(𝑡−1))
  
where 𝑚(𝜃) ≡ 𝑓(𝑦|𝜃)𝑝(𝜃) 
3. If  𝑟 ≥ 1, set 𝜃(𝑡) = 𝜃∗ 
Else if 𝑟 < 1, set 𝜃(𝑡) = {
𝜃∗ with probability 𝑟            
  𝜃(𝑡−1) with probability 1 − 𝑟
 
 
Under mild conditions, a draw 𝜃(𝑡) converges in distribution to a draw from the true 
posterior density 𝑝(𝜃|𝑦) as 𝑡 → ∞ (Banerjee et al., 2004). 
 
For the algorithm to be efficient, it is important that the acceptance rate is neither too 
high (suggesting the candidate density is too narrow) or too low (suggesting the 
candidate density is too wide, proposing jumps into low-probability areas). Both of 
these outcomes suggest high autocorrelation, with suggested optimal acceptance 
rates ranging between 25%-40% (Gelman et al., 1996).  
 
Green (1995) further generalised the Metropolis-Hastings algorithm to produce 
reversible jump MCMC by including auxiliary variables for dimension matching. 
This is very useful when multiple parameter spaces of different dimensionality are 
considered (Liang et al., 2010), but unnecessary for the problems considered in this 
thesis. 
 
2.3.3.2  Gibbs sampler 
 
The Gibbs sampler as proposed by Geman and Geman (1984) and further modified 
by Gelfand and Smith (1990) is a special form of a Metropolis-Hastings algorithm 
that samples from each of the full conditional distributions 𝑝(𝜃𝑖|𝜽𝑗≠𝑖, 𝒚) in the 
model. All proposals are accepted in Gibbs sampling, so a single new value of 𝜃𝑖 is 
generated at each iteration, conditional on all other 𝜃’s (Lawson, 2013). Although 
each iteration is likely to be slower for a Gibbs sampler when compared to the 
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Metropolis-Hastings algorithm, convergence is generally expected to be faster 
(Banerjee et al., 2004). 
 
The Gibbs sampler algorithm proceeds as follows for k parameters, given a set of 
starting values {𝜃1
(0)
, … , 𝜃𝑘
(0)
} : 
1. Draw 𝜃1
(𝑡)
 from 𝑝(𝜃1|𝜃2
(𝑡−1), 𝜃3
(𝑡−1), … , 𝜃𝑘
(𝑡−1), 𝒚) 
2. Draw 𝜃2
(𝑡)
 from 𝑝(𝜃2|𝜃1
(𝑡), 𝜃3
(𝑡−1), … , 𝜃𝑘
(𝑡−1), 𝒚) 
⋮ 
k. Draw 𝜃𝑘
(𝑡)
 from 𝑝(𝜃𝑘|𝜃1
(𝑡), 𝜃2
(𝑡), … , 𝜃𝑘−1
(𝑡) , 𝒚) 
 
Widespread implementation of Bayesian CAR models was enabled by the popular 
BUGS (Bayesian inference using Gibbs sampling) software (Lunn et al., 2000; 
Hughes and Haran, 2013). This program automatically constructed and sampled from 
full conditional distributions, rather than requiring specialised (and time-consuming) 
programming of Gibbs samplers in low or intermediate languages (Gilks et al., 1994; 
Spiegelhalter et al., 2004). Additional programs now enable Gibbs sampling, 
including Stan, JAGS, MLwiN, BACC and MCMCpack in R (Lawson, 2013).   
 
2.4 Cancer incidence 
 
Cancer incidence refers to the number of cancer cases diagnosed in a given time 
period. Cancer is one of the most common non-infectious disease applications in 
spatial epidemiology (Lyseen et al., 2014). Models used for cancer incidence are also 
applicable to cancer mortality.  
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2.4.1 Bayesian spatial models 
 
2.4.1.1  Besag, York and Mollié model 
 
The most popular Bayesian hierarchical model for disease mapping is the Besag, 
York & Mollié (BYM) model (Besag et al., 1991), which further developed the 
model of Clayton and Kaldor (1987). This Gaussian Markov random field model 
incorporates extra variation effects to enable efficient prediction of disease rates 
(Kim et al., 2002). 
The BYM model can be expressed as follows: 
 
𝑂𝑖~ Poisson(𝐸𝑖𝜃𝑖) 
log(𝜃𝑖) = 𝛼 + 𝑢𝑖 + 𝑣𝑖 
 
where 𝑂𝑖 is the number of disease events in i=1,…I regions, 𝐸𝑖 is the expected 
number of cases (calculated as the overall age-sex rates applied to the region’s 
population), 𝜃𝑖  is the standardised incidence ratio and 𝛼 is the intercept. The model 
incorporates extra-Poisson variability by including two spatial random effects: 𝑣𝑖 
allows for inter-area heterogeneity, while 𝑢𝑖 is structured and represents the spatial 
component (Ocana-Riola, 2007).  
 
Inclusion of both spatially structured and unstructured random effects enable the 
disease rates to be smoothed at both a global and local level (Bell and Broemeling, 
2000). Information about the overall non-spatial variability of the disease map 
(global smoothing) is provided by the unstructured variance parameter, 𝑣𝑖, which has 
a normal distribution centred on zero. The variability of disease risks relative to 
neighbouring areas (local smoothing) is described by the clustering component, 𝑢𝑖  
which is commonly an intrinsic conditionally autoregressive (CAR) normal 
distribution.   
 
The BYM model has been shown to produce robust estimates, although limitations 
include the potential for oversmoothing and sensitivity to the choice of priors 
(Lawson et al., 2000; Best et al., 2005; Goovaerts and Gebreab, 2008). Concerns 
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have also been raised over identifiability, as the residual component is decomposed 
into two independent, additive components (MacNab, 2011). Very sparse data, as 
would be seen for very fine resolution data, may cause difficulties when applying 
these models, particularly if there are also none or very few neighbours (Kokki et al., 
2001). Finally, if covariates are included, the spatial correlation is likely to inflate the 
variance of the 𝛽 components (Clayton et al., 1993; Hughes and Haran, 2013). 
 
2.4.1.2  Alternate Bayesian spatial models 
 
Modifications and alternative models to the BYM have been developed to address 
these limitations. 
 
The Poisson distribution is appropriate to model count data for rare, non-contagious 
diseases. When there are many zeros in the data, overdispersion, when the observed 
variance is greater than the expected variance, may result. More appropriate 
distributions may include the negative binomial or mixture models, such as zero-
inflated count distributions or hurdle distributions. Zero-inflated models divide the 
zero component into two components – those expected under the Poisson or negative 
binomial distribution (sampling zeros), and those considered a ‘true’ zero (structural 
zeros) (Hu et al., 2011). If the probability of a structural zero is 𝜔, and 𝐸𝑔(𝑂) 
represents the mean of the parent distribution, then the probability function of a zero-
inflated model is: 
Pr(𝑂) = {
 𝜔 + (1 − 𝜔)𝐸𝑔(𝑂)   if 𝑂 = 0
(1 − 𝜔)𝐸𝑔(𝑂)             if 𝑂 > 0
  
Hurdle models, in contrast, consider all zeros to be structural zeros, and model 
positive counts under a truncated distribution (Hu et al., 2011). 
 
Although extremely sparse cancer data was apparently successfully modelled in 
Spain using the standard BYM model (Lopez-Abente et al., 2005; Lope et al., 2006; 
Prieto et al., 2007), there can be advantages in using an alternate distribution to the 
Poisson. Potential options already used within the spatial Bayesian hierarchical 
context include the zero-inflated Poisson for brain cancer mortality in Spain (Ugarte 
et al., 2006; Gómez-Rubio and López-Quílez, 2010). 
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More complex models have been proposed to overcome the perceived limitations of 
the BYM in detecting sudden localised changes. Modifications have included 
alternate prior specifications (Besag et al., 1995; Best et al., 1999), or semi-
parametric versions of the model (Gangnon and Clayton, 2003; Bilancia and 
Fedespina, 2009). These models make fewer distributional assumptions and allow for 
disparate risks in neighbouring areas (Best et al., 2005). The relative risks can be 
separated into multiple components via mixture models, enabling different 
behaviours in the spatial correlation (Lawson and Clark, 2002; Prieto et al., 2007).  
 
Similarly, hidden Markov models (which can be considered a generalization of a 
mixture model) have been extended so each area is allocated to a risk category 
following a spatially correlated process (Green and Richardson, 2002; Best et al., 
2005). This was  applied to larynx cancer mortality in France, and found to avoid 
oversmoothing discontinuities in underlying rates, while giving equally good results 
for highly autocorrelated rates (Green and Richardson, 2002). Nonetheless, it 
remains difficult to determine when oversmoothing is occurring and if so, to what 
extent.  
 
An alternative to incorporating dependence hierarchically, is to incorporate it 
directly, as in the ‘automodel’ (Besag, 1974; Kaiser and Cressie, 1997, 2000). This 
Markov random field model has several theoretical and practical disadvantages, 
including computational difficulties, lack of parsimony in the residuals, and even 
conceptual and interpretational challenges when uncentred  (Hughes and Haran, 
2013). Sparse versions have recently been developed which aim to overcome some 
of these issues (Hughes and Haran, 2013; Nelson et al., 2014). 
 
2.4.2 Modelling risk factors 
 
Commonly, risk factors are incorporated as covariates in spatial models. However, 
when data on risk factors are unavailable or unreliable, or when extensive 
interactions between covariates are likely, alternate methods may be preferred. 
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2.4.2.1  No risk factor data available 
 
Factor analysis can be used to summarise multivariate data variance and covariance 
patterns into a smaller set of latent variables (Hogan and Tchernis, 2004; Mezzetti, 
2012). These latent variables are called common factors and hypothesised to account 
for intercorrelations between the observed variables (Tzala and Best, 2008). Because 
this approach is hierarchical, a Bayesian approach is natural (Hogan and Tchernis, 
2004). Despite this, Bayesian factor models incorporating spatial correlation are a 
comparatively recent development (Rowe, 2003; Wang and Wall, 2003; Hogan and 
Tchernis, 2004; Tzala and Best, 2008; Mezzetti, 2012).  
 
A shared component model can be considered a latent factor model with just one 
component (Tzala and Best, 2008). By including diseases with common aetiology in 
the joint analysis, the shared component is often considered to reflect common risk 
factors, and can be regarded as a weighted average of spatial random effects from 
individual models (Dabney and Wakefield, 2005).  
 
Oesophageal and oral cavity cancer mortality were jointly analysed in a  shared 
component model (Knorr-Held and Best, 2001). Three spatial components were 
included: one shared and one specific to each of the two diseases. To enable 
identification under this symmetric formulation, different spatial structure was 
required between the shared and specific components (Knorr-Held and Best, 2001).  
 
An alternative is to decompose into just two spatial components: one shared and one 
specific, and use an asymmetric formulation. This was used in jointly analysing 
bladder and lung cancer incidence (Dabney and Wakefield, 2005), and further 
expanded to oral, oesophageal, larynx and lung cancer mortality in Germany (Held et 
al., 2005). Spatio-temporal shared component models were also developed, and 
applied to male and female lung cancer as two separate diseases in the UK 
(Richardson et al., 2004).  
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Advantages of these models include their flexibility and ability to obtain risk 
estimates in each area for the shared component as well as disease-specific 
components (Best et al., 2005). 
 
2.4.2.2  Extensive interactions 
 
Nonparametric recursive partitioning approaches have become a popular approach 
when classical multivariable regression is not suitable, such as when the number of 
predictors is higher than the number of observations, or if there are higher order 
interactions (Strobl et al., 2009). Recursive partitioning sequentially separates the 
data into smaller parts. 
 
Although the first regression tree algorithm was introduced in 1963 (Morgan and 
Sonquist, 1963), concerns were raised about overfitting (Einhorn, 1972) and the 
masking of highly correlated variables (Doyle, 1973). It was only after Classification 
and Regression Tree (CART) analysis (Breiman et al., 1984) was introduced that 
recursive partitioning models gained traction in the statistical community (Loh, 
2014). 
 
The original CART analysis is able to categorise either categorical or continuous 
data. The data are split into binary groups, with the process repeated for each 
subgroup (Figure 2.2). A greedy algorithm is used, which selects the locally optimal 
choice at each stage (Cormen et al., 2009). For instance, splits can be determined for 
a classification tree based on maximal impurity reduction (Therneau and Atkinson, 
2011): 
∆𝐼 = 𝑝(𝐴)𝐼(𝐴) − 𝑝(𝐴𝐿)𝐼(𝐴𝐿) − 𝑝(𝐴𝑅)𝐼(𝐴𝑅) 
where 𝑝(𝐴) is the probability of some node of the tree (A) for future observations, 
𝐴𝐿 and 𝐴𝑅 represents left and right nodes, respectively, and the impurity of node A, 
𝐼(𝐴) = ∑ 𝑓(𝑝𝑧𝐴)
𝑍
𝑧=1
 
where 𝑝𝑧𝐴 is the future sample proportion of those in A that belong to class z (1,…Z 
classes), and common options for 𝑓(𝑝) include the information, or entropy, criterion 
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(−𝑝log(𝑝)) or the Gini index (𝑝(1 − 𝑝)). The Gini prefers to split the largest class 
into a separate category from the others, while the information index aims to balance 
the sample sizes at the terminal nodes (Breiman, 1996). When there are few classes, 
similar results are likely under either criteria (Breiman, 1996).  
 
Figure 2.2 Classification and Regression Tree (CART) structure  
 
 
 
Although the prior probability of each class can be specified (instead of using the 
default based on data proportions), this tree generation method is quite ad-hoc, and 
subsequent modifications remained largely deterministic (Loh, 2014).  
 
Trees are generally allowed to grow to saturation, so a pruning step is recommended 
for classification trees. The aim is to minimize the complexity parameter 𝜔, which 
represents the cost of including an additional variable. The cost for the tree, 𝑅𝜔(𝑇), 
is the sum of the risk of misclassification in the tree, 𝑅(𝑇), and the complexity 
parameter multiplied by the number of terminal nodes, 𝜔|𝑇|. The choice of the best 
pruned subtree may be determined by either using an independent test sample 
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(recommended for large datasets) or cross-validation (recommended for smaller 
datasets) (Izenman, 2008).  
 
Cross-validation involves dividing the data into disjoint subsamples (commonly 5 or 
10) of approximately equal size and re-running the analysis with these excluded 
(Izenman, 2008). The pruned tree with minimum cost is the preferred choice under 
the minimum cross validation criterion. In practice, often similar risk values are 
obtained among several models (Therneau and Atkinson, 2011). As both an estimate 
of the risk and its standard error is obtained in cross-validation, the simplest model 
within one standard error of the minimum can be selected instead of the minimum 
(the one standard-error approach).  
 
Bayesian tree formulations have been proposed, ranging from using similar greedy 
algorithms through to ensemble methods where several trees are generated (Wu et 
al., 2007). This remains an area of active research, with identified limitations 
including the intense computational processing required (Pratola et al., 2014). 
 
The advantages of standard classification and regression trees include ease of 
interpretation, predictive accuracy, and computational speed and simplicity (Loh, 
2014). These models are designed to segment populations into meaningful subsets 
(Speybroeck, 2012). Although interactions between variables are captured (Elith et 
al., 2008), no information is provided on whether these represent ‘true’ interaction 
effects, or are merely influencing the response. Other limitations include biases in the 
splitting and selection of surrogate variables when missing values are present (Kim 
and Loh, 2001). Also, linear regression is likely to outperform CART if there is a 
strong linear relationship between predictors and the outcome (De'ath and Fabricius, 
2000). 
 
2.4.3 Bayesian spatio-temporal models 
 
Spatio-temporal models, where space and time components are simultaneously 
modelled, have many benefits in interpretation of overall patterns of risk and 
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dynamics, as well as improved accuracy compared with purely spatial models 
(Marshall, 1991; Christakos and Lai, 1997; Abellan et al., 2008).  
 
Unsurprisingly, much of the earliest work extended the BYM model to the spatio-
temporal context. The CAR prior structure can define neighbourhood structures 
across space and time, so that a region’s neighbour set includes not just spatial 
neighbours but also its own value in the previous and following time periods (Carlin 
and Xia, 1999a). For instance, one of the earliest versions was the Bernardinelli 
space-time model (Bernardinelli et al., 1995), which  can be specified as follows:  
 
Oit ~ Poisson(Eitθit) 
log (𝜃𝑖𝑡) = 𝛼 + 𝑢𝑖  +  𝛽𝑡 + 𝛿𝑖𝑡  
 
where Oit are the observed cases for i=1,…,I areas and t=1,…,T time intervals, Eit are 
the expected number of cases, θit are the underlying relative risks, α is the mean log-
rate over all areas, 𝑢𝑖 represents the area effect and follows an intrinsic CAR 
distribution, 𝛽𝑡 is the mean linear time trend over all areas and 𝛿𝑖𝑡 represents the 
difference between the area-specific trend and the mean trend 𝛽𝑡 (Bernardinelli et al., 
1995). In this model, the intercept is the sum of 𝛼 + 𝑢𝑖, while the trend is the sum of 
𝛽𝑡 + 𝛿𝑖(𝑡) (Bernardinelli et al., 1995). The prior for 𝛿𝑖𝑡 was a modified CAR 
distribution that allowed for correlation between the intercept and trend.   
 
The Bernardinelli space-time model (Bernardinelli et al., 1995) has been applied to 
diseases such as insulin-dependent diabetes mellitus (Songini et al., 1998), and 
leishmaniasis (Assuncao et al., 2001). Covariates have been included (Bernardinelli 
et al., 1997; Kim et al., 2002), and it has been used to evaluate the effect of therapy 
on non-Hodgkin lymphoma mortality in a region of Italy by incorporation of the 
distance between the region centroid and the hospital (Dreassi and Biggeri, 2003). 
Errors in the estimates of indirectly observed covariates (such as, for example, 
estimating cigarette smoking prevalence from survey data) have also been 
incorporated in some cases (Bernardinelli et al., 1997; Xia and Carlin, 1998). 
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However, a limitation of the Bernardinelli model was the restriction to linear trends 
over time (Bernardinelli et al., 1995). Assuncao et al. (2001) extended the model by 
placing conditionally independent CAR priors on the components of log-relative risk 
(Carlin and Banerjee, 2003), resulting in quadratic instead of linear time trends 
(Schmid and Held, 2004). In contrast, Waller et al. (1997) applied the BYM model to 
each time point separately. This allowed the spatial structure to evolve over time, but 
basically treated time as exchangeable (Waller et al., 1997; Knorr-Held, 2000). This 
may not be ideal for modelling cancer as it would be unlikely to have a separate 
spatial distribution within each time period (Sun et al., 2000).  
 
Spatio-temporal interaction effects have also been incorporated.  Sun et al. (2000) 
and Kim et al. (2001) included random spatial and spatio-temporal interaction effects 
when modelling cancer mortality in Missouri, but the temporal component was still 
restricted to a linear form (Kim and Oleson, 2008). Abellan (2008) included a space-
time interaction term in a BYM-type model to capture any departure from 
predictable patterns based on the overall time trend and the overall spatial risk 
surface. Further extensions allowed for random spatial, temporal and spatio-temporal 
interaction terms, and was used to examine prostate cancer incidence (Kim and 
Oleson, 2008). 
 
Mixture models have also been extended to a spatio-temporal formulation, which 
were applied to lung cancer incidence and mortality in Germany for 30 years 
(divided into 3 time periods) across 215 counties (Bohning et al., 2000). When data 
are particularly sparse, zero-inflated Poisson models incorporating spatio-temporal 
interactions have been used (Fahrmeir and Osuna, 2006; Musio et al., 2010; Vicens 
et al., 2014). For instance, lymphoid leukaemia incidence (377 municipalities, five 3-
year time periods during 1988-2002, nine age groups (0-45,45-50,…75-80,80+)) in 
north-east France was modelled this way, due to the large number of zeros (98% of 
cells)  (Musio et al., 2010). Even with this model there were still difficulties as there 
was not enough information to include age-sex interactions, despite their apparent 
significance in exploratory analyses (Musio et al., 2010). In contrast, although only 
55% of cells had a value of zero  when examining prostate cancer in a region of 
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Spain, as only 35% were expected under Poisson, a ZIP model was preferred (Vicens 
et al., 2014). 
 
Knorr-Held and Besag (1998) combined the BYM model with dynamic models. 
Dynamic models allow estimates to ‘borrow’ strength from adjacent timepoints, so 
do not assume linearity or stationarity, but instead enable non-parametric estimation 
of temporal trends (Knorr-Held and Besag, 1998; Knorr-Held, 2000). This means 
time-changing effects of covariates can be included (Knorr-Held and Besag, 1998). 
In principle this model allows for estimation of any age-period interaction, including 
cohort effects (Schmid and Held, 2004). This model was demonstrated on Ohio lung 
cancer mortality data, stratified by age, gender, race for each year (of 21 years) and 
each county (of 88 counties) (Knorr-Held and Besag, 1998).  This formulation was 
also used to investigate the lag-time between socioeconomic factors and lung cancer 
mortality in Italy (Dreassi et al., 2005). The original version did not include space-
time interactions, however further extensions did (Knorr-Held, 2000). 
 
Specific age-period-cohort (APC) Bayesian hierarchical spatio-temporal models have 
also been proposed as a method to jointly study the spatial pattern of disease risk and 
evolution in time (Lagazio et al., 2003). Generally these are again based on the BYM 
model, with extra time main effects defining age, period and cohort specific 
parameters, space-time interactions  as specified in Knorr-Held (2000), or cohort 
effects (Lagazio et al., 2003). It assumes the time effects vary smoothly over space 
(Lagazio et al., 2003).  These models have been applied to lung cancer in Tuscany 
(Lagazio et al., 2003), and stomach cancer in Germany (Schmid and Held, 2004). A 
broader version of this model was proposed which incorporated age-area and age-
time effects (Congdon, 2006b). However, the inclusion of cohort effects increases 
model complexity, and cohort effects in small areas may be tenuous, particularly if 
there are high rates of migration between areas which would dilute cohort by 
birthplace effects (Congdon, 2006b).  
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2.5 Cancer survival 
 
Survival measures the proportion of people expected to remain alive for x years after 
diagnosis, and often requires individual-level data. In contrast to disease incidence or 
mortality, survival can be used for detailed exploration of the impact of the 
healthcare system (Osnes and Aalen, 1999).   
 
Cancer survival can be measured in a variety of ways, including all-cause (overall) as 
opposed to net survival. Net survival can be measured via either cause-specific or 
relative survival. Information on the recorded cause of death is required for a cause-
specific analysis, whereas for relative survival, deaths due to any cause among 
cancer patients are compared against background population mortality rates.  
 
The Cox proportional hazards model is the most widely used survival model 
(Dunson and Herring, 2005; Omurlu et al., 2009).  This model is applied to either 
overall or cause-specific survival, and has no assumptions regarding the nature or 
shape of the underlying survival distribution. Correlation can be incorporated 
between areas by including random effects termed ‘frailties’ (Banerjee and Carlin, 
2003; Sauleau et al., 2007b).  However, it does assume a proportional 
(multiplicative) relationship between the hazard and the log-linear covariate function 
(Omurlu et al., 2009), and this assumption is often violated (Banerjee et al., 2007). 
 
When using population-based data, such as from a cancer registry, generally relative 
survival is the preferred method for measuring net survival, as no information on 
cause of death is required, so results do not depend on whether the death was 
considered directly or indirectly attributable to the cancer (Dickman et al., 2004). 
Relative survival is also better suited to comparisons between different populations, 
as there may be differences in the underlying mortality rates (Hennerfeind et al., 
2008a). However, relative survival does assume independence between mortality 
from other causes and the disease of interest, and this assumption may not always be 
met. Our focus will be on Bayesian methods that enable spatial relative survival 
analysis. 
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2.5.1 Bayesian spatial relative survival models 
 
Relative survival separates the deaths into two components: disease-related 
mortality, and natural mortality. The additive relative survival model related to 
competing risks has become the most popular (Buckley, 1984; Esteve et al., 1990; 
Dickman et al., 2004), where both components are summed together. This can be 
expressed as ℎ(𝑡) = ℎ∗(𝑡) + λ(𝑡), where ℎ(𝑡) is the overall hazard, ℎ∗(𝑡) is the 
expected hazard from population mortality rates, and λ(𝑡) is the excess hazard.                                                   
 
This form is considered more biologically plausible than a multiplicative version, as 
it does not assume the mortality attributable to the disease to be related to the 
mortality rates from all other causes (Buckley, 1984). When the hazards are 
transformed to the survival scale, relative survival 𝑅(𝑡) is a ratio of overall survival 
𝑆(𝑡) to expected survival 𝑆∗(𝑡), ie. 𝑅(𝑡) =
𝑆(𝑡)
𝑆∗(𝑡)
.                                                      
 
2.5.1.1  Poisson piecewise models 
 
There have been few relative survival models incorporating spatial components 
within a fully Bayesian framework. Fairley et al. (2008) expanded the additive 
hazard model recommended by Dickman et al. (2004) to incorporate spatial and 
unstructured random effect components similar to the BYM model, as follows:  
 
         𝑑𝑖𝑘𝑡 ~ Poisson(𝜇𝑖𝑘𝑡) 
 log(𝜇𝑖𝑘𝑡 − 𝑑𝑖𝑘𝑡
∗ ) = log(𝑦𝑖𝑘𝑡) + 𝛼𝑡 + x𝑖𝑘𝑡β𝑘 + 𝑢𝑖 + 𝑣𝑖 
 
where 𝑑𝑖𝑘𝑡 is the number of deaths from any cause in i=1,…I areas, k=1,…,K age 
groups and t=1,..,T follow up time intervals, 𝑦𝑖𝑘𝑡 is the person-time at risk, 𝑑𝑖𝑘𝑡
∗  is the 
expected number of deaths due to causes other than the cancer of interest, 𝛼𝑡 is the 
intercept (which varies by follow-up year), x is the predictor variable vector 
(although proportional excess hazards are assumed, interactions can be 
accommodated),  𝑢𝑖 is the spatial component assigned a CAR prior and 𝑣𝑖 is the 
unstructured component with a normal prior centred on 0. The term log(𝜇𝑖𝑘𝑡 − 𝑑𝑖𝑘𝑡
∗ ) 
is a non-standard link function representing the log excess deaths, or the deaths 
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considered to result from the disease of interest (Dickman et al., 2004). The model is 
piecewise as 𝛼𝑡 represents the baseline excess hazard, which is allowed to vary 
arbitrarily between time intervals but considered constant during a follow-up time 
interval. Follow-up intervals can be of any duration, but often annual intervals are 
used. 
 
Fairley et al. (2008) used this to explore variation in prostate cancer survival over a 
region in England. This spatial model was subsequently independently proposed by 
Saez et al. (2012) to examine breast cancer survival in Spain. 
 
Many of the advantages for this approach are similar to that of the Cox proportional 
hazards model (indeed, if using cause-specific or overall survival with time split at 
each event, the Poisson piecewise model equates to the Cox proportional hazard 
model (Royston and Lambert, 2011)), including no assumption of the baseline 
survival shape. However, the disjointed piecewise process assumes constant risk over 
each time interval, which is biologically implausible. Also, since the input data are 
aggregated over each covariate level, time interval and area, it is not possible to 
include continuous variables without the model becoming too cumbersome. 
 
2.5.1.2  Alternate Bayesian spatial relative survival models 
 
A similar Poisson piecewise model was combined with Bayesian geoadditive models 
so the baseline hazard was modelled using p-splines, and applied to small-area breast 
cancer data in France (Hennerfeind et al., 2008a). This flexible semiparametric 
model overcomes many of the limitations of the Poisson piecewise approach, but is 
computationally intensive. 
 
An alternative approach is to combine a parametric formulation with splines for 
flexibility in modelling the baseline hazard, producing flexible parametric survival 
models (Royston and Lambert, 2011). This has been applied to relative survival 
(Nelson et al., 2007), but not in a spatial context. 
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In contrast, cure models calculate the proportion of ‘cured’ and survival among the 
‘uncured’. They consider cancer patients to be ‘statistically cured’ once their 
mortality matches that of the population, and can be conducted within a relative 
survival framework (Andersson et al., 2011). Few Bayesian cure models have 
examined spatial variation, with just one using relative survival (Yu and Tiwari, 
2012), and a few using cause-specific cancer data (Cooner et al., 2006; Seppa et al., 
2010; Hurtado Rua, 2011). Further exploration of relative survival approaches to 
cure models could be a fruitful potential area of research, but fell outside the scope of 
this project.   
 
2.5.1.3  Other Bayesian spatial survival models 
 
Some Bayesian spatial cancer survival analyses have preferred to use either overall 
or cause-specific survival analyses, and have based their models on variants of the 
Cox proportional hazards model (Henderson et al., 2002), or parametric models such 
as accelerated failure-time models (Zhang and Lawson, 2011; Wang et al., 2012; Li 
et al., 2014). Survival for multiple cancers has also been jointly modelled with 
spatial frailties (Diva et al., 2008). However, these either assume accurate cause of 
death data (if a cause-specific analysis), which is a key disadvantage for population-
based cancer data, while overall survival analyses may have confounding from 
unrelated differences in mortality between areas.  
  
2.5.2 Modelling risk factors 
 
Survival is likely to be influenced by individual specific factors (gender, ethnicity, 
type of cancer, age, disease stage) as well as environmental factors (access to 
healthcare facilities, treatment obtained etc.) (Sauleau et al., 2007b; Diva et al., 
2008). Although individual factors are typically collected by cancer registries, often 
environmental factors are not, however, spatial models can be used to approximate 
the shared effects (Sauleau et al., 2007b).   
 
Commonly prognostic covariates are included in the regression model (Fairley et al., 
2008). These often assume proportional hazards, unless interactions are included. 
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However, covariates may interact with spatial effects, so a recent suggestion was to 
apply a spatially structured discrete distribution to allow for potential discrete 
clustering of coefficients (Lawson et al., 2014). This was applied within a Bayesian 
formulation to overall survival for prostate cancer in Louisiana, and evidence of 
discrete spatial groupings was found, although only two groups were allowed. 
Although this model provided a better fit than a standard Bayesian accelerated failure 
time model, further assessment of the importance of flexibility in the number of 
groups selected, and whether this should vary by covariates, is desired (Lawson et 
al., 2014).   
 
2.5.3 Quantifying premature deaths 
 
One method to quantify the impact of spatial variation in survival is to calculate the 
number of premature deaths, or lives that might have been extended, had survival 
been consistently high across all geographical areas. 
 
The calculation can be divided into three stages (Dickman et al., 1997). First, 
survival is estimated for each area using a relative survival model adjusted for 
relevant predictors. Then the amount of systematic variation in relative survival is 
estimated. Finally, the number of deaths that would not have occurred within the 
designated timeframe if this systematic variation was eliminated is estimated. 
 
An early attempt focused on cancer deaths up to 10 years after diagnosis (15 years 
for breast cancer), was non-Bayesian and used comparatively large regions, dividing 
Nordic countries into administrative districts with the average population in each 
region over 225,000 people (Dickman et al., 1997). However, they found no 
evidence of regional variation in follow-up intervals for 6 years and beyond. 
 
Another attempt used empirical Bayes (Casella, 1985) methods to determine the 
number of people who were unlikely to die within 5 years of diagnosis if survival in 
each area matched the top quintile (Yu et al., 2004). This still used comparatively 
large administrative regions, but there was greater variation in population size, with 
rural regions having populations between 50,000 and 250,000, while in urban regions 
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populations ranged from 270,000 to 750,000 (Yu et al., 2004). Therefore the 
empirical Bayes approach was used to stabilise the estimates for each region by 
shrinking them towards the global mean.   
 
More recently a non-Bayesian approach focused on quantifying the uncertainty of 
these estimates to obtain confidence intervals (Seppä et al., 2012).  
 
No fully Bayesian approaches have been developed, which would enable estimates to 
be obtained for smaller regions and also inform uncertainty measures through 
posterior distributions. 
 
2.5.4 Bayesian spatio-temporal survival models 
 
As for incidence data, often it is of interest to explore differences in survival across 
time and region. Although relative survival is the preferred approach for population-
based cancer data, it appears that no spatio-temporal relative survival models have 
been proposed. The only relative survival studies examining temporal and regional 
changes used large regions in Canada via a (non-Bayesian) flexible parametric 
relative survival model for cervical (Akhtar-Danesh et al., 2012)  and ovarian cancer 
(Akhtar-Danesh et al., 2011). This model would not be appropriate for small regions 
as there was no smoothing between areas, so estimates would be unreliable. 
 
However, several spatio-temporal models have been developed for cause-specific 
survival, and applied to breast cancer. This includes a spatio-temporal Cox Bayesian 
frailty model (Banerjee and Carlin, 2003). In this study, the spatial correlation term 
was given a CAR prior, as geostatistical (kriging) models were avoided due to data 
limitations and computational complexity issues (Banerjee and Carlin, 2003; Carlin 
and Banerjee, 2003). Breast cancer in Iowa was also modelled allowing for potential 
correlation between different random effects within a region, by the use of the 
multivariate CAR prior (MCAR) (Jin and Carlin, 2005). Sauleau et al. (2007b) 
extended the continuous time geoadditive survival model by Hennerfeind et al. 
(2006) to an APC model and demonstrated it on breast cancer survival in a region of 
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France. The spatial component was modelled under the CAR prior, while age, period 
and cohort variables used Bayesian P-splines (Lang and Brezger, 2004; Sauleau et 
al., 2007b). 
 
2.6 Conclusion 
 
Bayesian hierarchical modelling has become a widely used approach for disease 
mapping. Bayesian hierarchical models are well-equipped to handle the challenges of 
modelling data in time and space, including data sparsity, complex clusters or 
patterns in disease rates or exposures and high irregularity (Christakos and Lai, 1997; 
Knorr-Held and Besag, 1998; Abellan et al., 2008).  
 
In this rapidly advancing field there remain many unexplored or underdeveloped 
methods. This project seeks to address several significant gaps through: 1) Further 
developing and refining spatial and spatio-temporal Bayesian hierarchical models 
appropriate for cancer incidence to allow application in contexts similar to 
Queensland, with its extreme data sparseness; 2) Greater development of appropriate 
models to examine and quantify spatial variation in relative survival, moving beyond 
the disadvantages associated with piecewise Poisson; and 3) Introduction of spatio-
temporal relative survival models.  
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CHAPTER 3 
 
Developing the Atlas of Cancer in Queensland: 
Methodological issues  
 
Preamble 
 
Disease maps can be an effective means of conveying large amounts of information 
concisely in a visually appealing manner. The rapid explosion of statistical analyses 
and data visualisation methods has greatly increased the available options for disease 
maps, but largely focused on incidence and mortality, rather than survival. 
 
The foundation of this thesis was to determine the types of cancer with spatial 
inequalities. This chapter addresses the first objective of documenting cancers with 
evidence of spatial inequalities in incidence and/or survival, by outlining the 
rationale behind decisions made in producing the Atlas of Cancer in Queensland 
report, available at:  www.cancerqld.org.au/cancer_atlas/. This was the first cancer 
atlas to include relative survival maps. 
 
This chapter was written as a journal article for which I am the principal author, and 
is reprinted here in its entirety. I was responsible for the statistical analysis, writing 
and modifying the manuscript, and also contributed to the study design. 
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3.1 Abstract 
 
Background 
Achieving health equity has been identified as a major challenge, both internationally 
and within Australia. Inequalities in cancer outcomes are well documented, and must 
be quantified before they can be addressed. One method of portraying geographical 
variation in data uses maps. Recently we have produced thematic maps showing the 
geographical variation in cancer incidence and survival across Queensland, Australia. 
This article documents the decisions and rationale used in producing these maps, 
with the aim to assist others in producing chronic disease atlases.  
 
Methods 
Bayesian hierarchical models were used to produce the estimates. Justification for 
the cancers chosen, geographical areas used, modelling method, outcome measures 
mapped, production of the adjacency matrix, assessment of convergence, sensitivity 
analyses performed and determination of significant geographical variation is 
provided. 
 
Conclusions 
Although careful consideration of many issues is required, chronic disease atlases are 
a useful tool for assessing and quantifying geographical inequalities. In addition they 
help focus research efforts to investigate why the observed inequalities exist, which 
in turn inform advocacy, policy, support and education programs designed to reduce 
these inequalities. 
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3.2 Background  
 
Since the 1978 declaration of Alma-Ata which highlighted the need to address 
inequalities in health status (World Health Organization, 1978), there have been 
important advancements for cancer outcomes. Many developed nations have seen 
improvements in cancer survival, notably for colorectal cancer, breast cancer, 
prostate cancer, non-Hodgkin lymphoma and leukaemia (Coleman et al., 2003; 
Gondos et al., 2007). Also, incidence and mortality rates for some cancers have 
declined (National Cancer Institute, 2010). However, notable inequalities in these 
outcomes persist, with numerous international studies reporting disparities in cancer 
outcomes across socioeconomic status or urban/rural categories (Wilkinson and 
Cameron, 2004; Woods et al., 2006; Ernst et al., 2010).  
 
Within Australia, one of the greatest recognised health challenges is achieving health 
equity for all (Armstrong et al., 2007). Cancer patients living in rural and 
disadvantaged areas are generally more likely to be diagnosed with advanced cancer 
and have poorer survival outcomes (Jong et al., 2004; Australian Institute of Health 
and Welfare and Cancer Australia & Australasian Association of Cancer Registries, 
2008). Often these areas have a higher prevalence of risk factors such as smoking, 
obesity and lower levels of physical activity (Australian Institute of Health and 
Welfare, 2008, 2010c). Distance is also important, with cancer patients in rural areas 
having reduced access to cancer care services (Kricker et al., 2001; Armstrong et al., 
2004; Coory and Baade, 2005).   
 
Inequalities need to be quantified before they can be addressed. Maps have been used 
to portray geographical data for a range of diseases since the mid-1800s, including 
cancer (Pickle, 2009). By providing a visual representation of cancer outcomes, 
geographic patterns of disease are able to be identified and effectively addressed 
(Lawson, 2008). For example, cancer mortality maps showed high mortality from 
oral cancer in south-eastern United States of America which led to the identification 
of snuff dipping as a risk factor (Mason et al., 1975). Similarly, mammography 
screening efforts were intensified after finding low in-situ breast cancer incidence 
rates from mapped data in north-eastern Connecticut (Kulldorff et al., 2006).  
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We  recently developed thematic maps showing the geographical variation in cancer 
incidence and survival across Queensland, Australia (Cramb et al., 2011a). With a 
population of  4.2 million (Australian Bureau of Statistics, 2008d) and covering an 
area of 1.9 million square kilometres, Queensland has the country’s most 
decentralized population (Australian Bureau of Statistics, 2003) and the highest 
incidence of cancer (Australian Institute of Health and Welfare & Australasian 
Association of Cancer Registries, 2008). As there is increasing interest in producing 
disease maps (Boulos, 2004; Jacquez, 2004; Bell et al., 2006; DeChello and Sheehan, 
2007; Bhowmick et al., 2008; Bilancia and Fedespina, 2009; Henry et al., 2009), it is 
hoped that by documenting the processes and rationale behind the many decisions 
made during the development of this Cancer Atlas, it may assist others seeking to 
produce similar types of chronic disease atlases. 
 
3.3 Methods  
 
Ethical approval to conduct this study was obtained from the Queensland Health – 
Central Office Committee Human Research Ethics Committee (HREC/09/QHC/25). 
Approval to extract the data was obtained from the Chief Executive Officer – Centre 
for Health Care Improvement, Queensland Health, under delegation by the Director-
General, Queensland Health. 
 
3.3.1 Data sources 
 
The Queensland Cancer Registry (QCR) supplied de-identified data on all primary 
invasive cancers diagnosed among Queensland residents during 1996 to 2007. The 
QCR is a population-based cancer registry that maintains a record of all cases of 
cancer diagnosed in Queensland since 1982, with data currently available to the end 
of 2007 (Queensland Cancer Registry, 2013b). Survival status of all cancer patients 
is obtained through routine linkage with the (Australian) National Death Index, 
enabling deaths of cancer patients who die interstate to be identified. Across all 
cancers, 91% of cancers registered by the Queensland Cancer Registry in 2007 were 
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histologically verified and 1.9% were registered based on death certificate only 
(DCO) (Queensland Cancer Registry, 2013b). Cases with unknown age group 
(0.001% of all cancers) were excluded from the analyses. 
 
Estimated resident population data grouped by age group (0-4, 5-9…, 80-84, 85+), 
sex, year and statistical local area (SLA) were obtained from the Australian Bureau 
of Statistics. To calculate the expected population mortality estimates, de-identified 
unit record mortality data for all causes of death for Queensland residents were also 
obtained from the Australian Bureau of Statistics (ABS) (Australian Bureau of 
Statistics, 2009b).   
 
3.3.2 Choice of cancers 
 
The Cancer Atlas described spatial variation in the leading cancers diagnosed in 
Queensland during the study period (Table 3.1). These included the (Australian) 
National Health Priority Area cancers of colorectal cancer, lung cancer, breast 
cancer, cervical cancer, prostate cancer and non-Hodgkin’s lymphoma. Although a 
national priority cancer, variation in non-melanocytic skin cancer was not assessed, 
since it is not routinely reported by population-based cancer registries in Australia. 
When a cancer was not gender specific, results were calculated for each gender. The 
only exception to this was breast cancer which was reported for females only due to 
the very small number of breast cancers diagnosed among males. 
 
3.3.3 Geographical areas 
 
SLAs were used to define the geographical areas. These are part of the Australian 
Standard Geographic Classification (ASGC) used by the ABS (Australian Bureau of 
Statistics, 2006a) and are often based on the incorporated bodies of local 
governments who are responsible for service provision and infrastructure at the local 
and regional level.   
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Table 3.1 Cancers examined for geographic variation, Queensland, 1998-2007 
Type of cancer ICD-O3 code Total number 
males diagnosed 
Total number 
females diagnosed 
All invasive cancers   C00-C80 (excluding C44 
(M805 to 811)) 
105,053 82,470 
Bladder cancer   C67 5,034 1,571 
Brain cancer   C70, C71, C72 1,504 1,067 
Breast cancer   C50 Not included 22,420 
Cervical cancer   C53 Not applicable 1,639 
Colorectal cancer   C18-C20 and C218 13,405 10,871 
Kidney cancer   C64-C66 and C68 3,117 1,883 
Leukaemia   M980-M994 3,084 2,094 
Lung cancer   C33-C34 11,152 5,683 
Melanoma   C44 and  M872-M879 13,793 10,110 
Myeloma   M973 1,192 913 
Non-Hodgkin lymphoma   M959, M967-M971 3,547 2,889 
Oesophageal cancer   C15 1,464 639 
Ovarian cancer   C56 Not applicable 2,120 
Pancreatic cancer   C25 1,940 1,706 
Prostate cancer   C61 25,222 Not applicable 
Stomach cancer   C16 2,193 1,070 
Thyroid cancer   C73 765 2,221 
Uterine cancer   C54  Not applicable  3,112 
 
The ABS adjusts the geographical boundaries of SLAs according to changes in the 
population composition over time. To ensure statistical analyses referred to the same 
geographical area for the entire study period, all SLAs were mapped to the 
boundaries used for the 2006 ASGC.  The mapping process was conducted within 
the Queensland Cancer Registry, and matched the suburb and postcode at diagnosis 
to the 2006 National Localities Index (Australian Bureau of Statistics, 2007a). There 
were 478 SLAs in Queensland in 2006 (Australian Bureau of Statistics, 2006a).  
 
Estimates of incidence and survival were also examined by area-level socioeconomic 
status and rurality. Socioeconomic status was defined using the Socioeconomic 
Indexes for Areas (SEIFA) Index of Relative Socioeconomic Advantage and 
Disadvantage (IRSAD) compiled by the ABS (Australian Bureau of Statistics, 
2008b). Queensland SLAs were ranked from the most disadvantaged to the most 
advantaged and then divided into quintiles, based on a variety of data items such as 
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the percentages of: people with high income, people unemployed, households paying 
cheap rental, households with no car and households with broadband internet 
connection. Rurality was defined using the ARIA+ (Accessibility/Remoteness Index 
for Australia plus) classification (Glover and Tennant, 2003), which defines 
remoteness on the basis of five categories: major city, inner regional, outer regional, 
remote and very remote. ‘Remote’ and ‘very remote’ categories were combined 
together. The level of remoteness is determined by average road-based distance to 
services. 
 
3.3.4 Methods to generate estimates 
 
To produce a useful map on a small-area scale it is important to have estimates that 
are robust, or relatively insensitive to outliers, across small areas. If estimates are not 
robust, these outliers from areas which are often based on very small populations, are 
more likely to be disproportionately influential, and thus compromise the overall 
interpretation of the map. 
 
Modelling or smoothing methods are commonly used to generate robust estimates for 
small geographical areas. As traditional regression models are unable to incorporate 
spatial correlation, approaches which enable hierarchical structure to be incorporated 
such as generalised linear mixed models may be used. These may be calculated using 
either Bayesian, multi-level, or likelihood-based models, however, Bayesian methods 
do not require the restrictive distributional assumptions in the other models (such as, 
for example, Gaussian random effects) (Waller and Gotway, 2004).  Smoothing 
methods often require no distributional assumptions and include interpolation 
methods, or non-parametric such as kernel regression, kriging and partition methods 
(Lawson et al., 2003; Goovaerts, 2006).   They are generally easier and faster to 
perform than modelling, but a comparison of various modelling and smoothing 
methods suggested Bayesian models performed better than the smoothing methods 
(Lawson et al., 2000).  
 
Bayesian models incorporate empirical Bayes and fully Bayes methods. In both types 
of Bayesian models, parameters are assigned probability distributions, usually based 
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on plausible or expected values, and termed ‘priors’. Fully Bayesian methods may 
assign second stage priors to the variance controlling this distribution 
(‘hyperparameters’). In contrast, empirical Bayes methods estimate the 
hyperparameter from the distribution of the data (Ghosh et al., 1999). Therefore, 
empirical Bayes methods give satisfactory point estimates, but are unlikely to 
provide accurate estimates of the associated uncertainty (Bernardinelli and 
Montomoli, 1992).  
 
Fully Bayesian models are becoming increasingly common in disease mapping (Best 
et al., 2005).  Advantages of Bayesian models in comparison to other methods 
include the ease of drawing strength from neighbouring regions so estimates are 
more reliable and robust, as well as providing better quantification of the uncertainty 
surrounding the calculated estimates (Ghosh et al., 1999; Wakefield, 2007). Also, 
Bayesian methods enable structuring of more complicated models, inferences and 
analyses (Shen and Louis, 2000). Other cancer atlases which have used fully 
Bayesian methods include NSW (Australia) (Bois et al., 2007) and Limburg 
(Belgium) (Buntinx et al., 2003) (Table 3.2). 
 
3.3.5 Outcome measures – what to map? 
 
Incidence estimates 
Incidence is defined as the number of new invasive cancer cases diagnosed within a 
given time period. When examining incidence in small areas, the traditionally used 
estimate is the SIR (indirectly Standardised Incidence Ratio). The SIR is an estimate 
of relative risk within each area which compares the observed counts against an 
expected number of counts, based on the population size.  
 
However, limitations associated with the SIR estimates have been previously noted 
(Lawson et al., 2003). For example, large differences can be observed in the SIR 
estimates even with relatively small changes in incidence counts, and areas with no 
cases automatically receive an SIR of zero, regardless of the expected counts 
(Lawson et al., 2000). 
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Table 3.2 Selected Cancer Atlases published from 1995 onwards 
Region Time period Outcome 
Statistic 
mapped Smoothing method 
N 
regionsa 
N cancers 
mappedb 
Presentation 
methodc 
Canada 1986-1990 Incidence CIF None 290 
17  
(M,F or P) Ecumene 
Europe ~1981-1990 
Incidence 
Mortality DSR 
Floating average of 
neighbouring rates for 
non-cities 
Not 
stated 31 (M,F) Isopleth 
India 2001-2002 Incidence DSR None 593 1 (M,F) Areal 
Limburg 
(Belgium) 1996-1998 Incidence SIR 
Poisson-Gamma and 
CAR Bayesian models 44 5 (M,F) Areal 
Netherlands  1989–2003 Incidence DSR 
Floating average of 
neighbouring rates for 
non-cities 458 11 (M,F) Isopleth 
New York 
(USA) Not stated Incidence DSR None 62 12 (M,F) Areal 
New South 
Wales 
(Australia) 1998-2002 
Incidence 
Mortality 
SIR, 
SMR CAR Bayesian model 192 
22 - inc 
(M,F) 
12 -mort 
(M,F) Areal 
Pennsylvania 
(USA) 1994-2002 Incidence DSR None 67 2 (M,F,P) Areal 
Queensland 
(Australia) 1998-2007 
Incidence 
Survival 
SIR, 
RER 
Bayesian hierarchical 
models: BYM and 
relative survival 478 19 (M,F) Areal 
South 
Australia 
(Australia) 1991-2000 
Incidence 
Mortality DSR None 117 11 (P) Ecumene 
Spain 1987-1995 Mortality SIR 
Non-parametric 
empirical Bayes 
estimation method 2218 
4 (M,F) 
out of 14 
maps Areal 
Sweden 1971-1989 Incidence 
DSR, 
CIF None 286 37 (M,F) Areal 
UK 2003-2005 
Incidence 
Survival  
Mortality 
DSR , 
RS None 350 17 (M,F,P) Areal 
UK/Ireland 1991-2000 
Incidence 
Mortality 
CIF or 
CMF None 127 21 (M,F) Areal 
USA 1950-1994 Mortality 
DSR, 
CIF None 3055 41 (M,F) Areal 
Sources: Canada (Le et al., 1995), Europe (Pukkala et al., 2001), India (Nandakumar et al., 2004), Limburg 
(Buntinx et al., 2000), Netherlands (Netherlands Cancer Registry), New York (New York State Department of 
Health), New South Wales (Bois et al., 2007), Pennsylvania (Lengerich et al.), Queensland (Cramb et al., 2011a), 
South Australia (SA Department of Health, 2005), Spain (Benach et al., 2001), Sweden (Swedish Oncological 
Centres, 1995), UK (UK Association of Cancer Registries et al.), UK/Ireland (Quinn et al., 2005), USA (Devesa 
et al., 1999) 
 
Notes: 
a. When multiple areas are available, as for some of the online Atlases, the number of regions is the 
number at the most detailed level. 
b. M=males, F=females and P=persons. 
c. Ecumene means only populated areas were coloured, Areal indicates that each individual region was 
coloured, and Isopleth means a continuous gradient was used. 
 
BYM=Besag, York and Mollié; CAR=Conditional AutoRegressive; CIF/CMF=Comparative Incidence/Mortality 
Figure, and is the ratio of the DSR of the area to the DSR of the entire region or country; DSR=Directly age 
Standardised Rates; RER = Relative Excess Risk of death; RS = Relative Survival; SIR/SMR = indirectly 
Standardised Incidence/Mortality Ratio 
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Modelling the SIR via spatial or Bayesian methods overcomes many of these 
problems by producing more reliable and robust estimates. Although there are many 
advantages to using a modelled SIR, they reflect the comparison of SLA-specific 
estimates against the Queensland average and not comparisons between SLA-
specific estimates themselves. The latter interpretation may be biased if the SLAs 
have different population age structures and the outcome measure varies by age. For 
this reason the maps must be interpreted in terms of which areas are higher or lower 
than the Queensland average  (Semenciw et al., 2000). Alternative measures, such as 
the Comparative Incidence Figure (CIF, which is the ratio of the local to national (or 
whole region) directly standardized rates, i.e. rates weighted by age groups using an 
external population), have been proposed to overcome this issue, but these have their 
own disadvantages, including larger standard errors (Breslow and Day, 1987). In 
light of these evaluations, the modelled SIR was adopted. 
 
Survival estimates 
Typically, cancer atlases have tended to report variations in cancer mortality, rather 
than cancer survival (Table 3.2). However spatial variations in cancer mortality 
reflect differences according to where people die, which may not be where they 
resided when diagnosed or treated. Mortality data are also prone to bias from death 
certificate inaccuracies in cause of death classification (German et al., 2011). In 
contrast, mapping cancer survival, which is the percentage of patients who survive 
for a given time after diagnosis, estimates the variation in outcomes based on where 
people lived when diagnosed. Since treatment generally occurs shortly following 
diagnosis, this better reflects the potential impact of barriers to treatment and support 
services.  
 
Survival after the diagnosis of cancer is the most important single measure for 
monitoring and evaluating the early diagnosis and treatment components of cancer 
control (Dickman and Hakulinen, 2014). When examining cancer survival using 
population-based data, relative survival is often the preferred method as it provides 
an estimate of the net cancer survival without errors from cause of death 
misclassification, including difficulties in assigning cause of death when cancer was 
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a contributing cause, but may not be completely responsible for the death (Dickman 
et al., 2004; Sarfati et al., 2010).   
 
Relative survival aims to measure deaths in excess of what would be expected, that 
is, the proportion of cancer patients alive x years after diagnosis in the hypothetical 
situation where the cancer in question is the only possible cause of death. Relative 
survival is modelled via an excess mortality model, which contrasts the mortality in 
the general population with the mortality of cancer patients. The difference is 
assumed to be due to cancer-related deaths (‘excess mortality’). This model 
generates the excess hazard, also called relative excess risk (RER).  
 
The median smoothed RER (i.e. exponential of the sum of the spatial and random 
heterogeneity components) was mapped. Note that only the sum of these components 
is identifiable. Similar to the interpretation of the SIR, the RER is a comparison 
against the State average, and comparison between individual small-areas is not 
recommended.  
 
3.3.6 Bayesian hierarchical models 
 
Incidence 
For incidence models the Besag, York and Mollié (BYM) model was used, as it has 
been shown to have desirable properties for disease mapping (Best et al., 2005). This 
model is specified as: 
yi ~ Poisson(eiθi) 
log(θi) = α + ui + vi 
where ei is the expected number of cases for the ith SLA, θi is the standardised 
incidence ratio, α is the overall level of relative risk, ui is the spatial component 
modelled with the conditional autoregressive (CAR) prior, and vi  is the unstructured 
random effects (which has a normal distribution centred around zero). Input data 
were aggregated over 1998 to 2007. Since incidence is likely to differ by gender, 
estimates for males and females were generated separately. Age differences between 
areas were accounted for in the calculation of expected counts. 
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Since this is a fully Bayesian model, priors were specified for α, ui and vi. The prior 
for α was given a vague normal distribution with mean 0 and variance of 1.0 x 1010. 
The prior distributions for ui and vi  required sensitivity analyses, and are discussed 
below. 
 
Relative survival  
For relative survival, a recommended approach is to model excess mortality under a 
generalized linear model based on collapsed data using exact survival times and a 
Poisson assumption (Dickman et al., 2004). The basic version of this model was 
extended to include spatial and random effects, similar to Fairley et al (Fairley et al., 
2008). 
𝑑𝑘𝑗𝑖~Poisson(𝜇𝑘𝑗𝑖) 
log(𝜇𝑘𝑗𝑖 − 𝑑𝑘𝑗𝑖
∗ ) = log(𝑦𝑘𝑗𝑖) + 𝛼𝑗 + xβ𝑘 + 𝑢𝑖 + 𝑣𝑖 
 
where 𝑑𝑘𝑗𝑖  is the number of deaths due to any cause in the kth age group, the jth 
follow up interval and the ith SLA, 𝑦𝑘𝑗𝑖 is person-time at risk, 𝑑𝑘𝑗𝑖
∗  is the expected 
number of deaths due to causes other than the cancer of interest, 𝛼𝑗 is the intercept 
(which varied by follow-up year), 𝛽𝑘 is the coefficient of the predictor variable 
vector x (representing the broad age groups: 0-49, 50-69, 70-89 years), 𝑣𝑖 is the 
unstructured random effects (which has a normal distribution) and 𝑢𝑖 is the spatial 
component modelled with the CAR prior. Both α and β were given priors with 
normal distributions having mean 0 and variance 1.0 x 106. The model was run 
separately for males and females. Broad age groups were included in the model to 
prevent bias due to differing age structures between SLAs.  
 
All cases considered ‘at risk’ during 1998 to 2007 were included. Since the earliest 
year of data was 1996, this meant that any cases diagnosed from 1996 onwards 
which were alive with up to 5 years follow-up at some stage during 1998-2007 were 
included. Cases alive on the 31st December 2007 were censored.  
 
Consistent with standard protocol, this model excluded persons aged 90 years or 
older at time of diagnosis, those whose diagnosis was based on death certificate or 
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autopsy only, or those with a survival time of zero days or less. In total, this was 
3.3% of the records from 1996-2007.  
 
3.3.7 Adjacency matrix 
 
Since the Bayesian models incorporate information from neighbouring regions, it is 
necessary to specify the definition of which SLAs are considered neighbours.  An 
adjacency matrix is generated to apply these definitions in the Bayesian model. 
Using the standard terminology for adjacency options, which follow the possible 
moves of chess pieces, we used the “Queen” definition, so that SLAs were 
considered to be neighbours if they shared a common border (Earnest et al., 2007). 
The adjacency matrix was calculated using the program GeoDa (Anselin et al., 2006) 
using 1st order queen adjacencies. Although it is possible to use higher-order weights 
than first-order (e.g. second-order weights will include neighbours of neighbours), 
this was not considered useful for this analysis due to the much denser 
neighbourhood matrix and, particularly in rural areas of the state, the very large 
distances between second-order neighbouring SLAs.  
 
Due to the large number of island SLAs in Queensland, 18 regions originally had no 
neighbours. Since estimates will not be smoothed unless a region has neighbours the 
default neighbourhood matrix was adjusted to ensure all regions had at least one 
neighbour. Additional neighbours were incorporated by considering they could share 
a border even if separated by a river, or a sea.  In particular, most of the Far North 
islands were grouped together, with some mainland areas also included to ensure 
enough strength was provided to generate meaningful estimates that were able to 
converge. 
 
3.3.8 Computation 
 
Models were run using WinBUGS (Lunn et al., 2000) interfaced with Stata 
(StataCorp, 2013) (using the wb commands written by John Thompson, University of 
Leicester (Thompson et al., 2006)) with a burn-in period of 100,000 iterations 
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(incidence models) and 250,000 iterations (survival models) followed by 100,000 
iterations. To decrease the correlation between iterations a subsample of every tenth 
iteration was kept. Only one chain was run for each estimate. 
 
3.3.9 Assessing convergence 
 
Convergence was assessed using visual examination of trace, density and 
autocorrelation plots, as well as the Geweke diagnostic (Geweke, 1992). Geweke 
diagnostics were calculated as the difference between the means for the first 1000 
iterations (10%) that were kept and the final 5000 iterations (50%), divided by the 
asymptotic standard error of the difference. These were generated for the SIR or 
RER estimates for all 478 SLAs, and any estimate that had a Geweke estimate with a 
p-value of less than 0.01 was considered unlikely to have converged. To save disk 
space and processing time, trace and density plots were only generated for 5% 
(n=24) of the SLAs, composed of SLAs of concern due to small numbers as well as a 
random selection. 
 
3.3.10 Sensitivity analyses 
 
For these types of models, and particularly when data are sparse, it is vital to 
carefully consider the choice of prior and compare the effects of alternate priors. The 
priors used on the distribution for the variance of the spatial and random effects 
components may particularly influence the results.  
 
There were three stages to conducting the sensitivity analyses. First, the literature 
was searched to determine what priors were being used in similar models. Many 
BYM models were found, however, there were few examples of Bayesian relative 
survival models containing spatial components. As there was no other source of 
information relevant to the study at hand on which to base informative priors, a range 
of non-informative priors were used for the relative survival models. Second, the 
effect of each prior was evaluated. Since the potential influence of the prior will be 
more pronounced for scarce data, Tables 3.3 and 3.4 show some of the comparative 
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numbers for a less common cancer - oesophageal cancer in males. In addition to 
these, observed values were plotted against those predicted by the model and 
quantile-quantile plots were examined. Third, convergence was examined, as 
outlined earlier. Lack of convergence could indicate a poor model, or it may simply 
indicate a longer burn-in period is required. Monitoring the estimate over the entire 
number of iterations (including burn-in) would show whether it is likely convergence 
will eventually be reached. In Tables 3.3 and 3.4 the proportion of SLAs for which 
the SIR or RER estimate did not converge after discarding 50,000 iterations is 
shown.  
 
For the sensitivity tests some of the less common cancers were examined (for 
incidence: oesophageal, brain, myeloma; for survival (based on number of deaths): 
oesophageal, thyroid), as well as a more common one (incidence: melanoma; 
survival: pancreatic).  
 
For both the incidence and survival models, u represents the spatial component, 
while v represents the random component. These components were each given 
hyperprior distributions, as below: 
𝑣𝑖~𝑁(0, 𝜏𝑣) 
 
[𝑢𝑖|𝑢𝑗 , 𝑖 ≠ 𝑗, 𝜏𝑢]~𝑁(?̅?𝑖, 𝜏𝑖) 
 
where ?̅?𝑖 =
1
∑ 𝜔𝑖𝑗𝑗
∑ 𝜇𝑗𝜔𝑖𝑗𝑗  
 
𝜏𝑖 =
𝜏𝑢
∑ 𝜔𝑖𝑗𝑗
 
where 𝜔𝑖𝑗 = 1 if SLAs i, j are adjacent (or 0 if they are not). The τ values control the 
variability of u and v. As such, the distribution can be specified using τ or σ, which is 
the square root of the inverse of τ (variance= σ2).  
 
The following priors were compared for the incidence model: 
1. τ u ~ Gamma(0.5, 0.0005),  τv  ~ Gamma(0.5, 0.0005) 
2. τ u ~ Gamma(1,1), τv ~ Gamma(7.801, 2.793) 
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3. τ u ~ Gamma(0.1, 0.1), τv ~ Gamma(0.001, 0.001) 
4. τ u ~ Gamma(0.1, 0.01),  τv ~ Gamma(0.1, 0.01) 
5. Reparameterised on σ: σu ~ Uniform(0,1), σv ~ Uniform (0,1) 
6. Reparameterised on σ: σu ~ Uniform (0,1000), σv ~ Uniform (0,1000) 
 
Prior 1 shrunk the estimates more than any other (the pD value is lower than the 
others, and the standard deviation smaller) (Table 3.3). Prior 2 induced far less 
shrinkage than the others (higher pD and standard deviation). Prior 2 also had a 
larger DIC (greater than 6 above the others), indicating worse model fit. Priors 3 to 6 
gave fairly similar results, although prior 6 had a larger standard deviation. It was 
decided to use prior 3 as it provided consistently plausible results and converged well 
across the range of cancers examined. 
 
Table 3.3 Sensitivity analyses for oesophageal cancer incidence among males 
 Prior 1 Prior 2 Prior 3 Prior 4 Prior 5 Prior 6 
Distribution of SIR       
Mean 100.8 99.4 101.5 100.7 100.6 103.6 
Standard deviation 10.2 30.8 16.3 14.5 13.5 23.2 
Maximum 140.6 455.1 181.2 169.5 166.4 201.8 
75% Quartile 107.2 113.1 111.7 110.2 109.4 109.8 
Median 96.5 93.5 95.1 95.6 95.9 95.7 
25% Quartile 93.3 78.7 89.4 89.9 90.7 90.2 
Minimum 87.4 55.9 79.6 79.3 80.0 79.8 
90% ratio1 1.3 2.3 1.6 1.5 1.5 1.6 
pD2 34.112 138.047 51.305 53.828 53.709 54.098 
DIC3 1652.57 1660.32 1650.62 1648.51 1651.02 1650.71 
Spatial fraction4  0.56 0.44 0.63 0.48 0.52 0.57 
Percent SLAs with 
Geweke <0.01 for SIR 41.0% 1.9% 3.3% 9.4% 10.3% 10.5% 
Notes: 
1. The 90% ratio is calculated as the 95th percentile divided by the 5th percentile of the smoothed SIR estimates. 
2. pD represents the effective number of parameters in the model. Larger values indicate less smoothing of 
estimates. 
3. DIC=Deviance Information Criterion (Spiegelhalter et al., 2002). Smaller values (of at least 5 below) 
indicate a better model fit. 
4. The spatial fraction estimates the relative contribution of spatial and unstructured heterogeneity, and is 
calculated as:  Spatial fraction =
𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2
𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2  + 𝜎2
  
where 𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2 = marginal spatial variance,  𝜎2= marginal variability of the unstructured random effects 
between areas. A value close to 1 indicates the spatial heterogeneity dominates, whereas a value close to 0 
indicates the unstructured heterogeneity dominates. The median 𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2 ranged from 0.014 to 0.121 across 
these priors, and the median 𝜎2 varied from 0.010 to 0.137. 
 
Prior 1 is used by Besag et al. (1991), Prior 2 is calculated using the method in Carlin and Perez (2000), prior 3 is 
the ‘fair’ prior (Best et al., 1999), Prior 4 was an alternate version of Prior 1, while the reparameterisation on 
sigma in Prior 5 used values from Pascutto et al. (2000) and prior 6 was an alternate version.  
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For the survival model, the following non-informative priors were compared: 
1. τ u ~ Gamma(0.5, 0.001),  τv ~ Gamma(0.5, 0.001) 
2. τ u ~ Gamma (0.1, 0.1), τv ~ Gamma(0.001, 0.001) 
3. τ u ~ Gamma(0.1, 0.01),  τv ~ Gamma(0.1, 0.01) 
4. τ u ~ Gamma(0.5, 0.0005),  τv ~ Gamma(0.5, 0.0005) 
5. Reparameterised on σ: σu ~ Uniform(0,1), σv ~ Uniform(0,1) 
6. Reparameterised on σ: σu ~ Uniform(0,1000), σv ~ Uniform(0,1000) 
 
Prior 3 was chosen because it demonstrated greater convergence properties across the 
range of cancers examined, while restricting the results to a narrower range of 
smoothed estimates than Prior 2 (Table 3.4). 
 
Table 3.4 Sensitivity analyses for oesophageal cancer survival among males 
 Prior 1 Prior 2 Prior 3 Prior 4 Prior 5 Prior 6 
Distribution of RER       
Mean 100.2 100.7 100.4 100.1 100.4 100.0 
Standard deviation 6.5 11.5 8.2 3.8 9.3 0.3 
Maximum 119.6 140.7 127.6 111.3 129.5 102.1 
75% Quartile 105.3 105.0 105.7 102.6 106.3 100.2 
Median 98.0 97.3 97.7 99.2 97.0 100.0 
25% Quartile 95.2 92.6 94.7 97.2 93.7 99.8 
Minimum 80.9 63.4 75.0 89.4 72.5 98.3 
90% ratio1 1.2 1.4 1.3 1.1 1.3 1.0 
pD2 23.988 36.021 33.105 18.663 30.524 18.218 
DIC3 3690.23 3690.27 3691.24 3691.32 3690.07 3694.96 
Spatial fraction4  0.62 0.87 0.51 0.48 0.80 0.00 
Percent SLAs with 
Geweke <0.01 for RER 
89.3% 9.8% 10.5% 19.5% 21.5% 63.0% 
Notes: 
1. The 90% ratio is calculated as the 95th percentile divided by the 5th percentile of the smoothed RER 
estimates. 
2. pD represents the effective number of parameters in the model. Larger values indicate less smoothing of 
estimates. 
3. DIC=Deviance Information Criterion (Spiegelhalter et al., 2002). Smaller values (of at least 5 below) 
indicate a better model fit. 
4. The spatial fraction estimates the relative contribution of spatial and unstructured heterogeneity, and is 
calculated as:  Spatial fraction =
𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2
𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2  + 𝜎2
  
where 𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2 = marginal spatial variance,  𝜎2= marginal variability of the unstructured random effects 
between areas. A value close to 1 indicates the spatial heterogeneity dominates, whereas a value close to 0 
indicates the unstructured heterogeneity dominates. The median 𝜃𝑚𝑎𝑟𝑔𝑖𝑛𝑎𝑙
2 ranged from 0.000 to 0.034 across 
these priors, and the median 𝜎2 varied from 0.002 to 0.014. 
 
Prior 1 is used by Fairley et al. (2008), Prior 2 is the ‘fair’ prior (Best et al., 1999), Prior 3 is an alternate version 
of Prior 4, which is used by Besag et al. (1991). The reparameterisation on sigma in Prior 5 used values from 
Pascutto et al. (2000) and prior 6 was an alternate version.  
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3.3.11 Production of maps 
 
A thematic scheme was chosen, with colours determined using color brewer 
(colorbrewer2.org) under the specifications of a diverging colour-scheme of 5 
categories which are suitable for print and colour-blind friendly (Figure 3.1). The 
SIRs and RERs were categorised as 10% above and 30% above the State average, 
and the inverse of these for the lower cut-offs. There is great variability in the 
categories used in other atlases, but these fairly broad categories were used to reduce 
the probability of reporting spuriously significant differences.  
 
Figure 3.1: An example of the incidence (risk of diagnosis) and survival (risk of 
death within 5 years of diagnosis) maps for all invasive cancers, males 
 
Note: Refer to Appendix A for comparison with raw, unsmoothed estimates. 
 
 
Mapping alternative measures, such as  the posterior probability of exceeding a 
certain value, were considered, but were deemed unsatisfactory due to difficulties in 
interpretation and the lack of information provided in regards to the size of the risk 
(Bell et al., 2006; Wakefield, 2007). Therefore we used graphs to show the precision 
of the mapped estimates.   
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Graphs 
To supplement the information provided in the maps, a graph showing the ranked 
SIR or RER with the associated 95% credible interval for each SLA was provided 
(Figure 3.2). Horizontal box plots of the SIR or RER estimates by socioeconomic 
status and rurality were also provided to provide additional information about where 
the extent of variability across the state (Figure 3.2). Since a primary purpose of the 
model was to provide overall estimates of variability across the State, we did not 
include these additional variables in the model.  
 
 
Figure 3.2: An example of the incidence graphs for all invasive cancers, males 
 
 
Additional estimates included 
For each cancer with significant variation (refer to Section 3.3.12), SIR or RER 
estimates with 95% credible intervals were also provided by socioeconomic and 
rurality classifications. To calculate these, each iteration of the 10,000 iterations had 
the modelled observed value (incidence) and the adjusted deaths value (survival) 
calculated as above. For survival (which incorporated age group and time period) 
these were summed to give 10,000 iterations for each SLA. Each SLA was then 
grouped into rurality or socioeconomic status categories, and the adjusted estimates 
summed. These were divided by the original expected values to produce 10,000 SIR 
or RER estimates by rurality and socioeconomic status categories. The median of 
these 10,000 was used as the SIR or RER point estimate, and the 2.5 and 97.5 
percentiles used to provide the lower and upper credible interval estimates, 
respectively. 
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3.3.12 Determining whether observed variation is significant 
 
Once the results have been produced and mapped, it is important to determine 
whether the apparent variation reflects true geographic differences. Therefore, a test 
for global clustering was conducted. Multiple tests are available (Kulldorff et al., 
2006), such as Besag-Newell's R, Moran's I, Oden’s Ipop, but we elected to use 
Tango’s MEET (Maximised Excess Events Test) (Tango, 2000) as it has been shown 
to perform well across a variety of datasets (Kulldorff et al., 2006).  
 
A small p-value from Tango’s MEET indicates that estimates differ between regions. 
As is consistent with standard statistical analysis (McPherson, 2001), adjusted p-
values from the Tango’s MEET statistic below 0.01 were considered to strongly 
indicate spatial variation, while values between 0.05 and 0.01 were moderately 
indicative of variation. Values of 0.05 or above were considered to not be significant, 
however two categories were defined. Values between 0.05 and 0.10 were 
considered to provide only weak evidence of geographic variation, while values 
above 0.10 no evidence of geographical variation. 
 
Since Tango’s MEET is calculated using Monte Carlo replications, it is expected that 
there could be slight variations in the results. To increase our confidence that the 
final classification of geographic variation was stable, Tango’s MEET was run an 
additional 5 times for each cancer and gender combination. There were only two 
cases where the final classification did change for different replication, and so these 
cancers were assigned to the more conservative, less significant category (Appendix 
B). 
 
Input for Tango’s MEET requires an observed and expected value. Since the 
modelled results were of interest, the modelled observed value needed to be 
calculated. For the incidence data, the observed value was calculated by the 
smoothed SIR median value multiplied by the expected value to produce a modelled 
observed value. For the relative survival model, the adjusted deaths for each data 
point were calculated as: (person-time at risk × expfollow-up time × expage group × RER) + 
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expected number of deaths due to causes other than the cancer of interest, i.e. 
(𝑦𝑘𝑗𝑖 × e
𝛼𝑗 × eβ𝑘 × e𝑢𝑖+𝑣𝑖) + 𝑑𝑘𝑗𝑖
∗  
 
These were then added together for each SLA to provide the input data for Tango’s 
MEET. 
 
3.4 Conclusions  
 
Chronic disease atlases are a useful tool for assessing and quantifying geographical 
inequalities, as well as assisting to focus research efforts in investigating why the 
observed inequalities exist. When developing these atlases, a myriad of decisions 
concerning how to model and present the results need to be made and this paper 
presents one decision-making algorithm used to generate a cancer atlas.  
 
There are several priority areas for future consideration in disease mapping including 
communicating spatial results, particularly finding ways to present the uncertainty 
surrounding the results; and the development and use of alternative statistical models 
such as classification and regression tree (CART) models. In addition, more detailed 
statistical models can be developed to investigate the impact of rurality, area-level 
and individual level socioeconomic status as well as temporal changes. 
 
As with all chronic disease atlases, it is hoped that the presented variations in 
outcomes will stimulate further research efforts to investigate the reasons underlying 
the disparities and inform advocacy, policy, support and education programs to 
effectively address these, so that health equity will become a reality. 
 
The full report is available (from February 2011) at: 
www.cancerqld.org.au/cancer_atlas/ 
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Appendix A: Additional maps 
 
Unpublished 
 
It can be of interest to compare raw or unsmoothed estimates (Figure A3.1) with 
smoothed estimates (Figure 3.1).  
 
Figure A3.1: The unsmoothed incidence (risk of diagnosis) and survival (risk of 
death within 5 years of diagnosis) maps for all invasive cancers, males  
 
Risk of diagnosis (raw SIR) 
 
 
Risk of death within 5 years of 
diagnosis (raw RER) 
  
SIR=Standardised incidence ratio; RER=Relative excess risk of death. 
 
The raw SIR is calculated as: 
𝑆IR𝑖 =
O𝑖
E𝑖
  
where O are the observed cases in each i=1,…I areas, E are the expected cases 
calculated for each area as: 
E𝑖 = ∑
Qld count
Qld population
× population𝑖
18
𝑗=1
 
where j represents the 18 five-year age groups (0-4,…85+ years). 
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The raw RER is estimated by including each area i as a fixed effect within the 
standard Poisson piecewise model, ie. exp(β𝑖) from the following: 
 
𝑑𝑘𝑗𝑖~Poisson(𝜇𝑘𝑗𝑖) 
log(𝜇𝑘𝑗𝑖 − 𝑑𝑘𝑗𝑖
∗ ) = log(𝑦𝑘𝑗𝑖) + 𝛼𝑗 + xβ𝑘𝑖 
 
Refer to Section 3.3.6 for further details on the model parameters. No priors were 
included in this model. 
 
Input data were duplicated to enable comparison against Queensland average, with 
duplicate observations set to equal area 0. The raw RER estimates are thus only 
rough approximations. 
 
 
Appendix B: Tango’s MEET 
 
Unpublished 
 
The minimum p-value in Tango’s MEET can be defined as (Tango, 2000): 
𝑃min = min
𝜆
Pr{𝐶𝜆 > 𝑐𝜆|𝐻0, 𝜆} = Pr{𝐶𝜆 > 𝑐𝜆|𝐻0, 𝜆 = 𝜆
∗} 
 
The observed test statistic 𝑐𝜆 is a function of cluster size 𝜆 (varies continuously from 
a very small value to around half the size of Queensland), and the minimum p-value 
of 𝐶𝜆 occurs at 𝜆
∗. 
 
Results across the six iterations of Tango’s MEET are shown in Table B3.1. 
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Table B3.1: Tango’s MEET p-values by type of cancer and sex, Queensland 
1998-2007 
 Incidence Survival 
 Males Females Males Females 
Cancer site Max. Min. Max. Min. Max. Min. Max. Min. 
All invasive cancers 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
Oesophagus 0.004 0.002 0.458 0.437 0.266 0.249 0.965 0.940 
Stomach 0.079 0.063 0.694 0.654 0.027 0.018 0.743 0.721 
Colorectal 0.706 0.668 0.227 0.207 0.001 0.001 0.003 0.001 
Pancreas 0.781 0.762 1.000 1.000 0.115 0.092 0.541 0.502 
Lung 0.001 0.001 0.001 0.001 0.001 0.001 0.001 0.001 
Melanoma 0.001 0.001 0.001 0.001 0.448 0.412 1.000 1.000 
Breast – females only   0.001 0.001   0.001 0.001 
Cervical   0.032 0.027   0.702 0.654 
Uterus   0.001 0.001   0.828 0.794 
Ovary   0.747 0.727   0.071 0.054 
Prostate 0.001 0.001   0.001 0.001   
Kidney 0.001 0.001 0.064 0.051 0.277 0.228 0.456 0.397 
Bladder 0.001 0.001 0.696 0.667 0.759 0.721 1.000 1.000 
Brain 0.358 0.335 1.000 1.000 0.991 0.984 0.976 0.959 
Thyroid 0.183 0.168 0.001 0.001 0.757 0.722 1.000 1.000 
Non-Hodgkin lymphoma 0.001 0.001 0.002 0.001 0.038 0.023 0.004 0.001 
Leukaemia 0.046 0.030 0.018 0.011 0.016 0.007 0.297 0.257 
Myeloma 0.083 0.070 0.195 0.183 0.228 0.199 0.226 0.187 
Max. = maximum Tango’s MEET p-value obtained from 6 repititions. 
Min. = minimum Tango’s MEET p-value obtained from 6 repititions. 
P-values are colour-coded by the categories of Strong, Moderate, Weak, None, based on their values. 
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CHAPTER 4 
 
Identification of area-level influences on 
regions of high cancer incidence in Queensland, 
Australia: a classification tree approach 
 
Preamble 
 
The investigation detailed in Chapter 3 was just the beginning. Of the National 
Health Priority Area (NHPA) cancers, all except colorectal cancer showed evidence 
of diagnostic spatial inequalities (Table 9.1). We wanted to understand the area-level 
factors influencing these spatial inequalities, but there was likely to be complex 
interplay between remoteness, socioeconomic disadvantage, and proportion of the 
population that are Aboriginal or Torres Strait Islander (hereafter respectfully 
referred to as indigenous). 
 
Commonly, classification and regression tree (CART) models and related analyses 
are used to assist in understanding interactions, and ‘raw’ data are generally the 
desired input. We sought to instead use these models to untangle the complex 
influence of and interactions between several area-level factors on small-area cancer 
incidence inequalities. (In this chapter, the term ‘interaction’ simply refers to 
multiple variables affecting the response.) The novel application demonstrated here 
was to apply a CART model to ‘smoothed’ results from a Bayesian hierarchical 
model. The exploration of influences from area-level factors on spatial inequalities in 
cancer incidence meets the second objective. 
 
This chapter was written as a journal article for which I am the principal author, and 
is reprinted here in its entirety. I was responsible for the statistical analysis, writing 
and modifying the manuscript, and also contributed to the study design. 
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4.1 Abstract 
 
Background 
Strategies for cancer reduction and management are targeted at both individual and 
area levels. Area-level strategies require careful understanding of geographic 
differences in cancer incidence, in particular the association with factors such as 
socioeconomic status, ethnicity and accessibility. This study aimed to identify the 
complex interplay of area-level factors associated with high area-specific incidence 
of Australian priority cancers using a classification and regression tree (CART) 
approach. 
 
Methods 
Area-specific smoothed standardised incidence ratios were estimated for priority-
area cancers across 478 statistical local areas in Queensland, Australia (1998-2007, 
n=186,075). For those cancers with significant spatial variation, CART models were 
used to identify whether area-level accessibility, socioeconomic status and ethnicity 
were associated with high area-specific incidence.  
 
Results 
The accessibility of a person’s residence had the most consistent association with the 
risk of cancer diagnosis across the specific cancers. Many cancers were likely to 
have high incidence in more urban areas, although male lung cancer and cervical 
cancer tended to have high incidence in more remote areas. The impact of 
socioeconomic status and ethnicity on these associations differed by type of cancer. 
  
Conclusions 
These results highlight the complex interactions between accessibility, 
socioeconomic status and ethnicity in determining cancer incidence risk.  
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4.2 Background 
 
Globally, almost 12.7 million people were diagnosed with cancer in 2008 (excluding 
non-melanoma skin cancers), and 7.6 million people died from cancer (Ferlay et al., 
2010b). Cancer was the third highest cause of death (following cardiovascular 
disease and infectious and parasitic diseases) (Health statistics and informatics 
Department, 2008).  
 
In Australia, cancer was responsible for almost 40,000 deaths and 108,368 diagnoses 
(again, excluding non-melanoma skin cancer) in 2007 (Australian Institute of Health 
and Welfare & Australasian Association of Cancer Registries, 2010). Cancer was 
estimated to be the greatest contributor to the burden of disease, causing 19% of the 
entire disease burden, and half of this was due to lung, colorectal, prostate and breast 
cancers (Australian Institute of Health and Welfare & Australasian Association of 
Cancer Registries, 2010). Due to its high morbidity and mortality, cancer is an 
Australian government health priority area, with specific emphasis placed on  the 
National Health Priority Area (NHPA) cancers of colorectal cancer, lung cancer, 
melanoma, non-melanoma skin cancer, breast cancer, cervical cancer, prostate cancer 
and non-Hodgkin’s lymphoma (Commonwealth Department of Health and Family 
Services & Australian Institute of Health and Welfare, 1998). 
 
Government strategies for cancer reduction and management are targeted at both the 
individual and area levels. Recognised risk factors at the individual level for cancer 
incidence include tobacco smoke exposure, ultraviolet exposure, air pollution, diet, 
exercise and genetics (World Cancer Research Fund and American Institute for 
Cancer Research, 2009). Evidence is accumulating that area-level effects, such as 
socioeconomic inequality, ethnic composition, civic engagement, government 
policies and accessibility can shape many of the individual risk factors (International 
Agency for Research on Cancer, 1997). Area-level strategies require careful 
understanding of geographic differences in cancer incidence, in particular the 
association with factors such as socioeconomic status, ethnicity and accessibility. 
These factors are not independent, since rural and remote regions of Australia are 
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more likely to be of lower socio-economic status, and similarly urban areas are more 
likely to have higher socio-economic status (Australian Bureau of Statistics, 2000). 
 
This study aimed to identify the complex interplay of area-level factors associated 
with areas of high incidence of the Australian priority cancers, and through this 
demonstrate the application of classification and regression trees (CART) for this 
purpose. Unlike more traditional regression models, CART models are able to 
identify interactions between ecological factors that best split geographical areas into 
homogenous subgroups based on their relative incidence rates. 
 
4.3 Methods 
 
Incidence data for the NHPA cancers (excluding non-melanoma skin cancer) 
covering the period 1998-2007 were obtained from the Queensland Cancer Registry 
(QCR) after obtaining approval from Queensland Health (Ethics approval number: 
HREC/09/QHC/25). The QCR is a population-based registry, which maintains a 
record of all cancer cases (excluding non-melanoma skin cancer) diagnosed in 
Queensland since 1982, and to which notification is required by law (Queensland 
Cancer Registry, 2013b). Cancers were classified according to the World Health 
Organization’s International Classification of Diseases for Oncology, 3rd edition 
(ICD-O3). Population estimates were obtained from the Australian Bureau of 
Statistics (ABS) (Australian Bureau of Statistics, 2008d, 2013). 
 
The geographic regions used for this analysis are Statistical Local Areas (SLAs) 
which cover Queensland without gap or overlap. In 2006 there were 478 SLAs, 
ranging in population size from 7 to 77,523, with a median population of 5,810. 
SLAs were categorised by accessibility, socio-economic status and Indigenous 
composition. Accessibility was defined by the Accessibility/Remoteness Index of 
Australia (ARIA+), which categorises areas as ‘Major Cities (MC)’, ‘Inner Regional 
(IR)’, ‘Outer Regional (OR)’, ‘Remote (R)’ or ‘Very Remote (VR)’ (Australian 
Institute of Health and Welfare, 2004).  These categories are determined by the 
minimum road distance from population localities to different levels of service 
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centres (Australian Institute of Health and Welfare, 2004). Socioeconomic status was 
defined using the Socioeconomic Indexes for Areas (SEIFA) Index of Relative 
Socioeconomic Disadvantage (IRSD) (Australian Bureau of Statistics, 2008b). SLAs 
in Queensland were ranked from the most disadvantaged to the least disadvantaged 
and then divided into quintiles. For clarity we refer to the quintiles as 'Most 
Disadvantaged (MD)', 'Moderately Disadvantaged (ModD)', ‘Middle SES (MSES)’, 
'Moderately Advantaged (ModA)' and 'Most Advantaged (MA)'. For ease of 
reference, 'advantaged' areas include 'most advantaged' and 'moderately advantaged', 
and similarly for 'disadvantaged' areas. SLAs were considered to be Indigenous if at 
least 10% of the population identified as Aboriginal or Torres Strait Islander in the 
2006 population census (Australian Bureau of Statistics, 2007b). 
 
The data analysis comprised four main steps: (i) estimating smoothed Standardised 
Incidence Ratios (SIRs) for each cancer; (ii) identifying cancers with significant 
spatial variation; (iii) identifying  SLAs with  “high” incidence for each cancer, 
based on the smoothed SIR estimates, and (iv) for these cancers, identifying the area-
level factors associated with high incidence SLAs.  
 
For Step (i), incidence data were adjusted for age by indirect standardization to 
provide empirical SIRs by cancer type and gender. A Bayesian hierarchical spatial 
smoothing model (known as the Besag, York and Mollié model) was then applied to 
produce smoothed SIRs (Besag et al., 1991). This model assumes that neighbouring 
SLAs should be more similar than SLAs further away, with respect to the SIR values 
(or the associated factors, such as accessibility, socio-economic status and ethnicity). 
Thus smoothed SIR estimates are to some extent averaged over neighbouring values; 
this also helps address the problem of unstable empirical estimates that are based on 
small population sizes (Best et al., 2005). The model was run using Stata interfaced 
with WinBUGS (Thompson et al., 2006). Further details regarding the methodology 
are described elsewhere (Cramb et al., 2011b). 
 
We restricted the detailed analyses to those cancers that had significant sex-specific 
area-level variation, or heterogeneity, in the smoothed SIR estimates (Step (ii)). This 
area-level variation was assessed using the Tango’s Maximised Excess Events Test 
Chapter 4: Identification of area-level influences 
 
 93 
 
(MEET) (Tango, 2000). Values of Tango’s MEET that were  < 0.05 were deemed to 
reflect statistically significant variation in estimates.  
 
For Step (iii), the smoothed SIR estimates were classified as ‘high’ if they were at 
least 10% greater than the Queensland average. Sensitivity analyses examining the 
influence of alternate cutpoints (5% and 15% above the Queensland average) were 
also conducted. 
 
For Step (iv), a weighted CART model was fitted for each of the cancers selected in 
Step (ii). The aim of the CART model is to identify a sequence of binary splits of the 
area-level factors (accessibility, socioeconomic status, ethnicity) that best divide the 
high/not high smoothed SIRs for each SLA into homogeneous subgroups. The 
resultant sequence of splits resembles a tree-like structure, and the final subgroups 
are known as ‘terminal nodes’ that can be described as high if the estimated Pr(high 
SIR) is greater than 0.5. The best tree was chosen using the minimum cross-
validation criterion, which chooses the tree with the lowest expected error if new 
data were to be applied to this model (cross-validated error) (Breiman et al., 1984). 
In all cases this gave the same result as using the alternative one-standard-error rule, 
which is calculated as the tree with the fewest nodes which has a cross-validated 
error below the sum of the minimum cross-validated error and its standard error 
(Breiman et al., 1984). The CART analysis was conducted using the RPART 
package in R version 2.11.1 (Ihaka and Gentleman, 1996). Annotated code is 
provided in the Appendix. To adjust for differences in the precision of the smoothed 
SLA-specific estimates, the inverse of the variance was used to weight the 
dichotomous SIR variable.  
 
The sensitivity and specificity for each final tree was also calculated.  Sensitivity was 
the weighted sum of true positive values (areas that were high SIR classified as such) 
divided by the weighted sum of false negative values (areas classified as low SIR 
that were high SIR). Similarly, specificity was calculated as the weighted sum of 
false positive values (areas classified as high SIR that were low SIR) divided by the 
weighted sum of true negative values (areas that were low SIR classified as such).  
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In the CART diagrams, the terminal nodes are portrayed by rectangles. Within each 
terminal node (or rectangle) are three rows of numbers. The first contains the number 
of SLAs with a high SIR value versus the total number of SLAs in the node. The 
second row contains the Pr(H) value, which is the weighted proportion of SLAs with 
a high SIR in the subgroup of SLAs represented in the node. The third row contains 
the 95% confidence interval (CI) for the probability of a high SIR, calculated as 𝑝 ±
1.96 × √
𝑝(1−𝑝)
𝑛
 where p is the Pr(H) and n is the number of SLAs. In the few 
instances where a CI value surpassed the possible (0,1) boundaries, this was 
restricted to the appropriate boundary value. The CART diagrams are also 
accompanied by summary diagrams showing which areas were likely to have high 
SIR values (shaded as dark grey), and which were likely to not have high SIR values 
(shaded as light grey). These contain ARIA and SEIFA combinations to facilitate 
comparison between cancer types. Combinations which do not exist were rendered in 
white. Note the same shading is also used for the terminal nodes in the CART 
diagram. Dark grey terminal nodes are likely to have a high SIR, in contrast to the 
light grey terminal nodes. 
 
4.4 Results 
 
The cancers that had statistically significant evidence of variation in the smoothed 
SIR estimates were lung cancer, melanoma, breast cancer (females), cervical cancer, 
prostate cancer, and non-Hodgkin lymphoma (Table 4.1). There was no significant 
evidence of geographical variation in colorectal cancer incidence for males (p=0.693) 
or females (p=0.216).  The sensitivity of the final CART models ranged from 51.5% 
(female lung cancer) to 97.2% (female non-Hodgkin lymphoma), while the 
specificity ranged from 31.1% (female melanoma) to 82.7% (female lung cancer) 
(Table 4.1).  
 
4.4.1 Lung cancer 
 
For lung cancer among males, socioeconomic status was the primary determinant, 
whereas for females it was the accessibility of an area (Figure 4.1). There were 
Chapter 4: Identification of area-level influences 
 
 95 
 
interactions between socioeconomic status and accessibility for both genders. Areas 
were more likely to have increased lung cancer incidence among males if they were 
disadvantaged or were remote and very remote areas of middle SES. Areas within 
major cities of middle or disadvantaged SES were likely to have a high incidence of 
lung cancer among females.  
 
Table 4.1: Summary of area-level variation for National Health Priority Area 
cancers and CART analysis results 
Type of cancer  
(ICD-O3 code) Gender 
Tango's 
MEET 
Number of SLAs 
with high SIR (%) Sensitivity Specificity 
Variables in 
final tree1,2 
Colorectal cancer  M 0.693 NA NA NA NA 
(C18-C20, C218) F 0.216 NA NA NA NA 
Lung (C33-C34) M 0.001 153 (32%) 70.1% 74.9% SEIFA, ARIA 
 F 0.001 83 (17%) 51.5% 82.7% ARIA, SEIFA 
Melanoma  M 0.001 91 (19%) 75.0% 49.8% ARIA 
(C44 and  M872-M879) F 0.004 54 (11%) 93.7% 31.1% ARIA, SEIFA 
Breast (C50) F 0.001 79 (17%) 86.5% 58.1% ARIA, SEIFA 
Cervical (C53) F 0.023 81 (17%) 79.2% 79.3% ARIA, I, SEIFA 
Prostate (C61) M 0.001 93 (19%) 70.1% 58.5% ARIA, SEIFA 
Non-Hodgkin's lymphoma  M 0.001 57 (12%) 90.1% 38.7% ARIA 
(M959,M967-M971) F 0.002 57 (12%) 97.2% 55.2% ARIA 
1. The final tree based on the lowest cross-validated error. 
2. NA: since there was no evidence of area-level variation for colorectal cancer, additional analysis was not 
conducted for colorectal cancer. 
ARIA: Accessibility/Remoteness index of Australia 
I: Indigenous 
SEIFA: Socioeconomic indexes for areas 
 
 
4.4.2 Melanoma 
 
Contrasting patterns were observed for melanoma incidence among males and 
females. Among males, an area was likely to have a high melanoma incidence if it 
was classified as a major city, inner or outer regional area and of middle or 
advantaged SES (Figure 4.2). In contrast, for females, incidence was higher in all 
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areas except those within the most advantaged quintile, and the very remote areas. 
Therefore areas of disadvantage were likely to have high incidence among females, 
but low incidence among males. 
 
Figure 4.1: The final classification and regression tree for lung cancer 
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Figure 4.2: The final classification and regression tree for melanoma 
 
 
 
4.4.3 Female breast cancer 
 
Breast cancer incidence was likely to be high in areas within major cities, except 
those that were most disadvantaged. Inner regional areas that were most advantaged 
were also likely to have high incidence (Figure 4.3).  
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Figure 4.3: The final classification and regression tree for breast cancer 
 
 
 
Figure 4.4: The final classification and regression tree for cervical cancer 
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4.4.4 Cervical cancer 
 
Areas that had the highest probability of having increased cervical cancer incidence 
were those that were most disadvantaged or were in outer regional, remote or very 
remote areas (Figure 4.4). However there was also interaction in areas with high 
Indigenous population; areas that were most disadvantaged, were in outer regional or 
remote areas and also had a low Indigenous population were more likely to not have 
a high cervical cancer incidence. Corresponding areas with a high Indigenous 
population were likely to have a high cervical cancer incidence.   
 
4.4.5 Prostate cancer 
 
Inner and outer regional areas, as well as the socioeconomically most advantaged 
areas within major cities were likely to have high incidence of prostate cancer among 
males (Figure 4.5). 
 
Figure 4.5: The final classification and regression tree for prostate cancer 
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4.4.6 Non-Hodgkin’s lymphoma 
 
High incidence of non-Hodgkin’s lymphoma was likely to occur among males in 
major cities or inner regional areas, and among females in major cities (Figure 4.6). 
 
Figure 4.6: The final classification and regression tree for non-Hodgkin’s 
lymphoma 
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4.5 Discussion 
 
The accessibility of a person’s residence was the greatest predictor of an increased 
risk of cancer diagnosis across a range of cancers, including lung (females), 
melanoma, breast (females), cervical, prostate, and non-Hodgkin’s lymphoma 
(Appendix B).  Socioeconomic status was the greatest primary explanatory variable 
for lung cancer (males).  
 
More remote areas had a greater probability of having high incidence of lung cancer 
among males, and cervical cancer. Cancers for which more urban areas were more 
likely to have high incidence included: lung cancer (females), melanoma, breast 
cancer, prostate cancer, and non-Hodgkin’s lymphoma. 
 
The interaction between accessibility, socioeconomic status and ethnicity varied 
depending on the type of cancer. The socioeconomic status interacted with 
accessibility for lung, melanoma, breast (females), cervical, and prostate cancers. 
The incidence of cancers that were often screen detected such as breast cancer 
(females), melanoma (males) and to a lesser extent prostate cancer tended to be 
higher in more affluent areas, and also more urban areas. In contrast, for lung, 
melanoma (females) and cervical cancer the incidence was higher in more 
disadvantaged areas. Cancers with a high incidence in disadvantaged areas did not 
have a consistent interaction with accessibility. Some tended to be higher in more 
urban areas (such as lung cancer (females) and melanoma (females)), while others 
were higher in more remote areas (lung cancer (males) and cervical cancer). 
Ethnicity also interacted with these factors for cervical cancer, with Indigenous areas 
more likely to have high incidence.  
 
These results are consistent with previous studies showing an increased incidence of 
cervical cancers among Indigenous women (Homewood et al., 2005), and an 
increased incidence of breast cancer among women in more urban or affluent areas 
(Youlden et al., 2009). However, there are also important differences compared to 
previous research. Melanoma incidence has generally been found to be higher in 
more affluent areas (Reyes-Ortiz et al., 2005). In contrast, our results found females 
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in the most advantaged areas were less likely to have high incidence, while all other 
SLAs (except for very remote) were more likely to have high incidence. Queensland 
has among the highest rates of melanoma in the world (Australian Institute of Health 
and Welfare & Australasian Association of Cancer Registries, 2008, 2010), and this 
may be impacting on these differences. Similarly, lung cancer incidence has 
previously been shown to be higher in remote areas for both males and females 
(Youlden et al., 2007). However, our results found high incidence among females in 
the lower socioeconomic areas of major cities. 
 
Individual risk factors could be influencing these geographic differentials. Lung 
cancer incidence is strongly determined by smoking prevalence 20-30 years earlier 
(Youlden et al., 2008). Tobacco smoking has been shown to be more prevalent in 
lower SES or more remote areas, which may explain the high incidence observed in 
these areas (Queensland Health, 1999; Siahpush and Borland, 2001; Alberg et al., 
2005; Australian Bureau of Statistics, 2006b; Australian Institute of Health and 
Welfare, 2008, 2010c). Similarly, women in affluent areas are more likely to delay 
childbearing, have fewer children and/or use hormone replacement therapy, all of 
which are risk factors for breast cancer (Robert et al., 2004; Carlsen et al., 2008; 
Shack et al., 2008). 
 
Preventive measures can also differ geographically. The leading cause of cervical 
cancer is infection with sexually transmitted human papillomaviruses. Papanicolaou 
screening (commonly called pap smear testing) detects precancerous lesions, which 
can then be treated, averting cancer and thus lowering incidence. The high incidence 
observed in very remote, Indigenous or the most disadvantaged urban areas may 
result from lower uptake of pap smears. Participation rates for cervical cancer 
screening (Papanicolaou screening) are lower in remote communities and areas of 
low socioeconomic status in Queensland and throughout Australia (Cancer Screening 
Services Unit, 2007; Australian Institute of Health and Welfare, 2010b). 
 
In contrast, screening for asymptomatic cancers, such as prostate or breast cancer, 
can be associated with increased incidence. Therefore access to screening or 
diagnostic services is another factor which influences incidence and can vary by area. 
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For instance, the incidence of prostate cancer may be inflated in areas where 
prostate-specific antigen (PSA) testing, which is used to detect asymptomatic 
prostate cancer, is commonly used. PSA testing is less common in more rural areas 
than in capital cities throughout Australia (Coory and Baade, 2005), and this could be 
contributing to the lower incidence in remote areas. Breast cancer may also be 
influenced by geographic variation in screening services, as there is variation in 
mammogram uptake by accessibility and socioeconomic status (Australian Institute 
of Health and Welfare & National Breast and Ovarian Cancer Centre, 2009). 
Similarly, the ease of access to skin cancer checking services in more urban areas 
may influence the incidence of melanoma. 
 
Strengths of the study include the use of routinely collected incidence data from a 
population-based registry to which notification of cancer is required by law. 
Queensland has the most decentralized population in Australia (Australian Bureau of 
Statistics, 2003), thus providing a unique opportunity to investigate these area-based 
differences in greater detail.  
 
Limitations of the study include the nature of cancer, which takes years to develop 
and be diagnosed. Therefore it is possible that the incidence of an area may reflect 
the risk factor prevalence from years earlier, rather than the current situation. Also, 
estimates were calculated based on area of residence at diagnosis. People may have 
migrated to different areas leading up to their cancer diagnosis, and any carcinogenic 
exposure or other area-level influences may have occurred at a different location to 
where they were diagnosed.  
 
The CART analysis was weighted by the inverse of the variance, which had the 
effect of placing greater priority on correctly identifying SLAs with high SIRs (or 
sensitivity), so the specificity (correct identification of SLAs with non-high SIRs) 
was found to vary considerably between cancers and gender. Two cancers with 
comparatively low sensitivity and specificity were prostate cancer and male 
melanoma. Therefore, results for these models should be treated with caution. 
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The ‘high’ SIR values were classified as an arbitrary cut-off of at least 10% above 
the Queensland average. This value was chosen to increase the probability that 
results were truly above the State average values. Since it was probable that choosing 
alternate cut-off values would influence the tree structure, sensitivity analyses (not 
shown) were performed under alternate cut-offs (5% and 15% above the Queensland 
average). Although different cut-off values often induced some variation in tree 
structure, the primary split remained identical for all cancers except for minor 
differences in the categories included on either side of the split for male lung cancer, 
female breast cancer, cervical cancer, prostate cancer and male non-Hodgkin’s 
lymphoma. 
 
Since the incidence of some cancers such as breast, melanoma and prostate is 
strongly influenced by screening practices, high incidence may result from 
overdiagnosis, where asymptomatic cancers are detected which would not otherwise 
have progressed to cause morbidity and/or death. While in this case a high incidence 
of cancers may not necessarily be an adverse outcome in itself, the morbidity 
associated with subsequent treatment is sometimes considerable (Australian Cancer 
Network Working Party on Management of Localised Prostate Cancer, 2002). 
Similarly, low incidence may not necessarily be beneficial if the cancers which are 
diagnosed are detected at a more advanced stage and therefore have worse prognosis. 
Consistent with other Australian Cancer Registries, the QCR does not routinely 
collect staging information for all cancers. Therefore it was not possible to 
differentiate between areas at high risk of having advanced cancers diagnosed, and 
those at high risk of having sub-clinical cancers diagnosed. 
 
Alternative methods are available to explore interactions. For instance, increasingly 
cancers are jointly modelled, either using multivariate structures on the relative risks, 
or latent class models (Downing et al., 2008). One benefit of these methods is using 
strength between the cancers to produce more efficient estimates (Held et al., 2005). 
By exploring spatial variation in common risk factors, latent class models can 
provide stronger evidence of any true clustering in the underlying risk surface (Held 
et al., 2005). However, under latent class joint modelling the shared components 
(risk factors) for each cancer are pre-specified, whereas the CART analysis 
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determines which of the risk factors are relevant for that cancer. The use of different 
modelling strategies may identify different features of the data that can lead to better 
understanding of the problem at hand and can thus lead to more informed inference. 
For example, in addition to being a valid approach in its own right, a CART model 
may identify useful interactions for inclusion in a subsequent (univariate or 
multivariate) regression analysis. 
 
4.6 Conclusions 
 
Identifying which area-level factors are associated with increased incidence enables 
targeting of resources as well as focusing further exploration for the underlying 
reasons. This study showed that the accessibility of an area was the main predictor of 
high incidence for most cancers examined. More often it was the more urban areas 
which had high cancer incidence, although notable exceptions were cervical and lung 
cancers (males). In addition, many cancers experienced interaction of the area-level 
effects, particularly between accessibility and socioeconomic status. These findings 
highlight the importance of conducting further research exploring the potentially 
complex reasons underlying these geographical inequalities. 
 
Appendix A: R code 
R code used for the CART model: 
 
library(rpart) 
 
#grow the classification tree 
fit<- rpart(fail ~ accessibility + socioeconomic + indigenous, weight=weight, 
method="class", parms=list(prior=c(.5,.5), split='information'), data=data, 
cp=0.0001) 
 
printcp(fit) # display the results  
plotcp(fit) # visualize cross-validation results  
summary(fit) # detailed summary of splits 
 
# plot tree  
plot(fit, uniform=TRUE, main="Classification Tree") 
text(fit, use.n=TRUE, all=TRUE, cex=.8) 
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# prune the tree  
pfit<- prune(fit, cp=  fit$cptable[which.min(fit$cptable[,"xerror"]),"CP"]) 
 
# plot the pruned tree  
plot(pfit, uniform=TRUE, main="Pruned Classification Tree") 
text(pfit, use.n=TRUE, all=TRUE, cex=.8) 
 
Appendix B: Variable importance 
 
Unpublished 
 
The improvement for each variable at the primary split is shown in Table B4.1. The 
actual value does not matter, rather, the relative size. The improvement is calculated 
as the number at the node multiplied by the change in impurity index. 
 
The overall variable importance (scaled to 100) is shown in Table B4.2. This is 
calculated as: 
𝐺𝑃 + 𝐺𝑆 × 𝐴 
where 𝐺 represents the goodness of fit for primary (subscript P) and surrogate 
(subscript S) splits, and A is the adjusted agreement. 
 
Table B4.1: Improvement values by variable at the primary split 
Type of cancer Gender ARIA SEIFA Indigenous 
Lung  Males 723.3 1979.5 669.9 
 Females 376.8 206.0 13.4 
Melanoma  Males 2006.8 752.2 609.0 
 Females 1299.5 790.2 630.6 
Breast Females 4422.8 1842.6 605.7 
Cervical Females 1724.7 1240.7 1704.8 
Prostate Males 2059.0 414.4 1266.1 
Non-Hodgkin's lymphoma  Males 905.4 199.1 526.0 
 Females 4358.8 611.0 863.6 
 
ARIA: Accessibility/Remoteness index of Australia 
SEIFA: Socioeconomic indexes for areas 
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Table B4.2: Variable importance overall (%) 
Type of cancer Gender ARIA SEIFA Indigenous 
Lung  Males 13 81 6 
 Females 42 51 7 
Melanoma  Males 61 13 27 
 Females 49 35 16 
Breast Females 66 19 15 
Cervical Females 55 29 17 
Prostate Males 52 25 23 
Non-Hodgkin's lymphoma  Males 60 21 19 
 Females 63 26 11 
 
ARIA: Accessibility/Remoteness index of Australia 
SEIFA: Socioeconomic indexes for areas 
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CHAPTER 5 
 
Inferring lung cancer risk factor patterns 
through joint Bayesian spatio-temporal analysis  
 
Preamble 
 
Often only limited risk factor data are available for small areas. This includes many 
cancer risk factors related to lifestyle, such as exercise, weight control, alcohol 
intake, diet and tobacco smoking. Of these, tobacco smoking is considered to 
contribute the greatest amount to the burden of disease. 
 
Within Australia, survey-based data has more recently been modelled to produce risk 
factor estimates by small areas (Population Health Information Development Unit, 
2012), but even then, many small areas had no estimates available due to data issues. 
These surveys are also typically measured at one point, and it is unknown how 
inequalities are changing over time. 
 
In this application-focused chapter, we sought to determine the feasibility of using 
population-based cancer data to understand underlying risk factor patterns across 
small-areas and time via a Bayesian shared component model. Not only do the 
Queensland small-areas contain fewer residents than areas previously examined 
using this model, but we also used annual time periods, instead of aggregating into 5-
year time periods. The sparseness of the resulting data caused us to investigate the 
use of alternative distributions to the Poisson, thus extending the previously 
developed model. 
 
This chapter addresses the third objective of, and was written as a journal article for 
which I am the principal author, and is reprinted here in its entirety. I was responsible 
for the study conception and design, statistical analysis, writing and modifying the 
manuscript. 
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5.1 Abstract 
 
Background 
Preventing risk factor exposure is vital to reduce the high burden from lung cancer. 
The leading risk factor for developing lung cancer is tobacco smoking. In Australia, 
despite apparent success in reducing smoking prevalence, there is limited 
information on small area patterns and small area temporal trends. We sought to 
estimate spatio-temporal patterns for lung cancer risk factors using routinely 
collected population-based cancer data.  
 
Methods 
The analysis used a Bayesian shared component spatio-temporal model, with male 
and female lung cancer included separately. The shared component reflected lung 
cancer risk factors, and was modelled over 477 statistical local areas (SLAs) and 15 
years in Queensland, Australia. Analyses were also run adjusting for area-level 
socioeconomic disadvantage, Indigenous population composition, or remoteness. 
 
Results 
Strong spatial patterns were observed in the underlying risk factor estimates for both 
males (median Relative Risk (RR) across SLAs compared to the Queensland average 
ranged from 0.48-2.00) and females (median RR range across SLAs 0.53-1.80), with 
high risks observed in many remote areas. Strong temporal trends were also 
observed. Males showed a decrease in the underlying risk across time, while females 
showed an increase followed by a decrease in the final two years. These patterns 
were largely consistent across each SLA. The high underlying risk estimates 
observed among disadvantaged, remote and indigenous areas decreased after 
adjustment, particularly among females. 
 
Conclusion 
The modelled underlying risks appeared to reflect previous smoking prevalence, with 
a lag period of around 30 years, consistent with the time taken to develop lung 
cancer. The consistent temporal trends in lung cancer risk factors across small areas 
support the hypothesis that past interventions have been equally effective across the 
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state. However, this also means that spatial inequalities have remained unaddressed, 
highlighting the potential for future interventions, particularly among remote areas.  
 
5.2 Introduction 
 
Due to its high incidence and low survival, lung cancer is the leading cause of 
cancer-related death in Australia (Australian Institute of Health and Welfare & 
Cancer Australia, 2011). More males are affected by this disease than females 
(Australian Institute of Health and Welfare & Cancer Australia, 2011). Most lung 
cancers are caused by cigarette smoking, accounting for around 65% of lung cancers 
among females and 90% among males (Ridolfo and Stevenson, 2001). Other 
modifiable risk factors include exposure to air pollution, radon, asbestos and certain 
heavy metals (Youlden et al., 2008).  
 
In the absence of effective early diagnostic tools or treatments for advanced lung 
cancer (Kathuria et al., 2014), preventing the initiation of lung cancer by reducing 
exposure to risk factors is vital. In particular, there has been much progress in 
reducing the prevalence of tobacco smoking in many developed countries (Jha and 
Peto, 2014). Between 1964 and 2010, the percentage of Australians who smoked 
cigarettes decreased from 43% to 15% (Organisation for Economic Cooperation and 
Development, 2013), although the prevalence of smoking among females increased 
until around the late 1970s, when it started to decline (Scollo and Winstanley, 2012). 
Yet this smoking prevalence varies geographically, with people living in rural and 
disadvantaged areas more likely to smoke (Australian Institute of Health and Welfare 
& Cancer Australia, 2011). However these geographical data are often compromised 
by small numbers and a reliance on self-reported surveys. This limits the ability to 
understand small area patterns of smoking prevalence, particularly over time.  
 
Given the lack of data on most risk factors at the spatial level, recent work has sought 
to model selected cancers jointly to extract spatial or spatio-temporal estimates of the 
common underlying risk factor components. Where high quality, population-based 
cancer registry data are available, this can be used to obtain objective risk factor 
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estimates. When a cancer has similar risk factors for both sexes, but a differential 
impact across space and/or time, there may be benefit in jointly modelling one cancer 
type and dividing into sex-specific components, e.g. male and female lung cancer. 
This joint modelling is often conducted using a shared component model. 
 
The premise of the shared component model, as first proposed by Knorr-Held and 
Best (Knorr-Held and Best, 2001), was to jointly model the relative risk by dividing 
into separate components, including one common to both diseases (e.g. representing 
the underlying risk factor exposure), as well as residual variation components (one 
for each disease). This enables information to be borrowed between diseases. In this 
model the shared component acts as a surrogate for spatially structured unobserved 
risk factors common to both diseases (Knorr-Held and Best, 2001). The model has 
been extended by incorporating covariates (Dabney and Wakefield, 2005), adjusting 
the number of components (Dabney and Wakefield, 2005), increasing the number of 
diseases (Held et al., 2005), and including temporal trends (Richardson et al., 2006; 
Tzala and Best, 2008). The joint modelling of multiple cancers at the spatial or 
spatio-temporal level has commonly been applied within a Bayesian context (Knorr-
Held and Best, 2001; Richardson et al., 2006).  
 
When there is only one shared component in these models, this component provides 
an estimate of all the risk factors common to the included diseases. However, when a 
particular risk factor is prominent in developing disease, such as tobacco smoking 
with lung cancer, underlying risk estimates are likely to reflect the most prominent 
risk factor. 
 
Our aims were to apply Bayesian spatio-temporal shared component models to 
routinely collected, population-based male and female lung cancer data to: 
 
1. Infer the spatio-temporal patterns of underlying lung cancer risk factors in 
Queensland. 
 
2. Determine how known influences (socioeconomic, remoteness and 
Indigenous status) impact on the modelled underlying risk factor patterns. 
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3. Identify geographical areas where the temporal underlying risk factor pattern 
differed from the pattern for total Queensland. 
 
5.3 Methods 
 
5.3.1 Data 
 
Lung cancers diagnosed among Queensland residents between 1997 and 2011 were 
sourced from the Queensland Cancer Registry (Queensland Cancer Registry, 2013a), 
a population-based cancer registry with high-quality data covering the entire state of 
Queensland. Australian legislation requires this Registry to be notified of every 
invasive cancer diagnosed in a Queensland resident, excluding only keratinocytic 
skin cancers. Ethical approval was obtained from Queensland Health (approval 
number: HREC/09/QHC/25).  
 
Details about patients’ usual residence at diagnosis were provided at the statistical 
local area (SLA) level. Geocoding was used to match the residence at diagnosis to 
the 2006 SLA definition, thus overcoming limitations of changing geographical 
boundaries over time. In 2006 there were 478 SLAs, with a median population of 
5,810.  
 
Population estimates based on the 2006 SLA boundaries were obtained from the 
Australian Bureau of Statistics, for each SLA, year and 5-year age groups up to 85+ 
years. Due to zero population counts in one SLA for several years during the time 
period of interest, only 477 SLAs were used in our analyses (population range in 
2006: 81 to 77,523). 
 
Each SLA was assigned a value for area-level socioeconomic disadvantage (3 
categories (Advantaged: top 20%, Middle SES: middle 60%, Disadvantaged: lowest 
20%), defined using the Index of socioeconomic advantage and disadvantage 
(IRSAD) from the Australian Bureau of Statistics Socioeconomic Indexes For Areas 
(SEIFA), remoteness (Urban (Major city), Regional (Inner/Outer regional) and 
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Remote (Remote/Very remote) based on the Accessibility/Remoteness Index of 
Australia+), and Indigenous population (2 categories based on 2006 census data: 
<10% or ≥10%). 
 
5.3.2 Model 
 
Most shared component models use a standard Poisson likelihood, as is appropriate 
for rare and non-contagious diseases. However, when area-specific count data are 
particularly sparse, an alternative formulation allowing for excess zero counts may 
be preferred. Therefore, we extended previous approaches by incorporating and 
comparing alternate distributions for the counts within the shared component 
framework. Specifically, we compared four alternative variants of the Poisson count 
distribution (Ntzoufras, 2009; Neelon et al., 2013): 
 
1. Poisson      𝑂𝑑𝑖𝑗~Poisson(𝜌𝑑𝑖𝑗𝐸𝑑𝑖𝑗) 
2. Negative binomial    𝑂𝑑𝑖𝑗~Poisson(𝑥𝑑𝜌𝑑𝑖𝑗𝐸𝑑𝑖𝑗) where 𝑥𝑑~Gamma(𝑟𝑑, 𝑟𝑑)  
3. Zero-inflated Poisson (ZIP) 𝑂𝑑𝑖𝑗~Poisson ((1 − 𝑢𝑑𝑖𝑗)𝜌𝑑𝑖𝑗𝐸𝑑𝑖𝑗) if 𝑂𝑑𝑖𝑗>0 
4. Poisson hurdle 𝑂𝑑𝑖𝑗~Poisson (
(1−𝑢𝑑𝑖𝑗)
1−exp (−𝜌𝑑𝑖𝑗𝐸𝑑𝑖𝑗)
𝜌𝑑𝑖𝑗𝐸𝑑𝑖𝑗) if 𝑂𝑑𝑖𝑗>0 
 
where 𝑂𝑑𝑖𝑗  are the observed lung cancer counts for each sex d=1,2 (representing 
males and females, respectively), i=1,2…477 areas and j=1,2…15 years, 𝜌𝑑𝑖𝑗 is 
commonly referred to as the relative risk (Lawson, 2013) and 𝐸𝑑𝑖𝑗  represents 
expected counts. To enable comparisons over time, the expected counts were 
calculated using the sex- and age-specific Queensland lung cancer incidence rates in 
1997-99. In the negative binomial model, here expressed as a Poisson-gamma 
mixture for comparability, 𝑟𝑑 is the sex-specific overdispersion parameter, which 
forms the shape and scale parameters in the gamma distribution, while the 𝑢𝑑𝑖𝑗 is the 
probability of zero in the ZIP and hurdle models. 
 
The Poisson hurdle model separates the zeros from anything above zero, modelling 
counts under a truncated Poisson distribution. The ZIP model can be considered a 
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special type of hurdle model. Here the zero counts are separated into excess (those 
above what is expected under a Poisson distribution) and non-excess zeros (those 
expected under a Poisson distribution).  
 
Using a modified version of the shared component model from Richardson et al 
(Richardson et al., 2006), the log relative risk for each of these models was then 
expressed as: 
 
log (𝜌𝑑𝑖𝑗)  = 𝛼𝑑 + 𝜇𝑑𝑖𝑗                                                                                
 
The sex-specific intercept is given by 𝛼𝑑, while the space-time structure is modelled 
through 𝜇𝑑𝑖𝑗, which represents exposure to the risk factors for lung cancer, here 
referred to as the underlying risk factor component. 
 
The underlying risk component is separated into several components so that spatial 
clustering and temporal trends can be presented separately. Log RRs of the 
underlying risk factor component for males (𝜇1𝑖𝑗) are constrained to capture the 
shared spatial and temporal trends, while the log RRs of the underlying risk factor 
estimates for females (𝜇2𝑖𝑗) include additional terms providing the sex differential, as 
follows:  
 
𝜇1𝑖𝑗 = 𝜆𝑖𝛿 + 𝜉𝑗𝜅 + 𝜙1𝑖𝑗                                                                       
         
𝜇2𝑖𝑗 =
𝜆𝑖
𝛿
+
𝜉𝑗
𝜅
+ 𝛽𝑖 + 𝛾𝑗 + 𝜙2𝑖𝑗 
 
where 𝜆𝑖 represents the common spatial pattern for SLAi, 𝛽𝑖 gives the female spatial 
difference (the sex-space interaction) for SLAi, 𝜉𝑗 is the shared time trend for 
calendar yearj, and 𝛾𝑗 the female temporal difference (the sex-time interaction) for 
calendar yearj. A sex-specific residual term 𝜙𝑑𝑖𝑗 was also included for the i
th SLA 
and jth year combination. The terms 𝛿  and 𝜅 are scaling parameters, enabling 
different risk gradients between sexes (Richardson et al., 2006).  
 
Prior distributions were assigned to each parameter as follows: the spatial 
components (𝜆𝑖, 𝛽𝑖) had a conditional autoregressive (CAR) prior with neighbours 
Chapter 5: Inferring lung cancer risk factor patterns 
 
 121 
 
based on adjacent SLAs, while temporal parameters had a one-dimensional CAR 
prior (𝜉𝑗, 𝛾𝑗) with neighbours consisting of the immediately previous and subsequent 
years. Because the CAR prior smooths the log RRs, spatio-temporal patterns can be 
recovered even when data are sparse. A zero-mean multivariate normal distribution 
with covariance matrix Σ was assigned to 𝜙𝑑𝑖𝑗. This term captures additional spatio-
temporal variation in each disease that is not explained by the other terms. To 
improve convergence, a centred parameterisation was used with the distribution 
specified on 𝜇𝑑𝑖𝑗, rather than directly on 𝜙𝑑𝑖𝑗. For identifiability, and as there were 
only 15 time periods, 𝜅 was fixed at a value of one (Richardson et al., 2006). Finally, 
log 𝛿 was described by a normal distribution, and 𝛼𝑑 by a normal distribution with 
large variance. Refer to Appendix A for further details on priors. 
 
To explore the impact of factors known to be associated with the prevalence of the 
main risk factor for lung cancer, tobacco smoking, covariates for area-level 
socioeconomic disadvantage, remoteness, and Indigenous population were added to 
the linear predictor. 
 
All models were run with single chain Markov Chain Monte Carlo (MCMC) using 
Stata version 13.1 (StataCorp LP, College Station, Texas, USA) interfaced with 
WinBUGS 1.4 (Imperial College and Medical Research Council, UK). The first 
300,000 iterations were discarded as burn-in, and a further 50,000 iterations 
monitored (with every tenth iteration kept).  
 
5.3.3 Sensitivity analyses 
 
We compared three commonly used versions of the hyperparameter distributions on 
the variance component of the spatial and temporal parameters for each of the four 
count distributions to check the influence exerted by priors on the results: 
Version 1: Gamma on the inverse variance (ie.  precision), 𝜏 ~ Γ(0.5, 2000)  
Version 2: Uniform on the standard deviation, 𝜎 ~ U(0.1,100) 
Version 3: Uniform on the standard deviation, 𝜎 ~ U(0.1,20) 
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These equate to means and variances on the precision of (1000,2 x 106) for the 
gamma distribution (version 1), and on the standard deviation of (50,832) for  
version 2 and (10,33) for version 3. These distributions deliberately aim to be non-
informative to minimise the risk of substantive influence on the estimates produced. 
 
All gave similar estimates and uncertainty measures for most parameters, so after 
examining deviance cumulative distribution functions, convergence trace and density 
plots, we selected version three.  Uniform distributions on the standard deviation 
have been recommended as more robust than gamma distributions on the precision 
(Gelman, 2006), and the tighter boundaries minimised convergence issues. 
 
One concern when examining diseases such as cancer is the potential influence of 
patient migration. People may have been exposed to an environmental or personal 
risk factor in one location, but then moved residence prior to diagnosis. Since 
information on residential history was not available before diagnosis, a sensitivity 
analysis was conducted to estimate the impact of changing location. Three 
alternatives were compared assuming up to a 10%, 20% and 40% population 
movement between SLAs. This internal migration was approximated by randomly 
increasing or decreasing the expected incidence count in each SLA up to the desired 
percentage, while constraining the overall count to match the Queensland total. The 
adjusted risk estimates for each scenario were categorised as low (<0.909), average 
(0.909-<1.10), and high (1.10+), and then these categories compared to those from 
the original scenario (0% migration). 
 
Given the data sparseness, a sensitivity analysis was conducted to ascertain if the 
modelled small area temporal trends were likely to reflect only the average trend due 
to inadequate data for individual SLAs. A modified version of the model was run 
with data aggregated by five broad remoteness groupings. No local spatial smoothing 
was performed between these areas, and the Poisson count distribution was used. All 
other model details remained the same. 
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5.3.4 Model comparison 
 
The deviance information criterion (DIC) is widely used in comparing Bayesian 
hierarchical models. However, it has a tendency to under-penalise complex models 
unless the effective number of parameters is much smaller than the number of 
independent observations, which may not occur in disease mapping (Plummer, 
2008). 
 
In light of this, we considered a collection of criteria representing different features 
of model fit – the overall goodness of fit (via the median squared predicted error 
(MSPE), Bayesian predictive p-value and L-criterion (Laud and Ibrahim, 1995), all 
of which compare model estimates against the data), the effective number of 
parameters (model complexity, defined as pD, which is the mean deviance minus the 
deviance at the mean of the posteriors and a component of DIC) (Spiegelhalter et al., 
2002), and the predictive distribution (via the conditional predictive ordinance 
(CPO)) (Congdon, 2006a). Lower values generally indicate better model fit, apart 
from Bayesian p-values (ideal is 0.5), or CPO, where many very low values suggest 
poor fit (Congdon, 2006a). 
 
5.4 Results 
 
The median number of observed lung cancer cases by SLA in 2011 was 2 for males 
(range: 0 to 29) and 1 for females (range: 0 to 25). The proportion of SLAs with no 
lung cancer cases diagnosed ranged from 33% (males) and 56% (females) in 1997 to 
28% and 39% in 2011 among males and females, respectively. Further details on the 
study cohort are available in Table 5.1. 
 
The different model distributions produced similar results for the majority of 
parameters, although the shared underlying risk factor estimates occasionally 
differed in very sparsely populated areas. There was minimal difference in model 
goodness of fit between the models (Table 5.2), but a slight preference for the 
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negative binomial formulation based on pD. Results presented are from the negative 
binomial model. 
 
Table 5.1: Study cohort and population characteristics, 1997-2011  
 Population Lung 
cancer 
cases 
Median 
IRSAD 
percentile 
N 
SLAs  
N SLAs with 
high indigenous 
population 
Total Queensland 57,990,293 26,664 50.5 477 55 
      
Sex      
  Male 28,937,540 17,313       
  Female 29,052,753 9,351       
      
Age structure      
  0-49 years 41,254,096 1,334       
  50-64 years 9,781,744 7,402       
  65-79 years 5,226,054 13,111       
  80+ years 1,728,399 4,817       
      
Years      
  1997-99 10,215,429 4,491       
  2000-02 10,734,471 4,810       
  2003-05 11,491,585 5,152       
  2006-08 12,338,515 5,898       
  2009-11 13,210,293 6,313       
      
Socioeconomic (IRSAD)      
  Advantaged  (top 20%) 9,164,720 2,952 90 95 0 
  Middle SES (middle 60%) 41,412,012 19,383 50.5 286 10 
  Disadvantaged  (lowest 20%) 7,413,561 4,329 11 96 45 
      
Remoteness (ARIA+)      
  Urban 33,456,103 15,034 71 252 0 
  Regional 21,443,351 10,239 35.5 144 6 
  Remote 3,090,839 1,391 14.5 81 49 
      
Indigenous population      
  High (10%+) 2,416,775 1,185 6 55 55 
  Other (<10%) 55,573,518 25,479 56 422 0 
ARIA+=Accessibility/Remoteness Index of Australia plus; IRSAD=Index of Socioeconomic Advantage and 
Disadvantage; SLA=Statistical Local Area 
 
Notes:  IRSAD percentiles are Queensland-specific, and high values indicate socioeconomic advantage. 
 IRSAD, ARIA+ and Indigenous population are defined based on SLA characteristics in 2006. 
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Table 5.2: Comparison of model fit measures under the final prior choice  
 MSPE Bayesian PPV L-criterion Effective 
number of 
parameters 
% 
CPO 
<0.01 
 Males Females Males Females  
Poisson 2.38 1.25 0.60 0.63 12888.4 574.2 0.8 
Negative binomial 2.45 1.25 0.60 0.64 13101.2 388.2 0.9 
ZIP 2.83 1.40 0.60 0.65 13753.2 518.8 1.1 
Poisson hurdle 2.51 1.32 0.60 0.64 13159.8 n.a. 1.0 
ZIP=Zero-inflated Poisson; n.a.=not available 
MSPE= Median squared predicted error, ie. (O-m)2. 
Bayesian PPV=predictive p-value, calculated as the probability of m>O, and ideally equal to 0.5. 
L-criterion=(sum of square root of (variance(m) + difference  from observed value(i.e. O-m)^2)). 
Effective number of parameters calculated as the posterior mean of the deviance minus the deviance of the 
posterior means (a component of Deviance Information Criterion (DIC). DIC is not calculated for hurdle models). 
CPO=Conditional predictive ordinate, also known as the leave-one-out predictive density as it represents the 
posterior probability of observing the value of Oi when the model is fitted to all data except Oi. Approximated 
here using the harmonic mean of the inverse likelihood of Oi. Very low values may represent outliers/influential 
observations. Model fit is considered adequate if few values are <0.01. 
 
 
Figure 5.1: Spatial variation in the underlying risk factor component by sex 
 
 
Note: Relative risk=1 corresponds to the specified Queensland average risk in 1997-99 (ie. males, females and the 
female: male differential, respectively). 
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Mapping the underlying risk factor component showed strong spatial variation 
throughout Queensland (Figure 5.1). The median SLA-specific underlying relative 
risks ranged across the State from 0.48 to 2.00 for males (exp(𝝀)), and 0.53 to 1.80 
for females (exp(𝝀 + 𝜷)). When females were compared to males (exp(𝜷)), many 
regions had similar risks (Figure 5.1). However, there were higher risk factor 
estimates among females in some urban South East areas, and lower risks among 
females in selected remote areas (Figure 5.1). 
 
Figure 5.2: Median relative risk of the male underlying risk component across 
time (exp(𝝁𝟏𝒊𝒋)) 
 
 
 
 
 
Note: Relative risk=1 corresponds to the Queensland male average risk in 1997-99. 
 
There was also strong evidence of trends across time in the underlying risk 
component (Figures 5.2 & 5.3). Males (exp(𝝃)) showed a decrease in the underlying 
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risk across time, while females (exp(𝝃 + 𝜸)) showed an increase followed by a 
decrease in the final two years (Figure 5.4). These patterns were practically 
universally consistent across each SLA. When data were aggregated by remoteness 
groupings, the same broad trend (exp(𝝁)) was observed across each remoteness 
group (Figure 5.4).   
 
Figure 5.3: Median relative risk of the female underlying risk component across 
time (exp(𝝁𝟐𝒊𝒋)) 
 
 
 
 
 
Note: Relative risk=1 corresponds to the Queensland female average risk in 1997-99. 
 
The high underlying risk factor estimates observed among disadvantaged, remote and 
indigenous areas decreased after adjustment, particularly among females (Figure 
5.5). Specifically, areas with a high Indigenous proportion largely explained the 
increased risk among disadvantaged and remote areas for females. 
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Figure 5.4: Time trends in the underlying relative risk by sex 
 
 
Notes: RR=Relative Risk 
            Black line is the median, blue shading represents the 80% credible interval. 
            Total Queensland results produced by the model based on statistical local areas (SLAs). 
            Results by remoteness produced by the model with broad remoteness groups replacing SLAs. 
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Figure 5.5: Relative risk (RR) of the underlying risk factor component before 
and after model adjustment, by remoteness, socioeconomic position and 
Indigenous population composition 
 
 
 
Risk factor estimates remained quite similar even after allowing for hypothetical 
migration patterns (Figure 5.6). As the proportion of migration increased, greater 
differences from the initial estimates were observed. However, even allowing for up 
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to 40% migration, few spatial underlying risk factor estimates changed between the 
broad categories of low, average or high risk. Both males and females had 6% of 
SLAs change from a higher to a lower category, while for males, 5% of SLAs moved 
from a lower to a higher category, and 9% of SLAs among females  
 
Figure 5.6: The median underlying risk with 80% credible intervals assuming 
up to x% migration by sex  
 
RR=Relative Risk; SLA=Statistical Local Area 
Note: SLAs ranked by the order in Figure 1 (0% migration) to enable comparison. 
 
5.5 Discussion  
 
This population-based study found strong evidence for differences by region of 
residence and across time in the shared underlying lung cancer risk factors. These 
patterns and trends are consistent with known trends in tobacco smoking prevalence 
(Australian Institute of Health and Welfare, 2011). Almost all areas followed a 
similar trend to that observed in the underlying risk factors overall (males decreasing 
and females increasing before recently decreasing). 
 
Tobacco smoking is the leading risk factor for developing lung cancer in Australia 
(Australian Institute of Health and Welfare, 2011), and the detected underlying risk 
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factor component is likely to strongly reflect past smoking patterns. Other key risk 
factors such as radon and/or air pollution exposure have very low levels in Australia 
(Australian Institute of Health and Welfare & Cancer Australia, 2011). However, 
some caution is required since 10-15% of lung cancers are diagnosed among non-
smokers (McCarthy et al., 2012).  
  
Patterns in the underlying risk factors by remoteness, socioeconomic disadvantage or 
areas with a high Indigenous population are also consistent with that reported for 
tobacco smoking (Australian Institute of Health and Welfare, 2011). Surveys have 
suggested around 50% of Indigenous Australians smoke cigarettes (Australian 
Bureau of Statistics, 2009a). Our results showed the increased risk in many 
disadvantaged or remote areas was diminished or annulled after adjusting for the 
Indigenous composition. This contrasted with the more minor changes observed after 
adjusting for remoteness or socioeconomic disadvantage.  
 
This methodology also allows trends over time for each region to be obtained. When 
data are very sparse, region-specific trends may simply reflect the overall average, so 
our consistent trends should be interpreted with caution. However, our sensitivity 
analysis using five broad remoteness groupings also obtained consistent temporal 
trends across these regions, supporting the hypothesis that the temporal patterns were 
consistent across most areas of Queensland.   
 
This is the first time the consistency in trends over time for lung cancer risk factors 
has been demonstrated at the small-area level within the Australian context. Tobacco 
smoking information reported in early surveys was not able to be analysed by small-
area geographic regions, and it has been unclear how trends across time varied across 
small regions. The similar trends  across time obtained for these small areas is 
consistent with the suggestion that smoking-related interventions were  equally 
effective across the different regions  of Queensland. Given that smoking-related 
interventions have incorporated state- or nation-wide price increases, public 
awareness of the health risks and advertising restrictions (Scollo and Winstanley, 
2012), this consistency in trends is not surprising. 
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Recently, small-area estimates of smoking prevalence were released for 2007-2008 
across Australia based on modelled self-reported survey data (Population Health 
Information Development Unit, 2012). A current smoker was defined as smoking 
cigarettes, cigars or pipes at least once a week. Although Queensland estimates were 
not available for many rural and remote SLAs, or sometimes only provided by 
aggregated SLAs, the results showed that smoking prevalence was generally higher 
outside of Brisbane.  This also agrees with 2011-2012 self-reported daily smoking 
estimates across 73 larger Queensland regions, with results released for 43 regions 
(Department of Health, 2013). Of the remote areas with available estimates, most 
showed higher smoking prevalence, while many urban areas tended to have lower 
estimates.  
 
The similarity of our geographical patterns to these recent results suggests past 
geographic differentials have not changed. Despite the overall decrease across time 
for males and more recently, females, many remote and rural areas are likely to 
continue to have higher smoking prevalence for many years into the future, unless 
preventive and remedial efforts are targeted at these areas. Given that population-
wide intervention programs have been shown to be more cost effective in tobacco 
control (World Health Organization, 2013), potential interventions should aim to 
address the prevailing social norms and practices, rather than an individualistic 
approach (Blue et al., 2014). This may include addressing the higher density of 
tobacco outlets and lower cigarette prices in socioeconomically disadvantaged areas 
(Dalglish et al., 2013).     
 
Although there are advantages in using population-based cancer data to understand 
risk factor patterns, there are also limitations. Only past estimates can be obtained, as 
the lag period between exposure and development of cancer suggests our underlying 
risk estimates are likely to reflect smoking prevalence up to 30 years previously 
(Youlden et al., 2008). Although theoretically all cancers with smoking as a risk 
factor could be included to obtain estimates, we found including a less common 
cancer (oesophageal), despite a strong link to smoking, decreased the precision of the 
estimates. This might reflect the influence of other key risk factors on oesophageal 
cancer, such as alcohol intake (International Agency for Research on Cancer, 2010), 
Chapter 5: Inferring lung cancer risk factor patterns 
 
 133 
 
or the sparseness of our data. In addition to tobacco smoke exposure, it is possible 
that these patterns reflect the impact of other risk factors (despite their rarity in the 
Australian context) that may also be captured in the underlying exposure component. 
 
The similarity of smoking patterns and lung cancer patterns raises the question of 
whether our latent component is simply detecting lung cancer, rather than an estimate 
of underlying exposure. In our model, the lung cancer relative risk (𝜌𝑑𝑖𝑗) is 
dependent on the sex specific intercept, any included covariates, and our latent 
component. The intercept terms consistently differed from one, with resultant 
differences in the relative risk estimates of lung cancer and latent components. 
  
The novelty of our approach is two-fold. Firstly, a review of the literature found no 
published comparisons of these four alternate count distributions in a fully Bayesian 
spatio-temporal shared component model. We are also not aware of these models 
being applied to such sparse data before, resulting both from the Australian context 
with its relatively small population across a large land area, and examining annual 
time periods. 
 
The small difference in model fit between the Poisson model and the three models 
allowing for excess zeros (negative binomial, ZIP and hurdle Poisson) at first seemed 
counter-intuitive given the large proportion of zeros. This is likely to be influenced 
by both the random effects included in the model, which allow for overdispersion, 
and the comparatively large number of cases observed in some SLAs. 
 
Both the ZIP and Poisson hurdle models can be considered mixture models, and we 
found that some underlying exposure estimates did not converge as well as under 
Poisson or negative binomial. The assumptions of a hurdle model (that zeros 
represent an inability to have a positive result) is questionable, although in our 
modelling of 𝜇 we assumed all areas and time periods had the ability to have lung 
cancer diagnosed, equating to assuming that all areas/time periods had a positive 
count. The negative binomial distribution was slightly preferred, but was the most 
computationally intensive model, taking twice as long as the  Poisson model to run. 
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If time had been an issue, the Poisson distribution could have been used instead in 
this study. 
 
Many variations on this model are possible, either by adjusting the included 
components (inserting and/or removing terms), or using alternative priors. For 
instance, we explored using a first-order autoregressive (AR(1)) prior instead of a 
CAR prior on the temporal components, which would have only smoothed based on 
the previous time period. This prior is useful when the aim is to extrapolate into the 
future. However, our aim was to identify smoothed patterns, and the larger 
uncertainty around estimates and less smoothing under the AR(1) resulted in 
preferring the CAR prior.  We also considered including a shared spatio-temporal 
interaction term 𝜈𝑖𝑗. However, estimates were all close to 1, so the additional model 
complexity was not justified.   
 
Similar methodology could be used to explore spatio-temporal variation in other 
disease risk factors. For instance, trends and patterns in diet-related influence were 
examined in Greece using a factor analysis model containing six cancers with 
particular dietary factors as recognised risk factors (Tzala and Best, 2008). Obesity 
has strong links to several cancers, and this may be a useful approach to obtain 
temporal and small-area estimates of obesity, which can be poorly self-reported.  
 
In conclusion, these shared component models have provided evidence supporting 
the similarity of temporal trends in lung cancer risk factors across small geographical 
areas, consistent with the hypothesis that past interventions designed to reduce lung 
cancer risk factors have been equally effective across the state. However, this 
consistency  in  temporal trends also means that current inequalities in these risk 
factors between areas have remained unaddressed, highlighting the potential for 
future interventions targeting the social norms and practices of people living in rural 
and remote areas.  
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Appendix A: Prior distributions 
 
Prior distributions (expressed as mean, precision): 
      
𝛼𝑑~Normal(0, 0.001) 
 
[
𝜇1𝑖𝑗
𝜇2𝑖𝑗
] ~MVN ([
𝜂1𝑖𝑗
𝜂2𝑖𝑗
] , Σ−1) 
 
𝛌~CARNormal(𝑊, 𝜏𝜆) 
 
𝛃~CARNormal(𝑊, 𝜏𝛽) 
 
𝛏~CARNormal(𝑄, 𝜏𝜉) 
 
𝛄~CARNormal(𝑄, 𝜏𝛾) 
 
log𝛿~Normal(0,0.2) 
 
MVN=Multivariate Normal, CARNormal=Conditional Autoregressive Normal. 
 
Note that by centring log𝛿 around 0, we are assuming that any value of 𝛿 is as likely 
as any value of 1/𝛿 (Knorr-Held and Best, 2001). This would allow the indices for 
the sexes to be switched and still the same posterior distributions to be obtained for 
each sex, as the posterior distribution on 𝛿 would change to the reciprocal.  
 
Hyperprior distributions: 
 
Σ−1~Wishart ([
0.01 0
0 0.01
] , 2) 
 
1
√𝜏𝜆
~Uniform(0.1,20) 
 
1
√𝜏𝛽
~Uniform(0.1,20) 
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1
√𝜏𝜉
~Uniform(0.1,20) 
 
1
√𝜏𝛾
~Uniform(0.1,20) 
 
The Wishart distribution is the conjugate for the precision parameter of the 
multivariate normal distribution, and is treated as a multivariate chi-squared 
distribution.  
 
Appendix B: Additional results 
 
Unpublished 
 
Estimates of the variance hyperparameter terms are shown in Table B5.1. Relative 
risk estimates for model parameters are shown where feasible in Table B5.2. All 
results are from the final version of the model using a negative binomial distribution. 
 
Table B5.1: Variance hyperparameter estimates by model 
 
Unadjusted 
Adjusted for 
disadvantage 
Adjusted for 
remoteness 
Adjusted for 
Indigenous 
 Median (80% CrI) Median (80% CrI) Median (80% CrI) Median (80% CrI) 
𝜏𝛽
−1
 0.013 (0.001,0.024) 0.012 (0.001,0.023) 0.007 (0.003,0.017) 0.013 (0.002,0.022) 
𝜏𝛾
−1
 0.006 (0.003,0.012) 0.006 (0.003,0.013) 0.006 (0.003,0.012) 0.006 (0.003,0.012) 
𝜏𝜆
−1
 0.211 (0.171,0.250) 0.169 (0.136,0.202) 0.216 (0.170,0.259) 0.201 (0.163,0.236) 
𝜏𝜉
−1
 0.001 (0.001,0.003) 0.001 (0.001,0.003) 0.001 (0.001,0.003) 0.001 (0.001,0.003) 
Σ components       
1_1 0.000 (0.000,0.000) 0.000 (0.000,0.000) 0.000 (0.000,0.001) 0.000 (0.000,0.000) 
1_2 0.001 (0.000,0.008) 0.002 (0.000,0.028) 0.001 (0.000,0.023) 0.001 (0.000,0.030) 
2_1 0.001 (0.000,0.008) 0.002 (0.000,0.028) 0.001 (0.000,0.023) 0.001 (0.000,0.030) 
2_2 0.000 (0.000,0.001) 0.000 (0.000,0.001) 0.000 (0.000,0.001) 0.000 (0.000,0.001) 
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Table B5.2: Relative risk estimates for selected parameters 
 
Unadjusted 
Adjusted for 
disadvantage 
Adjusted for 
remoteness 
Adjusted for 
Indigenous 
 Median (80% CrI) Median (80% CrI) Median (80% CrI) Median (80% CrI) 
Β1   1.00  1.00  1.42 (1.28,1.60) 
Β2   1.30 (1.22,1.38) 0.92 (0.87,0.98) 1.00  
Β3   1.69 (1.55,1.83) 1.15 (1.01,1.30) 1.37 (1.21,1.58) 
Β4   1.00  1.00  1.00  
Β5   1.25 (1.17,1.34) 0.81 (0.76,0.88)   
Β6   1.55 (1.37,1.71) 0.99 (0.86,1.13)   
𝜉1 1.14 (1.09,1.18) 1.14 (1.08,1.18) 1.13 (1.09,1.18) 1.13 (1.09,1.17) 
𝜉2 1.11 (1.07,1.14) 1.11 (1.07,1.14) 1.11 (1.07,1.14) 1.10 (1.07,1.14) 
𝜉3 1.09 (1.06,1.13) 1.10 (1.06,1.13) 1.10 (1.06,1.13) 1.10 (1.06,1.13) 
𝜉4 1.06 (1.03,1.09) 1.06 (1.03,1.10) 1.06 (1.03,1.09) 1.06 (1.03,1.09) 
𝜉5 1.04 (1.01,1.07) 1.04 (1.01,1.07) 1.04 (1.01,1.06) 1.04 (1.01,1.07) 
𝜉6 1.00 (0.98,1.03) 1.00 (0.98,1.03) 1.00 (0.98,1.03) 1.01 (0.98,1.03) 
𝜉7 0.97 (0.94,1.00) 0.97 (0.94,1.00) 0.97 (0.94,1.00) 0.97 (0.94,1.00) 
𝜉8 0.98 (0.96,1.01) 0.98 (0.96,1.01) 0.98 (0.96,1.01) 0.98 (0.96,1.01) 
𝜉9 0.98 (0.96,1.01) 0.98 (0.95,1.01) 0.98 (0.96,1.01) 0.98 (0.96,1.01) 
𝜉10 0.99 (0.97,1.02) 0.99 (0.96,1.01) 0.99 (0.97,1.02) 0.99 (0.97,1.02) 
𝜉11 0.96 (0.94,0.99) 0.96 (0.94,0.99) 0.96 (0.94,0.99) 0.96 (0.94,0.99) 
𝜉12 0.96 (0.94,0.99) 0.96 (0.93,0.99) 0.96 (0.93,0.99) 0.96 (0.93,0.99) 
𝜉13 0.93 (0.90,0.96) 0.93 (0.90,0.96) 0.93 (0.91,0.96) 0.93 (0.90,0.96) 
𝜉14 0.92 (0.90,0.95) 0.92 (0.90,0.95) 0.92 (0.89,0.95) 0.92 (0.90,0.95) 
𝜉15 0.90 (0.87,0.93) 0.90 (0.87,0.93) 0.90 (0.87,0.93) 0.90 (0.87,0.93) 
𝛾1 0.79 (0.74,0.85) 0.78 (0.74,0.84) 0.78 (0.73,0.84) 0.79 (0.74,0.85) 
𝛾2 0.80 (0.76,0.85) 0.81 (0.76,0.86) 0.80 (0.76,0.86) 0.80 (0.76,0.86) 
𝛾3 0.79 (0.74,0.85) 0.79 (0.74,0.85) 0.80 (0.75,0.85) 0.80 (0.75,0.85) 
𝛾4 0.88 (0.83,0.92) 0.87 (0.83,0.92) 0.87 (0.83,0.93) 0.87 (0.83,0.93) 
𝛾5 0.93 (0.88,0.99) 0.93 (0.89,0.99) 0.93 (0.88,0.99) 0.93 (0.88,0.98) 
𝛾6 0.99 (0.94,1.04) 0.99 (0.94,1.04) 0.99 (0.94,1.04) 0.99 (0.94,1.03) 
𝛾7 0.96 (0.91,1.01) 0.95 (0.91,1.00) 0.96 (0.91,1.01) 0.96 (0.91,1.01) 
𝛾8 1.04 (0.99,1.09) 1.04 (1.00,1.09) 1.04 (0.99,1.09) 1.04 (0.99,1.09) 
𝛾9 1.04 (1.00,1.09) 1.05 (1.00,1.10) 1.04 (1.00,1.09) 1.04 (1.00,1.09) 
𝛾10 1.04 (1.00,1.09) 1.04 (0.99,1.09) 1.04 (1.00,1.09) 1.04 (0.99,1.09) 
𝛾11 1.09 (1.02,1.14) 1.09 (1.03,1.14) 1.08 (1.02,1.14) 1.09 (1.03,1.14) 
𝛾12 1.15 (1.08,1.20) 1.15 (1.09,1.20) 1.15 (1.09,1.20) 1.15 (1.08,1.21) 
𝛾13 1.26 (1.18,1.34) 1.27 (1.19,1.34) 1.27 (1.19,1.34) 1.27 (1.19,1.34) 
𝛾14 1.24 (1.17,1.30) 1.24 (1.17,1.30) 1.24 (1.17,1.30) 1.24 (1.16,1.30) 
𝛾15 1.18 (1.11,1.24) 1.17 (1.10,1.24) 1.18 (1.11,1.25) 1.17 (1.10,1.24) 
𝛿 1.07 (1.02,1.12) 1.03 (0.98,1.08) 1.06 (1.02,1.11) 1.07 (1.01,1.12) 
Notes: Results are only shown for parameters where feasible, which excludes any parameters by area. B are the 
covariates included in adjusted models, 𝜉 is the main time effect by year, γ represents the sex-time interaction, 
and 𝛿 is the scaling parameter associated with 𝝀. The scaling parameter 𝜅 associated with 𝜉 was set to one. 
The interpretation of B differs by the model adjustment. For remoteness: B1 and B4 represent urban males and 
females, respectively. B2 and B5 represent regional males and females respectively. B3 and B6 represent remote 
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males and females respectively. For area-level disadvantage, B1 and B4 represent advantaged (top 20%) males 
and females, respectively, B2 and B5 represent middle SES males and females respectively, and B3 and B6 
represent disadvantaged (lowest 20%) of males and females, respectively. For Indigenous ethnicity, B1 and B3 
represent areas with an Indigenous population proportion of at least 10% for males and females, respectively, and 
B2 and B4 represent males and females for other areas, respectively. 
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CHAPTER 6 
 
Spatial inequalities in colorectal and breast 
cancer survival: Premature deaths and 
associated factors 
 
Preamble 
 
Effective action to address spatial inequalities is not possible unless the influencing 
factors can be determined. In this study we focused on the two cancers showing 
evidence of spatial survival inequalities that had tumour stage information available: 
breast and colorectal cancers. This was the first spatial relative survival analysis to 
incorporate tumour stage information. The influence of area-level socioeconomic 
disadvantage and distance to radiotherapy treatment was also considered. 
 
Similarly, as helpful as determining patterns in spatial inequalities can be, unless the 
impact of these inequalities are quantified, prioritising appropriately may be difficult. 
Yet no methods were available to enable this quantification from a fully Bayesian 
hierarchical spatial survival model. In this chapter, a method is proposed to achieve 
this. 
 
The focus of this chapter was to both understand the influence of certain prognostic 
factors on spatial survival inequalities and quantify the differences, as part of 
objective 4. As such, innovations in both application and methodology are presented 
here. 
 
This chapter was written as a journal article for which I am the principal author, and 
is reprinted here in its entirety. I was responsible for the statistical analysis, writing 
and modifying the manuscript, and also contributed to the study conception and 
design. 
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6.1 Abstract 
 
This study examines the influence of cancer stage, distance to treatment facilities and 
area disadvantage on breast and colorectal cancer spatial survival inequalities.  We 
also estimate the number of premature deaths after adjusting for cancer stage to 
quantify the impact of spatial survival inequalities. Population-based descriptive 
study of residents aged <90 years in Queensland, Australia diagnosed with primary 
invasive breast (25,202 females) or colorectal (14,690 males, 11,700 females) 
cancers during 1996-2007. Bayesian hierarchical models explored relative survival 
inequalities across 478 regions. Cancer stage and disadvantage explained the spatial 
inequalities in breast cancer survival, however spatial inequalities in colorectal 
cancer survival persisted after adjustment. Of the 6,019 colorectal cancer deaths 
within 5 years of diagnosis, 470 (8%) were associated with spatial inequalities in 
non-diagnostic factors, i.e.  factors beyond cancer stage at diagnosis. For breast 
cancers, of 2,412 deaths, 170 (7%) were related to spatial inequalities in non-
diagnostic factors. Quantifying premature deaths can increase incentive for action to 
reduce these spatial inequalities. 
 
6.2 Background 
 
Worldwide, breast cancer is the most common cancer in women, while colorectal 
cancer is the second most commonly diagnosed among women, and third most 
common among men (Ferlay et al., 2010a).  In developed nations, including 
Australia, survival for both these cancers has improved over recent decades 
(Australian Institute of Health and Welfare and Cancer Australia & Australasian 
Association of Cancer Registries, 2008), with Australia having one of the highest 
survival rates in the world (Coleman et al., 2011).   
 
However, the improvement in survival has not been observed equally across all 
population subgroups. Inequalities for both breast and colorectal cancer survival have 
been reported by deprivation and differences in health care access (Du et al., 2011; 
McKenzie et al., 2011). Within Australia, poorer survival has been observed for 
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those in areas of greater socio-economic disadvantage, geographic remoteness and, 
for rectal cancer, further distance to radiotherapy facilities (Australian Institute of 
Health and Welfare and Cancer Australia & Australasian Association of Cancer 
Registries, 2008; Baade et al., 2011b; Cramb et al., 2011a).  
 
The quality of patient management can be gauged by survival (Yu et al., 2004). The 
prognosis for breast and colorectal cancer depends in large part on the stage of 
disease at diagnosis (Schottenfeld and Fraumeni Jr, 2006), which may vary 
geographically (Tian et al., 2011; Tian et al., 2012).  Beyond that, the outcome 
depends on other non-diagnostic factors such as treatment, rehabilitation, 
environmental factors such as area disadvantage, and patient characteristics including 
comorbidities (Yu et al., 2005), all of which could potentially contribute  to 
geographical variation in cancer survival. Throughout this paper we use the term 
“non-diagnostic” to encompass these other factors.  
 
Since only a few population-based cancer registries collect stage information, not 
many studies have been able to separate the effect of diagnostic from other factors on 
geographic inequalities in cancer survival on a population basis. In New South Wales 
(NSW), Australia, it was found that adjusting for stage did not reduce the survival 
differential for colorectal cancer (Yu et al., 2005). However, in Italy, stage at 
diagnosis explained most of the colorectal cancer survival inequalities between 
Northern and Southern areas, while treatment had a minimal role (Fusco et al., 
2010). In England, stage at diagnosis and deprivation were important causes of breast 
cancer survival inequalities (Davies et al., 2010).  
 
However these previous studies have used relatively large geographical regions, 
which reduce the ability to measure spatial variation and can limit interpretation 
because of the greater heterogeneity within those regions. In contrast, inequalities in 
cancer survival at the small-area level have rarely been examined, typically due to 
difficulties associated with sparse data in small geographical areas and in accounting 
for the spatial correlation between neighbouring areas (Wakefield and Elliott, 1999). 
Bayesian hierarchical methods overcome both problems by incorporating 
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information from neighbouring areas for each estimate, producing more reliable 
small-area estimates (Carlin and Xia, 1999b).  
 
Spatial survival analysis is an emerging field. Most analyses have focused on cause-
specific survival (Huang et al., 2007; Henry et al., 2009; Wan et al., 2012). We 
chose to instead use Bayesian hierarchical methods to model relative survival 
(Fairley et al., 2008; Saez et al., 2012), where cancer patient mortality is compared 
against mortality in the population of similar age, sex and time period. Our focus was 
on comparing survival up to 5-years after diagnosis. 
 
To quantify the impact of spatial inequalities in cancer survival, previous studies 
have calculated the number of deaths that could have been prevented within a given 
timeframe if there was no systematic regional variation in survival (Dickman et al., 
1997; Yu et al., 2004). These estimates of avoidable premature deaths provide an 
objective measure by which to advocate for resource allocation and establish health 
priorities (Yu et al., 2004). 
 
This study has two aims: 
1. To examine the influence of cancer stage at diagnosis, distance to treatment 
facilities and area-disadvantage on spatial survival inequalities for breast and 
colorectal cancer, and 
2. To estimate the number of premature deaths due to non-diagnostic-related 
spatial survival inequalities after adjusting for cancer stage at diagnosis. 
 
6.3 Methods 
 
6.3.1 Data 
 
Study cohort 
 
Data on colorectal  (ICD-O3 C18-C20,C218) and breast  (ICD-O3 C50) cancers 
diagnosed in Queensland during 1996 to 2007 were obtained from the Queensland 
Cancer Registry (QCR) following approval from Queensland Health (Ethics approval 
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number: HREC/09/QHC/25). Due to small numbers, male breast cancers were 
excluded from analysis. The QCR is a population-based registry which has been in 
operation since 1982 (Queensland Cancer Registry, 2013b), and covers a population 
of 4.2 million (in 2007) (Australian Bureau of Statistics, 2008d). Notification of 
cancer (excluding non-melanoma skin cancer) to the QCR is required by law 
(Queensland Cancer Registry, 2013b). Data quality is high, as evidenced by the high 
percentage of cases diagnosed with histological verification (92.1%) and low 
percentage of cases diagnosed by death certificate only (1.4%) in 2007. 
 
The survival analysis included the first occurrence of a primary colorectal or breast 
cancer in individuals aged less than 90 years at diagnosis. Cases were excluded if 
they lacked age or SLA of residence information, were identified at autopsy, notified 
via death certificate only or had a survival time of less than one day. All cases were 
followed until 31st December 2007. 
 
Stage at diagnosis 
 
Colorectal cancer stage was extracted from pathology records held by the QCR 
(Krnjacki et al., 2008) and then classified based on the Dukes staging system (Haq et 
al., 2009). To increase accuracy (Krnjacki et al., 2008) and reduce problems with 
sparse data, stage was grouped into three categories: early (localized/non-localized), 
advanced (regional/distant) and unknown.  
 
The QCR does not collect detailed information about breast cancer stage at 
diagnosis. However, consistent with recent reports (Krnjacki et al., 2008; Youlden et 
al., 2009; Baade et al., 2011c), “Early” breast cancer was defined as ≤20 mm 
diameter with no evidence of lymph node involvement or distant metastases (stage I). 
Although it was unlikely these cases had metastasized, this could not be established.  
There was insufficient detail to distinguish between stages II, III or IV, so these were 
collectively categorized as “Advanced” breast cancers. Cancers diagnosed as a result 
of metastatic disease were included in this category.  The “Unknown” category 
included those with unknown tumour size or unknown lymph node status if the 
tumour size was ≤ 20mm.    
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Geographical location 
 
Statistical Local Areas (SLAs) were used as the region of analysis. Cancer incidence 
data across all years were mapped to the 2006 SLA boundaries based on suburb and 
postcode of residence prior to data extraction. In 2006 Queensland had 478 SLAs, 
which covered the State without gap or overlap, with a median population of 5,810 
(range: 7 to 77,523). 
 
Based on their SLA of residence, each patient was assigned to a quintile of area 
disadvantage based on the Australian Bureau of Statistics (ABS) Socioeconomic 
Indexes for Areas Index of Relative Disadvantage (SEIFA-IRSD) (Australian Bureau 
of Statistics, 2008c).  
 
Distance to treatment 
 
The distance to the closest radiation facility was calculated by geocoding the location 
of all radiation facilities in Queensland, and the centroid of each SLA at diagnosis. A 
custom GIS application was used to calculate the shortest travelling time by road 
from each SLA centroid to the closest radiation facility by each year to account for 
increasing coverage of the radiation facilities over time. Radiotherapy facilities are 
only located in larger cities. By the end of 2007 there were a total of 4 public and 5 
private radiotherapy facilities in Queensland. Five (3 public and 2 private) were 
located in Brisbane, three additional private facilities were located within a 125 km 
radius of Brisbane, and another public facility in Townsville (1,360 km north of 
Brisbane). 
 
Distance was classified into three categories based on practical considerations to 
improve the interpretation of estimates: < 2 hours (return travel within one day), 2-6 
hours (one full day of travelling) and > 6 hours (more than one day of travel with 
overnight accommodation required). 
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6.3.2 Survival estimates 
 
Unadjusted relative survival estimates were calculated using actuarial (life table) 
methods (Appendix A). Expected survival was estimated using the Ederer II method 
(Ederer and Heise, 1959)  with the Stata macro strs, based on Queensland life tables 
generated from mortality data obtained from the ABS. The population mortality was 
calculated by each SLA, gender and 5-year age group (to ages 90+). Estimates were 
calculated for two aggregated time periods for greater stability; 1997-2002 and 2003-
2007, and then applied to each year within the appropriate time period. 
 
Survival estimates were derived using period analysis, in which survival is calculated 
using patients alive during the time period of interest (Brenner and Hakulinen, 2009). 
Since the focus was on estimating survival inequalities up to 5 years after diagnosis, 
each individual’s follow-up time was censored at 5 years after diagnosis.  
 
The expected number of deaths, person time at risk, and deaths in the interval was 
calculated for each individual, then aggregated over each combination of SLA (1 to 
478 areas), follow-up period (1 to 5 years after diagnosis) and covariates consisting 
of age at diagnosis (0-49, 50-69 and 70-89 years), stage at diagnosis (early, advanced 
and unknown), distance to treatment facilities (<2 hours, 2 – 6 hours and 6+ hours) 
and for colorectal cancer, gender (male and female). Since there was an exact 
concordance between SLA and area disadvantage, aggregating by area disadvantage 
was not required. 
 
6.3.3 Statistical model 
 
The Bayesian spatial survival model adopted for this analysis assumed the hazards 
were constant within pre-specified follow-up time intervals, and was based on the 
model described by Fairley et al (Fairley et al., 2008), 
 
𝑑𝑘𝑡𝑖~Poisson(𝜇𝑘𝑡𝑖) 
log(𝜇𝑘𝑡𝑖 − 𝑑𝑘𝑡𝑖
∗ ) = log(𝑦𝑘𝑡𝑖) + α𝑡 + x𝑘β + 𝑢𝒊 + 𝑣𝑖                         [1]          
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where 𝑑𝑘𝑡𝑖, the observed deaths in the k
th stratum, tth follow-up interval and ith SLA  
follows a Poisson distribution with mean 𝜇𝑘𝑡𝑖, (𝜇𝑘𝑡𝑖 − 𝑑𝑘𝑡𝑖
∗ ) is the modelled number 
of excess deaths with 𝑑𝑘𝑡𝑖
∗  representing the expected number of deaths due to other 
causes, 𝑦𝑘𝑡𝑖 is person-time at risk, α𝑡 is an intercept which varies by time, 𝛽𝑘 is the 
coefficient vector of the predictor variable vector x (representing broad age at 
diagnosis groups, distance to treatment, area disadvantage, stage and, for colorectal 
cancer, gender), 𝑢𝑖 is the spatial random effects for the i
th SLA and 𝑣𝑖 is the 
unstructured random effects. Non-informative normal distributions were used as 
priors on the parameters, apart from 𝑢𝒊 which was assigned an intrinsic conditional 
autoregressive (CAR) prior. Refer to Appendix B for further information on the prior 
distributions. 
 
The effects of age, stage, area disadvantage and distance to treatment were explored 
by including various combinations in models. The Deviance Information Criterion 
(DIC)  (Spiegelhalter et al., 2002) was used to compare model goodness of fit, with 
lower values indicating a better model.  
 
The exponential of the parameter estimates are the excess hazard ratios, also called 
relative excess risks (RERs).  The RERs for estimates of the impact of the covariates 
of interest were calculated as exp(β) from Equation (1), and were in comparison to 
the baseline level of the covariate. For the estimates in each SLA the RER was 
calculated as exp(𝑢𝑖 + 𝑣𝑖), and provided an estimate of the excess risk of death in 
that SLA against the Queensland average excess risk of death.  
 
The models were analysed using Markov chain Monte Carlo (MCMC), via 
WinBUGS (Imperial College and Medical Research Council, UK), interfaced with 
Stata  (StataCorp, Texas) (Thompson et al., 2006). A burn-in period of 250,000 
iterations was discarded, and a further 100,000 iterations monitored (with every 10th 
iteration kept). A global clustering test (Tango’s Maximized Excess Events Test 
(MEET) (Tango, 2000)) was used to determine if there was significant variation in 
the RER estimates across the SLAs. This method was preferred over other global 
clustering tests as it has been shown to effectively identify overall spatial variation 
across a variety of datasets (Kulldorff et al., 2006). 
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The 80% credible interval (CrI) was provided for all posterior distributions, as this is 
considered to provide sufficient coverage (Richardson et al., 2004). For non-
Bayesian analyses we used the standard 95% confidence interval (CI). 
 
The probability of a specific estimate being higher than the estimate in the previous 
category can be used as an alternative to the credible interval when comparing 
categories. High values (above 80% when expressed as a percentage, consistent with 
80% credible intervals) indicate the estimate is likely to be above the former 
category. This was calculated as the percentage of MCMC iterations for a given 
estimate that were higher than the preceding stratum-specific estimate, and was 
provided for RER and the proportion of premature deaths. 
 
6.3.4 Premature deaths 
 
In calculating the number of premature deaths, we set the optimum benchmark for 
survival to be equal to the 20th centile RER of ranked SLAs, consistent with other 
published results (Yu et al., 2004). To exclude the diagnostic component of survival, 
and quantify only the non-diagnostic survival component, we used results from the 
Bayesian spatial survival model (equation 1) that included stage, along with age and 
gender. Areas with an RER below the 20th centile were excluded from the 
calculations of observed deaths (𝑑𝑘𝑡𝑖), expected deaths due to other causes (𝑑𝑘𝑡𝑖
∗ ) and 
person-time at risk (𝑦𝑘𝑡𝑖) to avoid theoretically increasing their risk of death to the 
20th centile. 
 
There were three parameters required to calculate premature deaths resulting from 
spatial inequalities: observed excess deaths, optimum excess deaths and the spatial 
fraction.  
 
Observed excess deaths 
 
In relative survival the ‘excess deaths’ are the deaths considered to be caused by the 
cancer. Instead of counting a death if the death certificate recorded it as a cancer 
death (as in cause-specific survival), all deaths among cancer patients are compared 
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against the mortality that would be expected among people of similar age, gender, 
SLA of residence and broad time period. This prevents bias due to inaccuracies in 
coding deaths. 
 
The modelled number of excess deaths within five years of diagnosis is calculated as 
𝜇𝑘𝑡𝑖 − 𝑑𝑘𝑡𝑖
∗  (from equation 1). The observed number of excess deaths within five 
years of diagnosis at each stratum is: 
 
𝐷𝑘 = ∑ ∑(𝑑𝑘𝑡𝑖 − 𝑑𝑘𝑡𝑖
∗ )
𝑖
5
𝑡=1
                                                                      [2] 
  
where dkti is the number of observed deaths from any cause in the k
th strata, tth 
follow-up period, and ith SLA, and 𝑑𝑘𝑡𝑖
∗  represents the number of expected deaths due 
to other causes estimated by applying the population mortality rates to the study 
cohort.   
 
Optimum excess deaths 
 
The optimum number of excess deaths is the number of deaths that would be 
observed within five years of diagnosis if there were no inequalities in non-
diagnostic factors. This was calculated by multiplying the excess mortality rate at the 
20th centile by person-time at risk, separately for each stratum and follow-up interval 
and then summed over the follow-up intervals: 
 
Opt𝑘 = ∑(exp(α𝑡 + 𝑥𝑘𝛽 + 𝑢20 +  𝑣20) × 𝑦𝑘𝑡)                                      [3]
5
𝑡=1
 
 
where 𝑢20 +  𝑣20 were the random effect values corresponding to the lowest 20
th 
centile of relative excess risk across all the SLAs, and other variables were as 
described in equation 1.  
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Spatial fraction 
 
The spatial fraction is used to distinguish between deaths influenced by spatially 
structured factors, and those due to random variation. This parameter estimates the 
relative contribution of the spatial component in the Bayesian spatial survival model, 
and is defined as: 
𝜓 =
𝜎𝑢(𝑚)
𝜎𝑢(𝑚) + 𝜎𝑣
                                                                           [4] 
            
where 𝜎𝑢(𝑚) is the marginal standard deviation of the spatial component u, and 𝜎𝑣 is 
the standard deviation of the random component v.              
                                                                
Premature deaths 
 
The number of premature deaths due to spatial inequalities in non-diagnostic factors 
was defined as the total number of deaths within five years of diagnosis that could be 
avoided, i.e.: 
Dprem = 𝜓 × ∑(D𝑘 − Opt𝑘)
𝑘
                                                        [5] 
where  𝜓 represents the spatial fraction (see equation 4), D𝑘 represents observed 
excess deaths in the kth stratum (equation 2), and Opt𝑘 represents the optimum 
excess number of deaths in the kth stratum (equation 3). 
 
The total number of avoidable premature deaths was calculated as shown in equation 
5, and was also calculated by stage, distance and area disadvantage categories. The 
median values of the 10,000 MCMC iterations were used as the Dprem value, and 
80% credible intervals were obtained from the 10th and 90th centiles.  The premature 
death percentages were calculated by dividing Dprem by the observed excess deaths 
(∑ (D𝑘)𝑘 ).  
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6.4 Results 
 
The final study cohort consisted of 25,202 females diagnosed with breast cancer and 
26,390 cases of colorectal cancer (14,690 males, 11,700 females) (Table 6.1), as 
there were 264 breast cancer cases (1.0%) and 280 colorectal cancer cases (1.0%) 
that did not meet the inclusion criteria. 
 
Table 6.1: Demographic characteristics of the study population and 5-year 
survival estimates 
  
 Colorectal cancer  Breast cancer 
Variable  N 
5-year relative 
survival % [95% CI] p-value N 
5-year relative 
survival % [95% CI] p-value 
Sex   
 
  
 
 Males 14,690 61.2 [60.2, 62.3]    
 
 Females 11,700 67.1 [65.9, 68.3] <0.001 25,202  85.2 [84.5, 85.8] 
 
Age group       
 0-49 2,067 68.9 [66.5, 71.2]  6,517  85.8 [84.7, 86.7] 
 
 50-69 11,525 66.5 [65.4, 67.5]  12,622  87.4 [86.7, 88.1]  
 70-89 12,798 60.4 [59.1, 61.7] <0.001   6,063  79.4 [77.7, 81.1] <0.001 
Stage       
 Early 12,299 84.6 [83.6, 85.7]  11,505  94.8 [94.1, 95.4]  
 Advanced 9,672 41.1 [39.8, 42.4]  10,707  80.2 [79.2, 81.2]  
 Unknown 4,419 54.0 [52.1, 56.0] <0.001  2,990  56.0 [53.5, 58.5] <0.001 
Distance       
 < 2 hours 19,865 64.9 [64.0, 65.8]  19,490  85.7 [85.0, 86.4]  
 2 – 6 hours 4,554 60.6 [58.7, 62.5]  3,978  83.2 [81.5, 84.7]  
 6+ hours 1,971 59.7 [56.8, 62.5] <0.001 1,734  83.2 [80.8, 85.5] 0.001 
Area disadvantage       
 Least disadvantaged 3,664 69.0 [66.9, 71.1]  4,098  88.4 [87.0, 89.8]  
 Less disadvantaged 5,908 64.4 [62.7, 66.1]  5,829  85.4 [84.1, 86.6]  
 Middle 6,587 64.2 [62.6, 65.8]  6,111  85.0 [83.8, 86.2]  
 More disadvantaged 6,834 61.7 [60.1, 63.2]  6,189  84.1 [82.8, 85.3]  
 Most disadvantaged 3,397 60.5 [58.2, 62.7] <0.001 2,975  82.6 [80.7, 84.4] <0.001 
 
Note: p-values calculated using log-rank test for equality of survivor functions. The test statistic can be calculated 
as the sum of the total of (O-E)2/E where O is the total observed deaths and E the total expected deaths. This tests 
the null hypothesis of equal probability of death at any time point between the populations using a 𝜒2 test. The 
log-rank test assumes that censoring is unrelated to prognosis, deaths occur at the specified time, and the 
probability of survival is unrelated to the time of study entry (Bland and Altman, 2004).  
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6.4.1 Breast cancer 
 
The unadjusted 5-year relative survival from breast cancer by area disadvantage 
showed that 88% of women in the least disadvantaged quintile were likely to survive 
at least 5 years, while for the most disadvantaged quintile this decreased to 83% 
(Table 6.1). Survival differences by distance to nearest radiation facility were slightly 
smaller (86% for those living less than 2 hours distance, and 83% for those with at 
least 6 hours travel time).  
 
Breast cancer survival was greatly impacted by stage at diagnosis. Based on DIC 
values, the full model containing age, stage, distance and area disadvantage; the 
model adjusted for age, stage and disadvantage and the model adjusted for age and 
stage were preferred against the alternatives (Table 6.2). 
 
After adjustment for all factors in the full model, the oldest age group (ages 70-89), 
advanced or unknown stage and increasing area disadvantage had higher risk of 
death. Notably the higher survival observed in the 50-69 compared against the 0-49 
age group, as well as the impact of distance from nearest radiotherapy treatment 
facility were no longer evident. 
 
As indicated in Figure 6.1, even after adjusting for stage there was still moderate 
evidence for spatial inequalities (Tango’s MEET p=0.042 for the model containing 
age and stage). After further adjusting for area disadvantage, spatial survival 
inequalities were attenuated to non-significance (p=0.452). 
 
Between 1998 and 2007 there were 2,850 deaths due to breast cancer among women 
in Queensland within five years of diagnosis. After removing the SLAs with a risk of 
death lower than the 20th centile, there were 2,412 deaths (Table 6.4). Of these 
deaths, 170 (7%) were estimated to be avoidable if there were no systematic spatial 
variation in non-diagnostic survival components, after adjusting for stage and age at 
diagnosis. 
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Figure 6.1: Relative excess risk of death from breast cancer among females in 
Queensland, 1998-2007. A) after adjusting for age; B) after adjusting for age 
and cancer stage at diagnosis; C) after adjusting for age, stage and area 
disadvantage; D) after adjusting for age, stage, distance to treatment and area 
disadvantage 
  
Tango’s MEET p-value=0.001 Tango’s MEET p-value=0.042 
  
Tango’s MEET p-value=0.452 Tango’s MEET p-value=0.631 
 
Note: The Queensland average RER=1.0 
 
A B 
C D 
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The proportion of premature deaths was high for those residing more than 2 hours 
distance from a treatment facility, and all area disadvantage quintiles above the least 
disadvantaged, particularly for the most disadvantaged. By stage, most premature 
deaths were among those diagnosed at advanced or unknown stage.  
 
Table 6.4: Premature deaths due to non-diagnostic spatial inequalities after 
adjusting for age, gender and stage at diagnosis among SLAs with a Relative 
Excess Risk of death above the 20th centile by stage, distance and area 
disadvantage categories 
 
Notes:  Due to the methodology employed and/or rounding, numbers may not sum to the total. 
Negative numbers of avoidable premature deaths were capped at zero.  
CrI=credible interval. 
 
Chapter 6: Spatial inequalities in colorectal and breast cancer survival 
 
 159 
 
6.4.2 Colorectal cancer 
 
The unadjusted 5-year relative survival varied by 8 absolute percentage points 
between the least disadvantaged (69%) and most disadvantaged (61%) areas (Table 
6.1). There were also survival differences by distance to treatment facilities, with 
those living within 2 hours travelling time having a better survival than those 
residing a travelling time distance of at least 6 hours away (65% versus 60%, 
respectively).  
 
Among the models considered, the best fit to colorectal cancer survival was the full 
model containing age, sex, stage, distance and area disadvantage as well as the model 
adjusted for age, sex, stage and area disadvantage based on DIC values (Table 6.3). 
After adjusting for stage at diagnosis, survival remained poorer among older patients 
and as area disadvantage increased. There was also some evidence that survival was 
poorer among those residing more than 6 hours travelling time to treatment, 
particularly in comparison to those living within 2-6 hours distance (88% probability 
that RER is higher).  
 
Mapping the stage-adjusted RER did not substantively alter the observed survival 
inequalities (Figure 6.2), with both models (age and gender only; age, stage and 
gender) having strong evidence of geographical variation (Tango’s MEET p=0.001). 
Further adjusting for area disadvantage and then distance to treatment only slightly 
reduced the spatial inequalities (p=0.004 and p=0.019, respectively). 
 
There were 7,357 deaths due to colorectal cancer within five years of diagnosis in 
Queensland during 1998-2007, and 6,019 deaths after removing the SLAs with a risk 
of death lower than the 20th centile (Table 6.4). Of these deaths, 470 (8%) deaths 
would not have occurred if there were no spatial inequalities in the non-diagnostic 
survival component, after adjusting for stage, age at diagnosis and gender. There was 
a clear gradient of a greater proportion of premature deaths occurring as distance 
from radiotherapy treatment facilities increased, and also generally as area 
disadvantage increased. This contrasted with the consistency of the proportion of 
premature deaths across cancer stage categories. 
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Figure 6.2: Relative excess risk of death from colorectal cancer among persons 
in Queensland, 1998-2007. A) after adjusting for age and gender; B) after 
adjusting for age, gender and cancer stage at diagnosis; C) after adjusting for 
age, gender, stage and area disadvantage; D) after adjusting for age, gender, 
stage, distance to treatment and area disadvantage 
  
Tango’s MEET p-value=0.001 Tango’s MEET p-value=0.001 
  
Tango’s MEET p-value=0.004 Tango’s MEET p-value=0.019 
 
Note: The Queensland average RER=1.0 
 
 
A B 
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The colorectal cancer stage categories differed from those used for breast cancer 
stage categories. To explore if differences between the cancers may have resulted 
from different stage groupings, analyses were also run using alternate colorectal 
stage categories (early: localized; advanced: non-localized/regional/distant; 
unknown). Results (not shown) were broadly consistent with those reported here. 
 
6.5 Discussion 
 
In this population-based study, cancer stage, age group, and disadvantage were 
important predictors of survival outcomes for people diagnosed with colorectal 
cancer and women diagnosed with breast cancer. After adjusting for stage and 
excluding the impact of random variation, we estimated that 470 (8%) premature 
deaths due to colorectal cancer and 170 (7%) premature deaths due to breast cancer 
could be attributed to spatial inequalities in management factors.  
 
Despite fairly similar numbers of incident cases for colorectal cancer and female 
breast cancer, the lower number of premature deaths attributable to spatial 
inequalities in management factors for breast cancer is due mainly to the higher 
survival, but also the strong influence exerted by stage at diagnosis on breast cancer 
spatial survival inequalities.  
 
A previous study found women living in more remote areas of Queensland were 
more likely to be diagnosed with advanced breast cancer (Baade et al., 2011c). These 
diagnostic inequalities have resulted in survival inequalities, as our study showed the 
lower survival in rural areas was reduced after adjusting for stage. Mammography 
screening has been shown to be effective in diagnosing tumours early (Australian 
Institute of Health and Welfare, 2010a), and the current low public mammography 
participation rate of 57% in the target age group (only slightly higher in more 
regional areas)  (Australian Institute of Health and Welfare, 2010a) provides 
considerable scope for the spatial survival inequalities resulting from late diagnosis 
to be addressed.  
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Although geographic differences have been demonstrated in the risk of being 
diagnosed with advanced colon cancer in Queensland (Baade et al., 2011a), we 
found these spatial differences in stage at diagnosis did not exert an important 
influence on the spatial survival inequalities. This is consistent with a previous 
Australian study which found stage at diagnosis had limited impact on geographical 
inequalities in colon cancer survival inequalities, but more evidence for rectal cancer 
(Yu et al., 2005). 
 
Population-based screening would be expected to reduce the stage at which a cancer 
is diagnosed. In Queensland, mammography screening was introduced in 1991 and is 
freely available for women aged 40+ years, with a target age group of 50-69 years. 
More recently, mobile mammography clinics have been used to overcome the barrier 
of distance for women in more remote regions, to the extent that women in rural 
areas now have higher participation rates for public mammography than women in 
urban areas. Since the screening differential (lower screening in urban areas) is the 
opposite for the stage differential (less advanced stage in urban areas), it is unlikely 
that screening patterns can explain this differential stage distribution.  
 
Screening is also an unlikely explanation for the colorectal cancer stage differences.  
In contrast to breast cancer, there is no population-based screening program for 
colorectal cancer. The Australian bowel cancer screening program (faecal occult 
blood test) started only in 2006, with gradual implementation for adults aged 50, 55 
and 65 years of age (Australian Institute of Health and Welfare, 2009). 
 
We found significant evidence that colorectal and breast cancer patients living in 
areas of greater socioeconomic deprivation had lower survival than their counterparts 
living in more affluent areas. This is consistent with other reports (Australian 
Institute of Health and Welfare and Cancer Australia & Australasian Association of 
Cancer Registries, 2008), however, as was the case in our study, it is unclear whether 
these patterns reflect treatment inequalities, or patient characteristics such as obesity, 
smoking, alcohol consumption and comorbidities rather than area-level 
characteristics (Frederiksen et al., 2009). 
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For breast cancer, stage at diagnosis and area-level disadvantage largely explained 
the survival inequalities, similar to a study in England (Davies et al., 2010).  An 
American study showed much of the socioeconomic inequality in breast cancer 
survival was explained by stage at diagnosis, initial treatment and race (Yu, 2009). In 
Western Australia, breast cancer patients in rural (often lower socioeconomic) areas, 
were less likely to undergo hormone therapy, radiotherapy or be treated by a high-
caseload surgeon (Mitchell et al., 2006). These treatment inequalities explained the 
remaining survival differentials in breast cancer after adjusting for age and tumour 
characteristics (Mitchell et al., 2006). 
 
In contrast, colorectal cancer survival inequalities only modestly decreased after 
adjusting for stage, area disadvantage and distance to treatment, suggesting 
additional factors are important. Colorectal cancer survival is influenced by treatment 
factors such as the type of surgery provided, hospital caseload and specialist 
expertise at the treating institution (Yu et al., 2005). Treatment inequalities may not 
have been adequately captured, as an American study found treatment disparities 
only slightly reduced after adjusting for socio-demographic characteristics and the 
availability of specialist oncology services (Haas et al., 2011). Further investigation 
to identify factors influencing colorectal cancer spatial inequalities is important, and 
may benefit from a qualitative approach. 
 
The higher proportions of premature deaths due to spatial inequalities in non-
diagnostic factors among the more disadvantaged and distant regions further suggest 
treatment inequalities. Enabling more remote patients to access the same level of 
treatment and care as urban patients is extremely challenging in the Australian 
environment of very large distances. Nonetheless, quantifying the impact of these 
inequalities will encourage efforts to identify ways to reduce these inequalities, 
leading to substantial public health gains.  
   
Our analysis was based on 478 geographical regions, finding that 7.1% and 7.8% of 
breast and colorectal cancer premature deaths respectively were due to spatial 
inequalities in non-diagnostic factors. Other studies have tended to use a smaller 
number of geographical regions. One study examined 81 regions across four Nordic 
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countries finding 2.6% of breast cancer deaths and 5.0% of colon deaths were 
considered ‘saveable’ if there was no regional variation (Dickman et al., 1997). A 
study in NSW, Australia, after adjusting for broad stage categories calculated a 
similar estimate across 25 regions as 4.4% of breast and 6.9% of colon cancer deaths 
within 5 years of diagnosis (Yu et al., 2004). Our higher percentages could reflect the 
increased potential to detect variability using small geographical areas, or greater 
variability in survival outcomes within Queensland.  
 
Strengths of this study include the high quality, population-based coverage of the 
Queensland Cancer Registry, the ability to adjust for stage at diagnosis, the benefits 
of analysing small-area data using Bayesian hierarchical models and the use of 
period analysis to provide more up-to-date survival estimates. 
 
Limitations include the lack of data on individual socioeconomic characteristics and 
comorbidities, the use of broad rather than clinical stage categories, the substantial 
proportion of cancers with unknown stage at diagnosis, the lack of treatment 
information and the relatively small number of covariates included in the models.  
 
In conclusion, although earlier cancer diagnosis would decrease survival inequalities 
for breast cancer patients in rural areas, there remain an important number of 
premature deaths for breast and colorectal cancer that could be avoided by removing 
spatial inequalities in non-diagnostic factors. Despite a freely available public health 
service, spatial variation in treatment utilization is likely to play an important role, 
although other environment or patient-factors may also be contributing. Identifying 
the precise non-diagnostic factors that cause these premature deaths will not be easy, 
but unless quantitative data such as these are disseminated, there will be little 
incentive on the part of researchers and health providers to investigate, develop and 
implement the necessary interventions. 
 
 
 
 
Chapter 6: Spatial inequalities in colorectal and breast cancer survival 
 
 165 
 
Appendix A: Life table survival estimates 
 
Unpublished 
 
The unadjusted survival estimates in Table 6.1 were calculated using the life table 
method, which is one of the earliest systematic approaches for survival analysis 
(Ahmed et al., 2007). In a life table, the survival time is divided into intervals. The 
number of cases that enter each interval alive (l), the number that die during the 
interval (d), and those that are censored in each interval (w), provide the tth interval-
specific survival proportion (p), as: 𝑝𝑡 = (𝑙𝑡
′ − 𝑑𝑡)/𝑙𝑡
′   where 𝑙𝑡
′ = 𝑙𝑡 −
1
2
𝑤𝑡, and 
equates to the number at risk. The cumulative survival proportion S is then the 
product of interval-specific survival, ie: 𝑆𝑡 = ∏ 𝑝𝑡
𝑡
𝑡=1 . 
 
Assumptions include that censoring is independent of survival times, censored values 
are uniformly distributed throughout an interval, and survival is constant across the 
interval. Numbers need to be reasonable in each interval for estimates to be reliable. 
 
Appendix B: Prior distributions 
 
Prior distributions for α and β were diffuse normal distributions with mean 0 and 
variance 1.0 x 106. An intrinsic CAR prior for 𝑢𝑖 was employed to describe local 
spatial dependence across the SLAs, specified as: 
𝑢𝑖|𝑢𝑗~𝑁 (
∑ 𝜔𝑖𝑗𝑢𝑗𝑗
∑ 𝜔𝑖𝑗𝑗
, 𝜎𝑢
2 ) 
where 𝜔𝑖𝑗= 1 if i, j are adjacent, and 0 otherwise (Besag et al., 1991). As usual, the 
unstructured residual form was modelled with a normal prior, 𝑣𝑖  ~ 𝑁(0, 𝜎𝑣
2).  
 
The variances  𝜎𝑢
2 and 𝜎𝑣
2  influence the relative weight given to describing residual 
variation through spatial correlation between the estimates or some other (random) 
source. Since this is often unknown, it is typical to place priors on these terms. 
Commonly the precision (the inverse of the variance) is described as a gamma 
distribution. To examine the impact of the selection of distributions for the precision 
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parameters (𝜏𝑢and 𝜏𝑣) on the  random effect components (𝑢𝒊 and 𝑣𝒊), sensitivity 
analyses were conducted by comparing three combinations of gamma distributions 
(Γ) on the precision and 2 combinations of uniform distributions (Unif) on the 
standard deviation:  
1. 𝜏𝑢~Γ(0.1,100), 𝜏𝑣~Γ(0.1,100)  
2. 𝜏𝑢~Γ(0.5,1000), 𝜏𝑣~Γ(0.5,1000)  
3. 𝜏𝑢~Γ(0.1,10), 𝜏𝑣 ~Γ(0.001,1000)  
4. 𝜎𝑢~Unif(0,10), 𝜎𝑣 ~Unif(0,10)  
5. 𝜎𝑢~Unif(0,1000), 𝜎𝑣 ~Unif(0,1000)  
 
These gamma distributions have means and variances on the precisions of (10, 
1000); (500, 500000); and for the third option, 𝜏𝑢 has (1,10), while 𝜏𝑣 has (1,1000), 
respectively. The uniform distributions have means and variances on the standard 
deviations of (5, 8.3) and (500, 83333.3). 
 
The priors were evaluated and compared on the basis of summary measures of the 
posterior distribution of the relative excess risk values, DIC values (Spiegelhalter et 
al., 2002), cumulative distribution function plots of the deviance (Aitkin et al., 
2009), and convergence diagnostics including trace and density plots as well as the 
Geweke diagnostic (Geweke, 1992). On the basis of these, the first option was 
selected for this study.  
 
The model formulation employed for this study has been criticized for potential lack 
of identifiability of the individual u and v components (Eberly and Carlin, 2000). 
Despite this, it is recommended to use the spatial fraction (𝜓) to determine the 
relative spatial and random effects (Eberly and Carlin, 2000). Leroux et al (2000) 
proposed an alternative model, where only one parameter is included for the 
spatial/random effects, but the prior on this term acts as a mixture distribution 
incorporating a spatial smoothing parameter λ, where λ provides the spatial 
proportion, similar to our spatial fraction (𝜓). We found this approach was not 
feasible in this study, as the posterior distribution on λ failed to converge. 
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CHAPTER 7 
 
A flexible parametric approach to examining 
spatial variation in relative survival  
 
Preamble 
 
The spatial relative survival model used in chapter 6 had certain disadvantages.  
Specifically, input data had to be aggregated over each combination of area and 
covariates to enable computation, the piecewise constant hazards provide a disjointed 
and non-biologically plausible estimate over time, and predicting smooth hazard or 
survival functions was problematic. 
 
 In this chapter, an alternative approach that overcomes these difficulties is 
introduced: the spatial flexible parametric relative survival model. By using a 
parametric formulation extended to include restricted cubic splines, a continuous, 
well-fitting hazard is possible, and predicting smooth survival functions simplified. 
 
This new model is the innovative aspect, so the chapter has a methodological focus. 
However, the case study continues investigating the influence of risk factors on 
spatial inequalities as part of Objective 4, with the capacity to also consider the 
impact on predicted survival estimates. 
 
This chapter was written as a journal article for which I am the principal author, and 
is reprinted here in its entirety. I was responsible for the study conception and design, 
developing the statistical model, statistical analysis, writing and modifying the 
manuscript.  
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7.1 Abstract 
Most of the few published models used to obtain small-area estimates of relative 
survival are based on a generalized linear model with piecewise constant hazards 
under a Bayesian formulation. Limitations of these models include the need to 
artificially split the time scale, restricted ability to include continuous covariates, and 
limited predictive capacity. Here, an alternative Bayesian approach is proposed: a 
spatial flexible parametric relative survival model. This overcomes previous 
limitations by combining the benefits of flexible parametric models: the smooth, 
well-fitting baseline hazard functions and predictive ability, with the Bayesian 
benefits of robust and reliable small-area estimates. Both spatially structured and 
unstructured frailty components are included. Spatial smoothing is conducted using 
the intrinsic conditional autoregressive prior. The model was applied to breast, 
colorectal and lung cancer data from the Queensland Cancer Registry across 478 
geographical areas. Advantages of this approach include the ease of including more 
realistic complexity, the feasibility of using individual-level input data, and the 
capacity to conduct overall, cause-specific and relative survival analysis within the 
same framework. Spatial flexible parametric survival models have great potential for 
exploring small-area survival inequalities, and we hope to stimulate further use of 
these models within wider contexts.   
 
7.2 Introduction 
Spatial analyses of routinely collected cancer data are being increasingly used to 
provide insight to disease etiology and to inform decisions regarding health care 
disparities (Lyseen et al., 2014). These analyses typically report on variation in 
cancer incidence and mortality (Cramb et al., 2011b). While providing important 
information on diagnostic and end of life care requirements, these endpoints provide 
limited information on the effectiveness of cancer-related health care systems. 
Spatial survival analyses provide greater opportunity to assess the geographical 
variation in the effectiveness of health services as they reflect both diagnostic and 
patient management components (Yu et al., 2004).  
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Cancer survival may be reported as overall survival, where deaths from any cause are 
included, or an estimate of net survival. Net survival is the survival that would be 
seen if the cancer under study was the only possible cause of death. Net survival is 
estimated using either cause-specific survival, where the recorded cause of death 
determines deaths due to cancer, or relative survival, where deaths from any cause 
among patients are compared against background population mortality rates. When 
using population-based data such as from a cancer registry, relative survival is often 
the preferred method for measuring net survival, as the accuracy of the recorded 
cause of death may be uncertain (Dickman et al., 2004).  
Few small-area analyses have used relative survival. Fairley et al. (2008) examined 
prostate cancer in a region of the UK, Cramb et al. (2011a) examined a range of 
cancers across Queensland, Australia, and Saez et al. (2012) investigated breast 
cancer in a region of Spain. Each of these analyses used a generalized linear model 
(GLM) with a modified link function, piecewise constant hazards and spatial frailties 
within a Bayesian framework. Reliable small area estimates were obtained by using 
prior distributions which smoothed estimates across adjacent areas. While the GLM 
has been recommended for modelling relative survival (Dickman et al., 2004), the 
disjointed piecewise hazards are biologically implausible. Hennerfeind sought to 
overcome this by using a similar model which incorporated splines to smooth the 
piecewise constant hazards (Hennerfeind et al., 2008a). However, while the use of 
splines has the potential to provide a better fit to the hazards function, the resulting 
calculations for this model are computationally-intensive (Hennerfeind et al., 2008a). 
Fully parametric models have several advantages over piecewise linear approaches. 
For instance, the time scale does not need to be artificially split, it is more feasible to 
model individual-level data rather than aggregating over covariates of interest, and it 
is simpler to obtain smooth survival or hazard function predictions (Royston and 
Lambert, 2011). However, the standard parametric formulations, such as the Weibull, 
log-logistic or log-normal distributions, assume a linear relationship between a 
specific transformation of the survival function and log survival time (Royston and 
Lambert, 2011), which often results in poorly fitting models.  
Flexible parametric models incorporate the advantages of standard parametric 
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models with nonlinear functions for modelling the baseline hazard, enabling 
improved model fit. One version of these flexible parametric models is the model 
proposed by Royston and Parmar which uses restricted cubic splines to model the log 
cumulative baseline hazard (Royston and Lambert, 2011). Nelson et al (2007) 
extended this flexible parametric model to the relative survival context. However, 
these models have not been previously used for small-area survival analyses.  
The purpose of this paper is to introduce an alternative method for geographic 
analysis of cancer survival data: the spatial flexible parametric relative survival 
model. We extend Nelson’s model (Nelson et al., 2007) to the spatial context, and 
place it within a Bayesian framework. We apply this new model to three common 
cancers in Australia: breast cancer (high survival), colorectal cancer (moderate 
survival), and lung cancer (low survival). Our focus is on the practical 
implementation, predictive capacity and interpretability of results. In sections 7.3 and 
7.4, details of the proposed model are presented, along with the data and analyses. 
Model assessment is described in section 7.5, and results presented in section 7.6, 
focusing on the predictive options available under the flexible parametric 
formulation. Finally, section 7.7 discusses the implications of these new models. 
 
7.3 Model Formulation 
Relative survival is related to competing risk analyses as it partitions the total 
mortality rate (overall hazard, ℎ(𝑡)) into that resulting from the disease of interest 
(excess hazard, λ(𝑡)) and that due to other causes (expected hazard (ℎ∗(𝑡), estimated 
from population mortality rates) (Royston and Lambert, 2011). This is also known as 
an additive hazards model since it can be expressed as: 
ℎ(𝑡) = ℎ∗(𝑡) + λ(𝑡).                                           (1) 
The relative survival function can be represented as: 
ln(-ln R(t;x)) = ln(Λ(t)) = ln(Λ0(t)) + xβ                          (2) 
where R(t;x) is the relative survival function, Λ(t) is the cumulative excess hazard, 
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which is the integrated form of λ(𝑡) in (1), Λ0(t) is the cumulative baseline excess 
hazard (the cumulative excess hazard when all covariates are 0) and β represents the 
vector of coefficients relating to the matrix of covariates x.  
The log cumulative baseline excess hazard (ln (Λ0(𝑡)) is modelled via restricted 
cubic splines (Durrleman and Simon, 1989) as a function of log time. When at least 
one interior knot is specified, the spline includes a constant term, 𝛾0, a linear function 
of log time with parameter 𝛾1, and a basis function for each interior knot, 𝑧𝑗(𝑡), with 
parameter 𝛾𝑗+1, as follows: 
ln (Λ0(𝑡)) = 𝛾0 + 𝛾1ln (𝑡) + 𝛾2𝑧1(𝑡) + ⋯ + 𝛾𝑚+1𝑧𝑚(𝑡)                   (3) 
The cubic basis functions for 𝑧1(𝑡), … , 𝑧𝑚(𝑡) are calculated as: 
𝑧𝑗(𝑡) = (ln(𝑡) − 𝑘𝑗)+
3
−
𝑘max−𝑘𝑗
𝑘max−𝑘min
(ln(𝑡) − 𝑘min)+
3 − (1 −
𝑘max−𝑘𝑗
𝑘max−𝑘min
) (ln(𝑡) − 𝑘max)+
3      
(4) 
with m interior knots 𝑘1, … , 𝑘𝑚 and two boundary knots (𝑘min and 𝑘max). The + 
subscript indicates that negative values are truncated at zero. Note that if no interior 
knots are specified, this model will revert to a standard Weibull model with 
ln (Λ0(𝑡)) = 𝛾0 + 𝛾1ln (𝑡). 
When this model is implemented in Stata (via stpm2 (Lambert and Royston, 2009)) 
or R (via package ‘flexsurv’ (Jackson, 2015)), the number and location of knots must 
be pre-selected. The number of interior knots may be selected using measures of fit 
such as the Akaike Information Criterion (AIC), Bayesian Information Criterion 
(BIC) or graphical plots of model fit. The two boundary knots 𝑘min, 𝑘max are placed 
at the smallest and largest uncensored log survival-times, respectively. The default 
for these models is to position interior knots using empirical centiles of the 
distribution of log event times, which allows data to be more closely modelled in 
regions of greater data density (Royston and Lambert, 2011). For example, 1 interior 
knot is positioned at the median, 2 interior knots are positioned at the 33rd and 67th 
centiles, 3 interior knots are positioned at the 25th, 50th and 75th centile, and so on. 
Maximum likelihood is used to estimate the spline parameters and the log hazard 
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ratios. Log-likelihood functions are maximised using the Newton Raphson technique 
(Nelson et al., 2007).  
We introduce the spatial flexible parametric relative survival model by extending 
Nelson’s model in (2) with the cumulative baseline excess hazard specified as in (3) 
to include additional spatial frailty terms, as follows:  
ln(Λ𝑖(𝑡)) = 𝛾0 + 𝛾1ln (𝑡) + 𝛾2𝑧1(𝑡) + ⋯ + 𝛾𝑚+1𝑧𝑚(𝑡) + xβ + 𝑢𝑖 + 𝑣𝑖              (5) 
where 𝑢𝑖 and 𝑣𝑖 represent the spatial and uncorrelated heterogeneity in the ith area, 
respectively, and the cumulative excess hazard (Λ(t)) is now indexed by area.  
A Bayesian framework was used to enable the smoothing of estimates over regions. 
Since the additional complexity of priors and hyperpriors precludes an analytical 
solution, Markov Chain Monte Carlo (MCMC) sampling was used to obtain 
estimates.  
Probability distributions were placed on each parameter, with Gaussian distributions 
expressed as N(mean, variance) as follows:  
𝛾𝑑~N(0, 10
6) 
𝛽𝑘~N(0, 10
6) 
𝑢𝑖|𝐮−𝐢 = N (?̅?𝑖,
𝜎𝑢
2
𝑛
) 
𝑣𝑖~N(0, 𝜎𝑣
2) 
𝜎𝑢~Uniform(0.01,20) 
𝜎𝑣~Uniform(0.01,20) 
Hyperpriors were provided as a uniform distribution on the standard deviation 
(Gelman, 2006). Priors on most model parameters were vague normal distributions, 
except for u, which is the spatially structured term. The prior specified on u locally 
smooths the data across neighbours (n=number of neighbours).  These are assigned 
according to the intrinsic CAR distribution (Besag et al., 1991), so consider areas 
with first-order contiguity (adjacent boundaries) to be neighbours. As Queensland 
has many small islands (which have no adjacent boundaries), these areas had their 
Chapter 7: A flexible parametric approach to examining spatial variation 
 
180  
 
default neighbourhood structure adjusted to incorporate nearby areas.  
Although (5) results in proportional hazards, alternative formulations are possible, 
including proportional odds models. The equivalent to (5) under proportional odds is: 
logit(1 − 𝑅𝑖(𝑡)) = logit(1 − 𝑅0(𝑡)) + xβ + 𝑢𝑖 + 𝑣𝑖                            (6) 
where 𝑅𝑖(𝑡) represents relative survival for area i, 𝑅0(𝑡) is the baseline relative 
survival function, the relative survival when all covariates equal zero and other terms 
are as before. Note that logit(1 − 𝑅0(𝑡)) is modelled as a restricted cubic spline just 
as for the log cumulative baseline hazard in (3). 
The choice of proportional hazards or proportional odds may be determined using the 
same measures as for choosing the number of knots (AIC, BIC or graphical plots of 
model fit), often in conjunction with the interpretability of estimates and audience 
needs. Hazard ratios may be easier to interpret due to their widespread use, but the 
proportional odds model assumes hazard ratios decrease as time from diagnosis 
increases, which is often sensible for cancer prognostic effects. 
 
7.4 Data and Analysis 
Breast (ICD-O3 C50), colorectal (ICD-O3 C18-C20,C218) and lung (ICD-O3 C33-
C34) cancer data for patients aged <90 years diagnosed from 1997 to 2011 were 
obtained from the Queensland Cancer Registry (QCR), a population-based registry 
that covers the entire state of Queensland (Queensland Cancer Registry, 2013b). The 
QCR conducts routine data linkage with the Australian National Death Index to 
determine the survival status of all cancer patients. Ethical approval was obtained 
from the Queensland Health Central Office Human Research Ethics Committee 
(HREC/09/QHC/25). 
The geographic regions used were 478 Statistical Local Areas (SLAs), defined under 
the Australian Bureau of Statistics’ Australia Standard Geographic Classification 
(ASGC) (Australian Bureau of Statistics, 2006a). Geocoded cancer patient residence 
information was assigned an SLA prior to data extraction using the 2006 ASGC 
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boundary definitions. SLAs cover Queensland without gap or overlap, and in 2006 
had populations ranging from 7 to 74,804 (median 5,723).  
The expected hazard rate (ℎ∗(𝑡) in (1)) was calculated from population and mortality 
data. Population data by 5-year age groups, sex, year and SLA were obtained from 
the Australian Bureau of Statistics (Australian Bureau of Statistics, 2013). Unit-
record level mortality data for Queensland residents were obtained from the 
Australian Bureau of Statistics (to 2005) (Australian Bureau of Statistics, 2007c) and 
the Australian Coordinating Registry (2006-2011) (Registries of Births et al., 2014). 
The SLA boundaries provided in this mortality data changed over time. These were 
adjusted to the 2006 SLA boundaries using correspondence files produced by the 
Australian Bureau of Statistics. Population mortality estimates for each SLA, sex, 
integer age and year was calculated using sex-specific aggregated 5-year age groups, 
5-year time periods (1997-2001, 2002-2006, 2007-2011), and over the same groups 
of SLAs used in the neighborhood structure for the CAR distribution. This 
smoothing enabled more stable population mortality estimates. 
The remoteness of each SLA was assigned based on the Accessibility Remoteness 
Index of Australia plus (ARIA+), which has five categories ranging from “Major 
City” to “Very Remote”, and is based on access to services and population sizes. 
Three categories of tumor stage were included: Localized, Advanced and Unknown. 
Colorectal cancer stage was defined using the Dukes staging system after extracting 
information from pathology records held by the QCR (Krnjacki et al., 2008). 
Although four stage categories were defined, these were aggregated for increased 
accuracy (Krnjacki et al., 2008).  ‘Localized’ stage cancer was defined as stages I 
and II, with ‘Advanced’ stage cancer defined as stages III and IV. Breast cancer 
stage was approximated based on information routinely collected by the QCR 
regarding tumor size, lymph node involvement and distant metastases, with 
‘Localized’ stage equivalent to stage I, and ‘Advanced’ equivalent to stages II-IV 
(Cramb et al., 2012). No information was available on lung cancer stage. 
Survival was calculated using the period method (Brenner et al., 2004), with the ‘at-
risk’ period covering 2002-2011. Under period analysis, all observations are left-
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truncated at the start of the at-risk period, in addition to being right-censored at the 
end (Brenner et al., 2004). This enables survival estimates to be based on more 
recent data, as for each cancer type included cases were the first primary cancer 
diagnosed during 1997 to 2011, and still alive during any part of 2002-2011. Data 
were censored at the 31st December 2011. 
The analysis was conducted in two stages. First several versions of the non-spatial 
standard flexible parametric model were run using stpm2 in Stata v13.1 (StataCorp 
LP, Texas, USA) to determine an appropriate transformation of the continuous 
variable patient age, as well as the preferred model form (hazards or odds) and 
number of pre-specified knots. These parameters were then used in the Bayesian 
spatial model, which was run with single chain MCMC using WinBUGS 1.4 
(Imperial College and Medical Research Council, UK) interfaced with Stata. The 
first 250,000 iterations were discarded and a further 100,000 monitored (with every 
10th iteration kept, for a total of 10,000). WinBUGS code for the spatial flexible 
parametric relative survival model is supplied in Appendix A. 
Age was included as a continuous variable by centering on the cancer-specific 
median age, then using fractional polynomial methods (Sauerbrei et al., 2006) in the 
non-spatial model to transform. A fractional polynomial extends a conventional 
polynomial by generalizing the powers to certain fractional and nonpositive values 
(Sauerbrei and Royston, 1999). The Stata multivariable fractional polynomial 
command was used (mfp), which fit different models with combinations of the 
default set of powers {-2, -1, -0.5, log, 0.5, 1, 2, 3}a up to second-order fractional 
polynomials. For each cancer second-order fractional polynomials were preferred, 
although the transformations selected varied. Alternate nonlinear methods such as 
splines could have been used instead of fractional polynomials. Both are likely to 
give similar results, but the spline is more influenced by local variation as opposed to 
the global fractional polynomial (Binder et al., 2013). 
The non-spatial model was also used to determine the appropriate number of pre-
specified knots for the restricted cubic spline on the cumulative baseline hazard. Both 
BIC values and graphs of the estimated hazard and survival functions were used to 
select the preferred number of knots. The examination of graphs aimed to prevent 
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overfitting models: if there were nominal differences between the plotted hazard or 
survival functions, then the model with the fewer number of knots was preferred.  
A common output from a spatial analysis is a map of the estimates of interest. Under 
the Bayesian formulation, it is possible to map not only the median estimates of 
excess mortality odds ratios (exp(𝑢𝑖 + 𝑣𝑖)), but also the probability of this ratio 
exceeding a certain value, such as 1. Thematic maps were produced using MapInfo 
Professional v12.5 (Pitney Bowes Software Inc., New York). Exceedance probability 
categories were defined based on standard 80% cut-offs, with a probability of 80% 
and above considered very likely to be true, while a probability below 20% is 
considered very unlikely to be true. 
A key benefit in modelling a smooth baseline function is the ability to predict smooth 
survival or hazard functions. A range of postestimation commands are available for 
standard Royston-Parmar models in Stata. To obtain further benefit from the 
Bayesian approach, we derived additional syntax to calculate the predictions at each 
MCMC iteration (see Appendix B for Stata code). This enabled us to predict survival 
curves with appropriate credible intervals for each area. Predicted survival was 
calculated for each SLA, sex and cancer type at age 60 years, and further by stage 
(for breast and colorectal cancers).  
 
7.5 Model Evaluation 
Convergence of MCMC chains for each parameter was assessed using trace and 
density plots. Due to the large number of areas, a subsample of 20 areas that included 
sparsely populated areas (<0.2 residents per km2) was selected for graphical 
monitoring of the 𝑢𝑖 and 𝑣𝑖 terms. No parameters showed evidence of non-
convergence. 
The accuracy of the posterior estimates was assessed using Monte Carlo (MC) error, 
calculated as [standard deviation √No. iterations]⁄  of the exponentiated odds ratio 
estimates for each parameter of interest (𝛾𝑑, 𝛽𝑘 and 𝑢𝑖 + 𝑣𝑖) . As autocorrelation may 
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influence MC error values, autocorrelation for each parameter was assessed via 
graphical plots, and found to be negligible. 
Sensitivity analyses (Lambert et al., 2005) compared three different hyperpriors on 
the variance components 𝜎𝑢
2 and 𝜎𝑣
2: 
1. Gamma distribution (shape, scale) on the precision, 
1
𝜎2
~Γ(0.1,100) 
2. Uniform distribution (minimum, maximum) on the standard deviation, 
𝜎~U(0.01,20) 
3. Uniform distribution on the standard deviation, 𝜎~U(0.01,100) 
Similar estimates were obtained in each version, while examination of convergence 
trace and density plots indicated a slight preference for version 2. Results presented 
use version 2. 
 
7.6 Results 
Based on BIC under the non-spatial model, the proportional odds formulation was 
preferred over the proportional hazards form for the three cancers examined, except 
for breast cancer unadjusted for stage, where the hazards form was marginally 
preferred (Table 7.1). Results presented here use the proportional odds form.  
Although 4 interior knots were preferred for colorectal cancer based on BIC values 
(Table 7.1), graphs of the hazard function suggested fewer knots would suffice. The 
final number of interior knots selected was 2, 1 and 3 for breast, colorectal and lung 
cancers, respectively.  
The flexible parametric form fitted the data better than using a piecewise approach or 
standard log-logistic distribution (Figure 7.1). Small numbers are likely to influence 
the rapid increase in mortality in the smoothed hazard function as time approaches 15 
years after diagnosis. Although only shown for breast cancer, colorectal and lung 
cancer also exhibited similar patterns.  
All models had very low MC error estimates. The maximum MC errors for any 
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parameter were 0.0042, 0.0028 and 0.0029 for breast, colorectal and lung cancer, 
respectively (in the models unadjusted for tumor stage), and 0.0406 for breast and 
0.0031 for colorectal cancer (in the models adjusted for tumor stage). MC errors 
within 5% of the parameter’s standard deviation are considered acceptable (Powers 
and Xie, 2008), and all met this criteria. 
 
Table 7.1: Variations in BIC values by model form and number of internal 
knots 
 Unadjusted for tumour stage Adjusted for stage 
# knots Breast Colorectal Lung Breast Colorectal 
PH      
0 43280 72198 42385 41227 67116 
1 43284 71747 40391 41234 66727 
2 43231 71702 40294 41170 66667 
3 43237 71690 40175 41178 66654 
4 43244 71669 40183 41187 66624 
5 43251 71673 40197 41195 66625 
6 43261 71681 40201 41204 66636 
7 43265 71686 40195 41206 66639 
PO      
0 43286 71942 40431 41055 66754 
1 43294 71698 40300 41059 66627 
2 43245 71654 40281 41004 66580 
3 43251 71632 40112 41013 66555 
4 43259 71612 40113 41021 66525 
5 43266 71617 40127 41030 66530 
6 43276 71625 40135 41038 66539 
7 43280 71630 40135 41040 66543 
BIC=Bayesian Information Criterion; PH=Proportional Hazards; PO=Proportional Odds 
Notes: Italicised values show the lowest BIC value for each model, bolded values are the 
selected choice.  
BIC values are comparing the non-spatial model versions in Stata. 
 
All three cancers showed strong evidence of spatial inequalities in cancer survival 
after adjusting for age and sex (Figure 7.2). There was a consistent pattern of lower 
survival among remote areas, and higher survival among areas in the urban south-
east corner. The probability of excess mortality odds ratios exceeding 1 was most 
definitive for lung cancer (Figure 7.2). This is partly influenced by the number of 
deaths, with more deaths providing greater precision. 
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Figure 7.1: Comparison of flexible parametric model hazard estimates for 
breast cancer with the weighted smoothed hazard function (kernel density 
estimate) and a) log-logistic distribution and b) piecewise hazards 
 
A 
 
B 
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Figure 7.2: Excess mortality odds ratio spatial pattern and exceedance 
probability after adjusting for age and sex, Queensland, 2002-2011 
Excess mortality odds ratio 
Breast Colorectal Lung 
   
Probability excess mortality odds ratio>1 
Breast Colorectal Lung 
   
 
After further adjusting for stage, most breast cancer median excess mortality odds 
ratios were somewhat attenuated, and this was most clearly demonstrated by the 
marked reduction in the probability of estimates differing from 1, with fewer remote 
areas showing high (>80%) probability of excess mortality odds ratios above the 
Queensland average (Figure 7.3). In contrast, colorectal cancer results were much 
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less impacted by adjustment for tumor stage (Figure 7.3).  
 
Figure 7.3: Excess mortality odds ratio spatial pattern and exceedance 
probability after adjusting for age, sex and tumour stage, Queensland, 2002-
2011 
Excess mortality odds ratio  
 Breast Colorectal 
  
Probability excess mortality odds ratio>1  
Breast Colorectal 
  
 
The median posterior predicted survival for each SLA was grouped by remoteness 
and cancer type to consider the range of survival predictions (Figure 7.4). Although 
urban areas often had higher survival than remote areas, there was variation even 
within these groupings, and often the highest survival in remote areas was on par 
with the predicted survival in certain urban areas. 
Chapter 7: A flexible parametric approach to examining spatial variation 
 
 189 
 
Figure 7.4: Predicted 5- and 15-year relative survival at age 60 years for each 
SLA and sex by remoteness groupings, Queensland, 2002-2011 
Males 
5 years 15 years 
  
Females 
5 years 15 years 
  
 
Notes: Red vertical line represents the predicted relative survival for Queensland for each cancer type and sex at 
age 60 years. 
 
Survival curves were also predicted for each SLA. To illustrate the maximum 
survival differential, the major city SLA with the highest survival is compared 
against the very remote SLA with lowest survival (Figure 7.5). Survival differences 
for breast and colorectal cancer increased over time, while for lung cancer the largest 
inequalities were observed around 2-4 years after diagnosis, and these had 
diminished by 15 years (Figure 7.5). This is likely to reflect the very aggressive 
nature of lung cancer. The high number of deaths from lung cancer is also apparent 
by less uncertainty around the lung cancer survival estimates.  
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Figure 7.5: Predicted relative survival curves with 80% credible intervals at age 
60 years for the major city SLA with the highest survival and the very remote 
SLA with the lowest survival. 
Breast cancer, females  
Overall Localised tumour stage Advanced tumour stage 
   
Colorectal cancer, males 
Overall Localised tumour stage Advanced tumour stage 
   
Colorectal cancer, females 
Overall Localised tumour stage Advanced tumour stage 
   
Lung cancer 
Males Females 
 
  
CrI=credible interval 
 
 
When assessing patterns by spread of disease, there were only small differences in 
survival observed for localized breast cancers, but much poorer survival for 
advanced breast cancers in the remote SLA compared to the major city SLA (Figure 
7.5). The maximum absolute differential in 5-year survival between SLAs for 
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advanced stage breast cancers was 6.7%, compared to 1.3% for localized breast 
cancers. In contrast, colorectal cancer showed marked survival differences between 
SLAs for localized cancers (maximum 5-year survival difference of 4.7%) and even 
higher for advanced cancers (14.0%). 
 
7.7 Discussion 
We have proposed an extension to Nelson’s flexible parametric relative survival 
model to produce small-area survival estimates. This new model includes additional 
random effect components within a Bayesian framework to enable small-area 
smoothing. This combines the benefits of flexible parametric models: the smooth, 
well-fitting baseline hazard functions and predictive ability, with the Bayesian 
benefits of robust and reliable small-area estimates.  
The predictive ability of these flexible parametric models remains an important 
advantage over piecewise based approaches. Concepts that are relative to the 
average, such as the excess mortality odds ratio, do not provide direct information on 
the survival impact, which is of most interest to cancer patients. Quantifying survival 
differences provides a more intuitive and balanced measure of inequalities, and we 
are not aware of survival curves being produced for such small areas previously.  
Wide variation between SLAs was observed for predicted cancer survival, and this 
was particularly noticeable for cancers diagnosed at an advanced stage. Unlike breast 
cancer, comparatively large survival differences were observed even for colorectal 
cancers diagnosed at a localized stage. This is consistent with an impact of 
geographical differences in the management that patients receive depending on 
where they live (Yu et al., 2005). Treatment data is not routinely collected by 
registries, so in the absence of data this remains speculative. However, multiple 
studies suggest that colorectal cancer patients often have better outcomes when 
treated by specialist surgeons with higher case volumes (Meagher, 1999; Anwar et 
al., 2012). In Queensland, these specialist surgeons with high-throughput are 
predominantly located in the urbanized south-east corner, which is classified as a 
major city region. 
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Robust survival estimates in small areas are only possible by incorporating spatial 
smoothing methods. Here, Bayesian methods used priors designed to smooth across 
neighboring regions, which produced reliable estimates and predictions despite data 
sparseness. As per the popular Besag, York and Mollie (BYM) model, two random 
effect area-level components were included with different priors: an intrinsic CAR 
normal prior for local smoothing and a normal distribution for global smoothing 
towards the overall mean (Besag et al., 1991). Although the BYM model has been 
shown to perform well when compared to other Bayesian disease mapping 
approaches,(Best et al., 2005) concerns have been raised about the potential for 
oversmoothing (Goovaerts and Gebreab, 2008). Investigating alternative approaches, 
such as including a component that allows for discrete changes between areas 
(Lawson and Clark, 2002), could be a fruitful area for future research. This may be 
particularly important if the cancers of interest are strongly linked with known 
infectious or lifestyle components with large socioeconomic differentials, as 
neighboring regions can have markedly different socioeconomic profiles.  
Although demonstrated here on relative survival, this model can easily be adjusted to 
model cause-specific or all-cause survival, broadening the diseases it can be applied 
to. To interpret relative survival as net survival, conditional independence between 
mortality from the disease, and mortality due to other causes must be assumed 
(Gamel and Vogel, 2001). For lung cancer, due to the association with smoking, this 
assumption is questionable (Royston and Lambert, 2011). However, due to the high 
mortality rate, the bias is small in practice (Hinchliffe et al., 2012). One advantage 
then is the ease of also running a cause-specific analysis within the same modelling 
framework and comparing results. 
Royston-Parmar models can be built on a range of parametric models. For all cancers 
examined, the odds form was either preferable or similar to hazards. Other 
alternative model formulations include probit. Both odds and probit formulations 
assume non-proportional hazards that will converge to 1 as 𝑡 → ∞, although the 
probit form has slightly longer tails. Prognostic influences on cancer often 
demonstrate a diminishing impact on mortality as time from diagnosis increases 
(Royston and Lambert, 2011).  
Chapter 7: A flexible parametric approach to examining spatial variation 
 
 193 
 
Additional complexity could easily be incorporated into the models. Temporal 
components would enable comparison of small-area variation in survival across time, 
or time-varying components could also be incorporated in a straightforward manner. 
These time-dependent effects can also be modelled using splines, providing a 
smooth, continuous hazard. Model averaging over different numbers of knots could 
be investigated, although given the similarity of functions once the number of knots 
reaches a certain threshold, unlikely to influence results. Allowing the number of 
knots to be determined within the Bayesian model would also be possible, but the 
insight into the model behavior and sensitivity obtained from comparing different 
numbers of knots was advantageous. 
Perhaps the greatest disadvantage is the computational intensity of using MCMC 
analysis for these models. Although the time to run was only slightly longer than the 
previous piecewise MCMC-based approaches used for small-area analyses (~8 hours 
on a high quality computer), it is substantially longer than producing estimates 
analytically in Stata or R. Also, as the number of knots increased, computational time 
further increased. Using an MCMC approximation method such as INLA (Integrated 
Nested Laplace Approximation) (Rue et al., 2009) could overcome this difficulty. 
In conclusion, these flexible parametric survival models have great potential for 
exploring spatial and spatio-temporal survival inequalities, and we hope to stimulate 
further development and application of these models within wider contexts.  
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Appendix A: WinBUGS code 
 
WinBUGS code for the breast cancer spatial flexible parametric survival model including 
age (as a centered, continuous, transformed variable) and tumour stage. The ‘zeros trick’ is 
used to specify a general likelihood. 
Note that N=number of data rows (individual-level observations), and Nsla=number of areas. 
 
model { 
 
 K <-10000 
 
 for(i in 1:N) { 
     stage2[i]<- equals(stage[i], 2)   
     stage3[i]<- equals(stage[i], 3) 
 
 zeros[i]<-0 
  eta[i]<-
gamma[1]+gamma[2]*rcs1[i]+gamma[3]*rcs2[i]+gamma[4]*rcs3[i]+beta[1]*agec1[i]+beta[2]*agec2[i]+beta[3]
*stage2[i]+beta[4]*stage3[i]+u[slano[i]]+v[slano[i]] 
  eta0[i]<-
gamma[1]+gamma[2]*s0rcs1[i]+gamma[3]*s0rcs2[i]+gamma[4]*s0rcs3[i]+beta[1]*agec1[i]+beta[2]*agec2[i]+b
eta[3]*stage2[i]+beta[4]*stage3[i]+u[slano[i]]+v[slano[i]] 
   
 dsp[i]<-gamma[2]*drcs1[i]+gamma[3]*drcs2[i]+gamma[4]*drcs3[i] 
 
 lnL[i]<- d[i]*log((haz[i])+(1/t[i])*max(dsp[i]*exp(eta[i]),0.00001)/(1 + exp(eta[i]))) + 
log(pow((1+exp(eta[i])),-1)) + (log(1+exp(eta0[i]))*t0[i]) 
 c[i]<- -lnL[i]+K 
 
 zeros[i]~dpois(c[i]) 
} 
#Prior Distributions 
#CAR prior for spatial random effect 
 u[1:Nsla] ~ car.normal(adj[], weights[], num[], tauu)   
 for (k in 1:sumNumNeigh) {weights[k] <- 1 . 
  
#Normal prior for uncorrelated heterogeneity term 
 for (i in 1:Nsla) { 
 v[i]~dnorm(0,tauv) 
 } 
   
 # Other priors           
     tauu<- pow(sigmau,-2) 
 tauv<- pow(sigmav,-2) 
 sigmau~dunif(0.01,20) 
 sigmav~dunif(0.01,20) 
 varucon <-1/tauu 
 varv<-1/tauv 
 varumarginal<-sd(u[])*sd(u[]) 
 fracspatial<-varumarginal/(varumarginal+varv) 
 
for(j in 1:4){ 
beta[j]~dnorm(0,0.001) 
} 
for(j in 1:4){ 
gamma[j]~dnorm(0,0.001) 
} 
 
} 
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Appendix B: Survival calculations 
 
Stata syntax for predicted survival calculations 
*Breast cancer by stage survival predictions at age 60 years 
set more off 
*Calculate transformed age values at age 60 years (as age is centered, median=0 but 
represents 59 years) 
  scalar a1=(((1+39)/10)^.5)-1.978965433 
  scalar a2=(((1+39)/10)^2)-15.33743848 
 scalar list 
*Loop over each area 
forvalues i=1/478{ 
*Skipped steps to read in and organise data, but have 10,000 rows with results from 
WinBUGS (gamma, beta, u, v) and input data to WinBUGS from Stata (rcs1, rcs2) for ~50 
time points, producing a total of ~500,000 rows of data. 
*Calculate predictions 
* Loop over to generate results by stage, coded here as 0=localised, 1=advanced 
forvalues s=0/1{ 
preserve 
gen stage=`s’ 
*Log odds of the probability of an event  
gen double 
h_`i'=gamma_1+(gamma_2*rcs1)+(gamma_3*rcs2)+(beta_1*a1)+(beta_2*a2) 
+(beta_3*stage)+u_`i'+v_`i' 
 *Survival function (odds formulation) 
 gen double s_`i'=(1+(exp(h_`i')))^-1 
* Calculate median and 80% credible interval values 
collapse (p50) h50_`i'=h_`i' s50_`i'=s_`i' (p10) h10_`i'=h_`i' s10_`i'=s_`i' (p90) 
h90_`i'=h_`i' s90_`i'=s_`i', by(_t) 
 save _sf`s’_`i', replace 
 list _t s* if _n==_N 
restore 
} 
} 
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CHAPTER 8 
 
Spatio-temporal relative survival of breast and 
colorectal cancer in Queensland, Australia 
1997-2011  
 
Preamble 
 
The introduction of the spatial flexible parametric relative survival model in chapter 
7 unleashed new possibilities. Because the input data are at the individual-level and 
the time scale does not need to be split, increasing model complexity is not penalised 
as when aggregating data across every covariate, time interval and area. This means 
it is simpler and more feasible to increase model complexity and include additional 
or continuous covariates. In this chapter, we extend the previously developed model 
to introduce the spatio-temporal flexible parametric relative survival model. 
 
Investigating changes in small-area survival inequalities is the key focus here, 
meeting Objective 5. The extension to the spatio-temporal context forms the first 
spatio-temporal relative survival model, and this is the key innovation. 
 
This chapter was written as a journal article for which I am the principal author, and 
is reprinted here in its entirety. I was responsible for the study conception and design, 
developing the statistical model, statistical analysis, writing and modifying the 
manuscript.  
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8.1 Abstract 
Despite improvements in cancer survival across many developed countries, it is 
unclear how survival is changing over time in small areas. This study investigated 
changes in breast and colorectal cancer survival across 478 areas over 15 years 
(1997-2011), and the influence of early diagnosis on changes. Queensland Cancer 
Registry data were analysed using an introduced Bayesian spatio-temporal flexible 
parametric relative survival model. All areas showed survival improvements between 
1997-2001 and 2007-2011. The median absolute 5-year survival improvement for 
localised breast cancer was small (2.1%), compared to advanced breast cancer 
(5.6%), and both localised (4.6%) and advanced (7.9%) colorectal cancers. 
Improvements in non-diagnostic factors, such as patient treatment and management, 
appear to be the main influence on recent survival increases for breast and colorectal 
cancers. Important inequalities in survival between small areas remain, and lower 
breast cancer survival in some remote areas results from a higher proportion of 
advanced cancers. 
 
8.2 Introduction 
Overall cancer survival is improving in Australia, as for many developed countries 
(Coleman et al., 2011). Improvements have been suggested to result from improved 
treatment and/or earlier diagnosis, depending on the type of cancer (Shahnam et al., 
2014). 
 
Breast and colorectal cancer are two of the leading cancers diagnosed in Australia, 
and survival has improved for both cancers during recent decades (Australian 
Institute of Health and Welfare, 2014b). The introduction of screening methods that 
aim to diagnose tumours at an earlier stage may have influenced these increases in 
survival.  In 1991, breast cancer mammography screening was introduced for 
Australian women aged 50-69 years (Australian Institute of Health and Welfare, 
2014b). In 2006, national colorectal cancer screening (faecal occult blood testing) 
started, with restricted eligibility (ages 55 and 65 years initially, then from 2009 
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onwards 50 year olds were also included) (Australian Institute of Health and 
Welfare, 2014b). 
 
Treatment has also changed during recent decades for both cancers, with the 
development of additional and more targeted chemotherapies, improvements in 
irradiation technology and enhanced surgical treatment/monitoring techniques 
(D'Angelo-Donovan et al., 2012; Sun and Thacker, 2015; Zurrida and Veronesi, 
2015). Australian clinical practice guidelines were published to disseminate 
knowledge about treatment options and efficacy, starting in 1995 and 1999 for breast 
and colorectal cancer, respectively (National Health and Medical Research Council, 
1995; NHMRC National Breast Cancer Centre, 2001b, a; Australian Cancer Network 
Colorectal Cancer Guidelines Revision Committee, 2005).   
 
Despite these initiatives, breast and colorectal cancer survival in Queensland has 
been shown to vary across small-areas, with people living in rural and remote areas 
often having lower survival (Cramb et al., 2011a). For breast, but not colorectal 
cancer, stage at diagnosis was a key contributor to survival inequalities, with many 
remote areas having a higher proportion of advanced breast cancers diagnosed 
(Cramb et al., 2012). However, these purely spatial analyses cannot determine 
whether inequalities are changing over time. 
 
Few spatio-temporal cancer survival analyses have been conducted. Bayesian Cox 
proportional hazards models (Carlin and Banerjee, 2003), as well as parametric 
models (Jin and Carlin, 2005), have been used to estimate spatial and temporal 
patterns in either overall survival or cause-specific survival. However, despite 
relative survival being the preferred approach for population-based cancer data, we 
could find no spatio-temporal models designed specifically for relative survival 
outcomes.  
 
Among the existing relative survival models that consider the spatial perspective 
only, there are a number that use a Bayesian approach with a generalised linear 
model including piecewise hazards and structured and unstructured heterogeneity 
components (Fairley et al., 2008; Cramb et al., 2012; Saez et al., 2012). An 
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alternative is  a similar geoadditive model (Hennerfeind et al., 2008b), which uses 
splines to smooth the piecewise hazards. Recently we introduced a Bayesian flexible 
parametric spatial relative survival model (Chapter 7) by extending Nelson’s flexible 
parametric relative survival model (Nelson et al., 2007). The advantages of this 
approach over previous include the ease of: 1) predicting smooth survival functions; 
2) including continuous independent variables, and; 3) using individual-level input 
data.  
 
In this paper, our aim is to expand this Bayesian flexible parametric spatial relative 
survival model to the spatio-temporal context to determine whether temporal changes 
in survival differ by small areas, and the possible impact of diagnostic stage on 
observed temporal changes.  
 
8.3 Methods 
8.3.1 Data 
 
Data on breast (ICD-O3 C50) and colorectal (ICD-O3 C18-C20,C218) cancers 
diagnosed during 1997 to 2011 were obtained from the Queensland Cancer Registry 
(QCR) following ethics approval from the Queensland Health Central Office Human 
Research Ethics Committee (HREC/09/QHC/25). The QCR is a population-based 
cancer registry covering the entire state of Queensland (20% of Australia’s 
population). All cancers diagnosed among Queensland residents (apart from non-
keratinocytic skin cancers) are reported to the QCR as required by legislation.  
 
Tumour stage definitions varied by cancer type. The Dukes staging system was used 
to assign colorectal cancer stage using information extracted from pathology records 
held by the QCR (Krnjacki et al., 2008). ‘Localised’ cancer was defined as stages I 
and II, with ‘Advanced’ cancer defined as stages III and IV. In contrast, breast cancer 
stage could only be approximated based on information routinely collected by the 
QCR regarding tumour size, lymph node involvement and distant metastases, with 
‘Localised’ stage equivalent to stage I, and ‘Advanced’ equivalent to stages II-IV 
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(Cramb et al., 2012). These categorisations are consistent with previous definitions 
used for Queensland data (Baade et al., 2011a; Baade et al., 2011c).  
 
The Australian Standard Geographic Classification (2006 ASGC) divides 
Queensland into 478 Statistical Local Areas (SLAs) (Australian Bureau of Statistics, 
2006a). SLAs cover Queensland without gap or overlap, and in 2011 had populations 
ranging from 2 to 83,600 (median 6,390). Details of the residential SLA for each 
patient at diagnosis were obtained.  
 
Unit record file population mortality data were supplied for 2006-2011 from the 
Australian Coordinating Registry (Registries of Births et al., 2014). The equivalent 
files for 1997-2005 were previously obtained from the Register of Births, Deaths and 
Marriages (Australian Bureau of Statistics, 2007c). Location information provided 
was concorded to 2006 SLA boundaries using correspondence files from the 
Australian Bureau of Statistics. 
 
Inclusion criteria were the first primary invasive breast/colorectal cancer diagnosed 
during the study period in an individual aged less than 90 years who survived for at 
least one day (and so was not diagnosed via death certificate or autopsy), and had 
SLA information available. 
 
8.3.2 Statistical analysis 
 
Cause of death information is not always available or reliable. In relative survival, 
deaths from any cause among cancer patients are compared against deaths expected 
in a cancer-free population (Crowther and Lambert, 2014). This requires population-
based cancer data, as the cancer-free population mortality is estimated using 
population mortality rates.  
 
Relative survival was calculated using the period method (Brenner et al., 2004). 
Here, cases are left truncated at the beginning of the time period of interest (called 
the ‘at-risk’ time period), as well as right censored if they survive to the end of the 
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at-risk period (Brenner et al., 2004). For further details on the period method see 
Brenner and Gefeller (1996). Three at-risk time periods were considered, aggregated 
over the years: 1997-2001, 2002-2006, and 2007-2011. Censoring was either at the 
end of the at-risk time period (31 December 2001, 2006 or 2011) or 5 years from 
diagnosis, whichever came first. Censoring at 5 years allowed for estimates in 
different time periods to be more comparable. Note that the same person can 
contribute to survival estimates in different at-risk time periods.  
 
The analysis was conducted in two stages. First, a standard flexible parametric 
relative survival model was fitted with time periods as a fixed effect, but no temporal 
or spatial random effects using the user-written Stata command stpm2 (Lambert and 
Royston, 2009) . This allows the preferred model to be selected and generates the 
input data for the restricted cubic spline components. Both the number of knots and 
their location for the cubic restricted splines must be pre-specified, and for both 
cancer types in this analysis, one interior knot was preferred based on Bayesian 
Information Criterion (BIC) (Schwarz, 1978) values. This interior knot was placed at 
the median of all death times. The same model with temporal effects changed to 
random effects and additional spatial effects was then run under a Bayesian 
formulation. This second step was implemented using WinBUGS version 1.4 
(Imperial College and Medical Research Council, UK) interfaced with Stata version 
13.1 (StataCorp LP, Texas, USA).   
 
8.3.3 Statistical model 
 
For relative survival, the overall hazard is separated into the expected hazard (ℎ∗(𝑡), 
from population mortality rates) and the excess hazard λ(𝑡)), as follows: 
 
ℎ(𝑡) = ℎ∗(𝑡) + λ(𝑡).                                                       (1) 
 
When integrated to the cumulative form and then transformed to the survival scale, 
this becomes: 
𝑆(𝑡) = 𝑆∗(𝑡) × 𝑅(𝑡)                                                       (2) 
i.e. relative survival (𝑅(𝑡)) is the ratio of overall (𝑆(𝑡)) to expected survival (𝑆∗(𝑡)).  
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Recently, we introduced and demonstrated the versatility of Bayesian flexible 
parametric spatial relative survival models (Chapter 7). These models are based on a 
parametric distribution such as the Weibull (producing proportional excess hazard 
ratios) or log-logistic (producing proportional excess odds ratios), but incorporate 
restricted cubic splines to flexibly model the baseline hazard which improves model 
fit (Royston and Lambert, 2011). In this analysis the excess proportional odds form 
was preferred based on BIC values. 
 
A proportional excess odds model (Royston and Lambert, 2011) could be specified 
as: 
 
logit(1 − 𝑅𝑘(𝑡)) = logit(1 − 𝑅0(𝑡)) + xβ𝑘                                   (3) 
 
where 𝑅0(𝑡) is the baseline relative survival function, the relative survival when all 
covariates equal zero and xβ𝑘 is the covariate-predictor matrix for covariates k. Note 
that logit(1 − 𝑅0(𝑡)) is modelled as a restricted cubic spline, and under the preferred 
one interior knot 𝑧1(𝑡), with parameter 𝛾2, this would be: 
 
logit(1 − 𝑅0(𝑡)) = 𝛾0 + 𝛾1ln (𝑡) + 𝛾2𝑧1(𝑡)                                  (4) 
 
The cubic basis functions for 𝑧1(𝑡) containing one interior knot 𝑘1 are: 
 
𝑧1(𝑡) = (ln(𝑡) − 𝑘1)+
3 −
𝑘max−𝑘𝑗
𝑘max−𝑘min
(ln(𝑡) − 𝑘min)+
3 − (1 −
𝑘max−𝑘1
𝑘max−𝑘min
) (ln(𝑡) − 𝑘max)+
3  
(5) 
 
with boundary knots at the minimum and maximum times of death (𝑘min and 𝑘max). 
The + subscript represents the truncation of negative values at zero. 
 
To allow for spatial variation, (3) can be extended to become: 
 
logit(1 − 𝑅𝑖𝑘(𝑡)) = logit(1 − 𝑅0(𝑡)) + xβ𝑘 + 𝑢𝑖 + 𝑣𝑖                         (6) 
 
where 𝑢𝑖 and 𝑣𝑖 represent the spatial and excess heterogeneity of data in the ith SLA, 
respectively. The small areas necessitate some form of smoothing, so this model is 
placed within a Bayesian framework and each parameter assigned a prior 
distribution. The intrinsic conditional autoregressive (CAR) distribution that smooths 
across areas with adjacent boundaries was used for the 𝑢𝑖 terms, while 𝑣𝑖 had vague 
normal distributions, as did β𝑘. 
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In order to look for spatial variation in the temporal trend, we then extend (6) to 
include an interaction between time period and SLA to generate the spatial-temporal 
model, as follows: 
 
logit (1 − 𝑅𝑖𝑗𝑘(𝑡)) = logit(1 − 𝑅0(𝑡)) + xβ𝑘 + 𝑠𝑖𝑗𝛿𝑗 + 𝑢𝑖 + 𝑣𝑖             (7) 
 
where sij represents the modelled excess mortality for the ith SLA and jth time period 
(0,1,2 representing 1997-2001, 2002-2006, 2007-2011, respectively) and 𝛿 is the jth 
time period. The parameter 𝑠𝑖𝑗 was given a vague normal prior, with a different 
variance for each time period. 
 
Three versions of hyperpriors on the variance of 𝜎𝑠1
2 , 𝜎𝑠2
2 , 𝜎𝑢
2 and 𝜎𝑣
2were compared to 
ensure estimates were not unduly influenced by these distributions: 
Version 1: Gamma distribution (shape, scale) on the precision, 
1
𝜎2
~Γ(0.1,100) 
Version 2: Uniform distribution (minimum, maximum) on the standard deviation, 
𝜎~U(0.01,20) 
Version 3: Uniform distribution on the standard deviation, 𝜎~U(0.01,100) 
 
Comparison of autocorrelation, convergence trace and density plots and modelled 
estimates gave similar results. Although the gamma distribution is conditionally 
conjugate and a common hyperprior choice, inferences may be very sensitive to the 
parameters (Gelman, 2006). Version 2 was thus selected as the tighter range on the 
uniform distribution is less likely to overestimate 𝜎 (Gelman, 2006). 
 
Additional model checks included assessing the precision of estimates using Monte 
Carlo (MC) error. This was considered in light of the very weak autocorrelation, and 
calculated as the [standard deviation √N iterations]⁄  of the exponentiated odds 
ratio estimates for each parameter. All parameters had MC error well below the 5% 
rule of thumb (Powers and Xie, 2008). 
 
Full details on priors and hyperpriors are available in the WinBUGS code in the 
Appendix. 
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8.3.4 Visualisation 
 
Maps were generated using MapInfo Professional v12.5. The mapped excess odds 
ratios for each SLA and time period were calculated as exp(𝑠𝑖𝑗𝛿𝑗 + 𝑢𝑖 + 𝑣𝑖), with the 
baseline time period (1997-2001) represented by j=0.  
 
Probability maps of the excess odds ratio being less than the baseline time period, 
which equates to exp(𝑠𝑖𝑗)<1, were also generated. A decrease in excess mortality 
equates to improved survival. Expressing probability as a percentage hereon, 
between  80% and 90% (shown in green) was categorised as likely to be a true 
decrease in mortality from cancer since 1997-2001, while above 90% (blue) has very 
high certainty of true decreases in cancer mortality. Between 20%-80% probability is 
considered inconclusive, and as no probabilities in this analysis were below 50%, 
categories below 20% (representing either no change or a probable increase in cancer 
mortality) were not included. 
 
Relative survival (𝑅𝑖𝑗𝑘(𝑡)) was calculated at each time point by each SLA i, 
covariates k (sex, tumour stage, continuous age) and time period j as  (1 +
exp(𝜂𝑖𝑗𝑘))
−1 where 𝜂𝑖𝑗𝑘 = logit (1 − 𝑅𝑖𝑗𝑘(𝑡)). The median posterior 5-year relative 
survival at age 60 years was plotted in the graphs. Improvements in survival between 
1997-2001 and 2007-2011 were also calculated at each MCMC iteration, and the 
posterior median difference for each SLA tabulated. 
 
8.4 Results 
8.4.1 Breast cancer 
 
Of the 34,816 women diagnosed with breast cancer and included in the study, almost 
equivalent proportions were diagnosed at a localised or an advanced stage (Table 
8.1). Many women were included in multiple at-risk time periods, with 55,177 
records included in the analysis (Table 8.2). 
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Table 8.1: Demographic characteristics of the study population 
 
       N=number of people; %=row percentage 
 
 
Improvements in survival were observed during each ‘at-risk’ time period (Figure 
8.1). After adjusting for tumour stage, it was apparent that much of the higher excess 
mortality observed among remote areas resulted from a large proportion of advanced 
tumours (Figure 8.1). In contrast, the lower excess mortality among residents of the 
South-East corner was barely altered after adjusting for tumour stage.  
 
Although the majority of areas showed decreases in mortality from breast cancer 
over time, seven areas exhibited weaker support for this trend (ie.  <80% probability 
of lower excess mortality) during 2002-2006 after adjusting for only age, and this 
increased to 61 areas after further adjusting for tumour stage (Figure 8.2). This may 
indicate that the apparent decreases in excess mortality between 1997-2001 and 
2002-2006  resulted from improved diagnosis in these areas. However, all areas 
Chapter 8: Spatio-temporal relative survival 
 
212  
 
showed evidence of a reduction in breast cancer mortality between 1997-2001 and 
2007-2011 regardless of adjustment for tumour stage.  
 
Table 8.2: Data characteristics by at-risk period and tumour stage 
 
     N=number of people; %=row percentage 
 
When 5-year relative survival was predicted from the model, small improvements 
over time were found for localised breast cancers, but larger gains for advanced 
breast cancers (Figure 8.3). Between 1997-2001 and 2007-2011, all SLAs showed 
improved survival for both localised and advanced breast cancers, regardless of 
remoteness (Table 8.3). A slight gradient was observed, with more remote areas 
having slightly higher improvements in 5-year relative survival during this 
timeframe. Overall, the median improvement for advanced breast cancer 5-year 
relative survival was 5.6% (range of posterior median estimates across all SLAs: 
4.0% to 7.2%), which was higher than the 2.1% for localised breast cancers (range: 
1.5% to 2.9%).  
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Figure 8.1: Breast cancer excess mortality odds ratios by at-risk time period, 
Queensland 
 
Unadjusted 
1997-2001 2002-2006 2007-2011 
   
Adjusted for tumour stage 
1997-2001 2002-2006 2007-2011 
   
Note: 1=Queensland average during 1997-2001. 
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Figure 8.2: Probability breast cancer excess mortality odds ratio is lower than 
during 1997-2001 by at-risk time period, Queensland 
Unadjusted 
2002-2006 2007-2011 
  
Adjusted for tumour stage 
2002-2006 2007-2011 
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Table 8.3: Median differences in 5-year relative survival by SLA between 1997-
2001 and 2007-2011 
 Localised  Advanced 
 Median Lowest Highest  Median Lowest Highest 
Breast, females        
  Major city 1.9% 1.5% 2.7%  5.2% 4.0% 7.1% 
  Inner regional 2.1% 1.5% 2.8%  5.6% 4.3% 7.2% 
  Outer regional 2.3% 1.8% 2.9%  6.0% 4.9% 7.1% 
  Remote 2.4% 1.8% 2.6%  6.2% 4.9% 6.7% 
  Very remote 2.5% 2.3% 2.6%  6.3% 5.6% 6.6% 
Colorectal, males        
  Major city 4.6% 4.1% 5.2%  7.9% 6.5% 9.1% 
  Inner regional 4.9% 3.9% 5.6%  7.8% 6.6% 8.9% 
  Outer regional 5.2% 4.5% 6.1%  7.6% 6.8% 8.4% 
  Remote 5.3% 4.4% 5.6%  7.6% 7.1% 7.8% 
  Very remote 5.5% 5.2% 5.7%  7.5% 6.4% 8.0% 
Colorectal, females        
  Major city 4.1% 3.6% 4.7%  8.0% 6.5% 9.0% 
  Inner regional 4.3% 3.4% 5.0%  8.0% 6.6% 8.9% 
  Outer regional 4.7% 3.9% 5.4%  7.9% 7.1% 8.6% 
  Remote 4.7% 3.8% 5.0%  7.9% 7.4% 8.1% 
  Very remote 4.9% 4.6% 5.2%  7.8% 6.9% 8.2% 
SLA=Statistical Local Area 
Notes: The difference between time periods was calculated at each MCMC iteration by SLA. The median 
posterior difference for each SLA was then combined into remoteness groupings and summarised.  
 
 
8.4.2 Colorectal cancer 
 
Although more localised (46%) than advanced stage (34%) colorectal cancer 
tumours were diagnosed, 20% of the 35,942 included cases were unable to be staged 
(Table 8.1). There was substantial overlap between at-risk time periods with 52,362 
records included in the analysis (Table 8.2).  
 
Survival improved during each ‘at-risk’ time period (Figure 8.4). However, similar 
estimates for colorectal cancer mortality were observed after adjusting for tumour 
stage, suggesting that stage differentials had minimal impact on spatial survival 
inequalities (Figure 8.4).  
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Figure 8.4: Colorectal cancer excess mortality odds ratios by at-risk time 
period, Queensland 
 
Unadjusted 
1997-2001 2002-2006 2007-2011 
   
Adjusted for tumour stage 
1997-2001 2002-2006 2007-2011 
   
 
 
There were 37 areas with <80% probability of lower excess mortality in the 
unadjusted analysis during 2002-2006, and this increased to 65 areas after adjustment 
for tumour stage (Figure 8.5). Excess mortality clearly decreased between 1997-2001 
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and 2007-2011 (>99% probability across all areas), even after adjustment for tumour 
stage.  
 
Localised colorectal cancers for both sexes showed gains in 5-year relative survival 
between 1997-2001 and 2007-2011  (median 4.6%, range 3.4% to 6.1%) with even 
larger improvements for advanced colorectal cancers (median 7.9%, range: 6.4% to 
9.1%) (Figure 8.3 & Table 8.3).  
 
Figure 8.5: Probability colorectal cancer excess mortality odds ratio is lower 
than during 1997-2001 by at-risk time period, Queensland 
Unadjusted 
2002-2006 2007-2011 
  
Adjusted for tumour stage 
2002-2006 2007-2011 
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8.5 Discussion 
This study is, to our knowledge, the first to present a spatio-temporal flexible 
parametric relative survival model. Although survival was shown to have improved 
over time across all areas, important differences in spatio-temporal patterns were 
observed between breast and colorectal cancers. 
 
Our results suggest that improvements in non-diagnostic factors, which may include 
patient treatment and management, are the main drivers of recent survival increases 
for breast and colorectal cancers. As improvements in predicted 5-year relative 
survival were observed for each tumour stage, it seems unlikely that survival 
improvements are greatly influenced by any earlier diagnosis of tumours. This is also 
consistent with a study in another Australian state (New South Wales) which 
suggested the broad remoteness inequalities they found for non-localised breast 
cancer might result from systemic treatment differences (Yu et al., 2015). 
 
Uptake for the national bowel cancer screening program remains low (37.4% 
reported for Queenslanders in the target ages during 2008-2011 (Australian Institute 
of Health and Welfare, 2012a)), and during the study period only limited ages were 
eligible. Nonetheless, among program participants, there has been some evidence of 
earlier diagnosis of tumours and reduced mortality (Australian Institute of Health and 
Welfare, 2014c).  
 
For breast cancer screening, participation in the freely-available mammogram for 
Queensland women aged 50-69 years in 2010-2011 was 57.6% (Australian Institute 
of Health and Welfare, 2013). Nationally, during 1997-2011 participation has 
remained between 55%-57% (Australian Institute of Health and Welfare, 2013). It is 
not known how many women participate in mammography screening through private 
hospitals and clinics nor whether this has varied over time. A greater proportion of 
tumours detected through mammography are smaller, with an associated better 
prognosis (Australian Institute of Health and Welfare, 2013). The apparently 
consistent uptake of mammography is congruent with our findings that recent breast 
cancer survival improvements are independent of earlier diagnosis. 
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Larger gains in survival were observed between 2002-2006 and 2007-2011, rather 
than between the earlier time periods (1997-2001 and 2002-2006). Survival 
improvements were largely consistent regardless of remoteness of an area, with some 
evidence of slightly greater improvements with increasing remoteness for localised 
and advanced breast cancer, as well as localised colorectal cancer. Although another 
Australian state found increasing inequality over time between broad urban-rural 
groupings for breast cancer 5-year relative survival (Yu et al., 2015), inequalities at 2 
years follow-up had arguably decreased. 
 
Previous studies have explored the cause of improvements in survival over time for 
breast and colorectal cancer. Colorectal cancer survival improvements are commonly 
attributed to advances in both surgical (van Vugt et al., 2014) and pharmaceutical 
(Cheng et al., 2013) treatments. A Queensland-based study investigated the cause of 
breast cancer survival improvements across 1980-1994 (Webb et al., 2004), which 
spanned the introduction of population-based screening and dramatic changes in the 
surgical management and use of adjuvant therapy. Both earlier diagnosis and 
treatment improvements were considered to be influencing survival improvements 
(Webb et al., 2004), but this analysis did not overlap with the time period in this 
study, nor attempt to determine if there was variation between smaller areas. 
 
The poorer survival experienced by people diagnosed with breast or colorectal cancer 
while living in more remote areas was again confirmed in this study. Consistent with 
previous analyses using multilevel models, even after adjustment for tumour stage, 
colorectal cancer patients in remote areas had lower survival (Baade et al., 2013), as 
did breast cancer patients (Baade et al., 2011c).  Previous studies indicated the higher 
proportion of women diagnosed with advanced cancer contributed substantially to 
the survival differentials for breast, but not colorectal, cancer (Cramb et al., 2012). 
Commonly, lower colorectal cancer survival is attributed to less experienced 
surgeons in more remote areas (Spigelman and McGrath, 2002; Armstrong et al., 
2004). This study has shown that despite improvements in cancer survival, 
particularly for advanced cancers, people diagnosed with these cancers living in 
more remote areas still have lower survival.  
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Strategies such as telehealth, which have the potential to remove the barriers of 
distance for both the clinician and patient thus saving costs and enhancing service 
provision, may be one option to assist in reducing these observed spatial inequalities 
(Fox and Boyce, 2014).  One rural South Australian hospital partly attributed their 
urban-comparable 5-year colorectal cancer survival results to the multidisciplinary 
teams including urban specialists via video/audio links (Wichmann et al., 2013). 
Nonetheless, telehealth is currently in its infancy in Australia with limited qualitative 
evidence available regarding its effectiveness (Bursell et al., 2013).  
 
Limitations of this research include that arising from the use of routinely collected 
data, including missing information (particularly unknown tumour stage 
information), and limited information on potential explanatory covariates.  Unstaged 
breast cancers tend to have very low survival, suggesting that a sizable proportion 
may be particularly advanced cancers. In contrast, survival for unstaged colorectal 
cancers suggests a mixture of localised and advanced tumours.  
 
The data sparseness due to small area-specific incidence counts will influence the 
extent of smoothing. The potential exists for over-smoothing when using the CAR 
prior (Goovaerts and Gebreab, 2008), and this risk increases with greater data 
sparseness. If one sparsely populated area did not experience increasing survival over 
time, but all neighbouring regions did, the one region with the adverse trend may not 
be detected in this model. We were not able to quantify the extent to which this may 
have occurred. 
 
Advantages include the use of Bayesian methods to produce robust small-area 
survival estimates over time. Our focus was on documenting and understanding the 
changes over time in each small area. Alternate structures could have been used to 
answer similar questions, including spatially-varying coefficient models (Cai et al., 
2013), or even applying a multivariate version of the CAR prior (Carlin and 
Banerjee, 2003). The greater complexity of these models was not considered 
necessary to answer our key research questions. 
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In conclusion, we have presented a method to obtain reliable spatio-temporal relative 
survival estimates. Our findings that survival has consistently improved across the 
vast distances of Queensland between 1997-2001 and 2007-2011 is a cause for 
optimism. However, important inequalities in survival between small areas remain, 
and for breast cancer, some are likely to result from a higher proportion of cancers 
diagnosed among women living in more remote areas being diagnosed at an 
advanced stage.    
 
Appendix: WinBUGS code 
WinBUGS code for spatio-temporal model, breast cancer with adjustment for tumour 
stage and centred, 2nd order transformed age as a continuous variable. 
 
Note: rcs are spline terms; age is a continuous, centred, transformed variable; haz is the population 
mortality; t0 is an indicator variable which equals 1 if delayed entry and 0 otherwise. 
 
model { 
 
 K <-10000 
 
 for(i in 1:N) { 
     stage2[i]<- equals(stage[i], 2)   
     stage3[i]<- equals(stage[i], 3) 
     year1[i]<- equals(yearcat[i], 1) 
     year2[i]<- equals(yearcat[i], 2)  
 
 zeros[i]<-0 
eta[i]<-gamma[1]+gamma[2]*rcs1[i]+gamma[3]*rcs2[i]+s1[slano[i]]*year1[i]+ 
s2[slano[i]]*year2[i]+beta[1]*agec1[i]+beta[2]*agec2[i]+beta[3]*stage2[i]+beta[4]*stage3[i]
+ u[slano[i]]+v[slano[i]] 
 
eta0[i]<-gamma[1]+gamma[2]*s0rcs1[i]+gamma[3]*s0rcs2[i]+s1[slano[i]]*year1[i]+ 
s2[slano[i]]*year2[i]+beta[1]*agec1[i]+beta[2]*agec2[i]+beta[3]*stage2[i]+beta[4]*stage3[i] 
+u[slano[i]]+v[slano[i]] 
 
 dsp[i]<-gamma[2]*drcs1[i]+gamma[3]*drcs2[i] 
   
lnL[i]<- d[i]*log((haz[i])+(1/t[i])*max(dsp[i]*exp(eta[i]),0.00001)/(1 + exp(eta[i]))) + 
log(pow((1+exp(eta[i])),-1)) + (log(1+exp(eta0[i]))*t0[i]) 
  
c[i]<- -lnL[i]+K 
 
 zeros[i]~dpois(c[i]) 
} 
 
#Prior Distributions 
#CAR prior for spatial random effect 
 u[1:Nsla] ~ car.normal(adj[], weights[], num[], tauu)   
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 for (k in 1:sumNumNeigh) {weights[k] <- 1 } 
 
#Normal prior for uncorrelated heterogeneity term 
 for (i in 1:Nsla) { 
 v[i]~dnorm(0,tauv) 
 s1[i]~dnorm(mus1,taus1) 
 s2[i]~dnorm(mus2,taus2) 
 } 
   
 # Other priors           
 tauu<-pow(sigmau,-2) 
 sigmau~dunif(0.01, 20) 
 tauv<-pow(sigmav,-2) 
 sigmav~dunif(0.01, 20) 
  
for j in 1:2{ 
  taus[j]<-pow(sigmas[j],-2)     
  sigmas[j]~dunif(0.01, 20) 
  mus[j]~dnorm(0,0.1) 
  } 
 varucon <-1/tauu 
 varv<-1/tauv 
 varumarginal<-sd(u[])*sd(u[]) 
 fracspatial<-varumarginal/(varumarginal+varv) 
 
for(j in 1:4){ 
beta[j]~dnorm(0,0.001) 
} 
for(j in 1:3){ 
gamma[j]~dnorm(0,0.001) 
} 
 
} 
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CHAPTER 9 
 
Discussion 
 
Effective cancer control requires reliable evidence (Australian Institute of Health and 
Welfare, 2012b). This project demonstrated the versatility of using Bayesian 
hierarchical models in cancer control, while expanding the range of models and 
methods available. This included developing the first fully Bayesian approach to 
quantify premature deaths, and introducing the first Bayesian spatial flexible 
parametric relative survival model as well as extending this to the first 
spatiotemporal version. 
 
The modelling approach enabled reliable and robust small area estimates to be 
obtained, clearly documenting spatial and spatio-temporal inequalities in cancer 
incidence and survival throughout Queensland. The impact of various influences was 
determined, including remoteness, socioeconomic status, and tumour stage. This 
project produced the first available evidence at the small-area level to assist in cancer 
control in Queensland. 
 
9.1 Research Contribution & Findings 
 
An overview of research innovation by chapter is available in Table  9.1. A summary 
of the findings for each objective along with their applied and/or methodological 
contribution are provided below. 
 
9.1.1 Document cancers with evidence of spatial inequalities in 
incidence and/or survival 
 
Small-area cancer incidence patterns were made available for the first time in 
Queensland. Previous work in other states included Western Australia (Threlfall et 
al., 2004) and South Australia (SA Department of Health, 2005) calculating 
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unsmoothed cancer incidence estimates at the SLA level. This caused difficulties in 
interpreting areas with either small expected counts or zero observed counts. In 
contrast, New South Wales (Bois et al., 2007) had applied a fully Bayesian approach 
to slightly larger regions called local government areas (192 areas, with each area 
composed of 1 to 4 SLAs) and smoothed across areas using the CAR prior. No 
previous publication had applied fully Bayesian models to examine cancer incidence 
across individual SLAs within Australia. 
 
Small-area patterns of cancer survival were also produced for the first time anywhere 
in Australia. Earlier geographical survival analyses in Australia were restricted to 
large regions, generally dividing states into less than 20 districts.  These analyses 
would either have no smoothing (Australian Institute of Health and Welfare and 
Cancer Australia & Australasian Association of Cancer Registries, 2008), or employ 
an empirical Bayes method to smooth estimates towards the mean to prevent 
spurious fluctuations (Yu et al., 2003; Baade et al., 2005). 
 
The decisions made in generating and presenting the results of this investigation 
across a range of cancers was the focus of Chapter 3. Determining whether patterns 
reflected either random variation or spatial inequalities was a crucial aspect. 
Applying Tango’s MEET to modelled results to determine the significance of the 
observed patterns was a novel, albeit recommended, approach (Tango, 2000). 
 
Several cancers showed evidence of spatial inequalities in incidence and/or survival 
(Table 9.2). A consistent overall pattern of lower survival among remote areas, and 
higher survival among urban areas, was observed for all cancers demonstrating 
spatial survival inequalities (Cramb et al., 2011a). This differed from the spatial 
inequalities for incidence, which varied by type of cancer. Some cancers had higher 
incidence in remote areas (cervical, male lung and male oesophageal), while others 
had higher incidence in urban areas, including breast, prostate, non-Hodgkin 
lymphoma, male kidney and male bladder (Cramb et al., 2011a). 
 
 
Chapter 9: Discussion 
 
 231 
 
 
T
a
b
le
 9
.1
: 
S
u
m
m
a
ry
 o
f 
re
se
a
r
ch
 c
o
m
p
o
n
en
ts
 
B
Y
M
: 
B
es
ag
, 
Y
o
rk
 a
n
d
 M
o
ll
ié
; 
 C
A
R
T
: 
C
la
ss
if
ic
at
io
n
 a
n
d
 R
eg
re
ss
io
n
 T
re
e
; 
 M
E
E
T
: 
M
ax
im
is
ed
 E
x
ce
ss
 E
v
en
ts
 T
es
t;
  
N
H
P
A
: 
N
at
io
n
al
 H
ea
lt
h
 P
ri
o
ri
ty
 A
re
a
. 
Chapter 9: Discussion 
 
232  
 
Table 9.2: Evidence for spatial variation by type of cancer and sex, Queensland 
1998-2007 
 Incidence Survival 
Cancer site Males Females Males Females 
All invasive cancers Strong Strong Strong Strong 
Oesophagus Strong None None None 
Stomach Weak None Moderate None 
Colorectal None None Strong Strong 
Pancreas None None None None 
Lung Strong Strong Strong Strong 
Melanoma Strong Strong None None 
Breast – females only  Strong  Strong 
Cervical  Moderate  None 
Uterus  Strong  None 
Ovary  None  Weak 
Prostate Strong  Strong  
Kidney Strong Weak None None 
Bladder Strong None None None 
Brain None None None None 
Thyroid None Strong None None 
Non-Hodgkin lymphoma Strong Strong Moderate Strong 
Leukaemia Moderate Moderate Moderate None 
Myeloma Weak None None None 
Strong represents Tango’s MEET p-value<0.01. 
Moderate represents Tango’s MEET  0.01≤p-value< 0.05. 
Weak represents Tango’s MEET  0.05≤p-value< 0.10.  
None represents Tango’s MEET p-value≥0.10. 
Cancers with either ‘Strong’ or ‘Moderate’ evidence were considered to have spatial variation present. 
 
 
9.1.2 Explore factors influencing the spatial inequalities in cancer 
incidence 
 
The influence of remoteness and its interaction with other key factors such as 
socioeconomic disadvantage, and the Indigenous proportion of the population in each 
small area, was investigated further in Chapter 4. Due to the expected complex 
interactions between these factors, CART models were applied to the smoothed SIRs 
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from the Bayesian hierarchical models. Attempting to decipher interactions between 
small-area raw SIRs would have been difficult due to the instability of estimates. 
This application of a CART analysis to modelled results in a spatial context provided 
a novel contribution. 
 
The remoteness of an area was found to be a key influence on spatial incidence 
inequalities for many of the NHPA cancers, while Indigenous ethnicity was an 
important influence only for cervical cancer. Socioeconomic disadvantage interacted 
with remoteness for lung cancer as well as certain screen detected cancers including 
melanoma, breast (females), cervical and prostate cancers. 
  
9.1.3 Explore spatio-temporal inequalities in cancer 
incidence/risk factors 
 
Risk factor prevalence often shows spatio-temporal patterns, but available data is 
often limited. Lung cancer, with its clear risk factors, and evidence of spatial 
inequalities, was examined in detail for this objective in Chapter 5. As no data was 
available for tobacco smoking prevalence in all Queensland SLAs, a shared 
component model was applied to estimate the common underlying risk factor for 
male and female lung cancer. Due to the extreme data sparseness, a spatio-temporal 
shared component model was extended beyond Poisson to distributions more 
appropriate for zero-inflated and sparse data. This innovative refinement of a 
previously developed model provided an applied contribution. 
 
The shared component appeared to reflect past tobacco smoking patterns, and 
demonstrated consistent time trends across all small areas, with males decreasing 
over time and females increasing before recently decreasing. This suggests that 
spatial inequalities have remained fairly consistent between areas. High risk areas 
may benefit from interventions aimed at modifying social norms.  
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9.1.4 Quantify the importance of cancer survival spatial 
inequalities, and consider factors influencing this 
 
Important methodological advances resulted from pursuing this objective. In Chapter 
6, for the first time, a fully Bayesian approach was described to quantify the number 
of premature deaths from cancer due to spatially structured variation in survival. The 
advantages of this include obtaining measures of uncertainty, the ability to adjust for 
prognostic influences, and excluding deaths considered to result from random 
variation. 
 
An estimated 7% of breast cancer deaths and 8% of colorectal cancer deaths were 
considered to result from spatial inequalities, after adjusting for tumour stage and 
excluding the impact of random variation. This was a total of 640 deaths across 10 
years. There was large uncertainty around these estimates, so potentially it could be 
as few as 407 deaths or as many as 944 deaths (80% CrI). This places the premature 
deaths associated with spatial inequalities for just these two cancer types on par with 
the 642 fatal road crashes associated with blood alcohol concentration ≥ 0.05 
grams/100mL during 2002-2011 on Queensland roads (Department of Transport and 
Main Roads, 2012). 
 
Another methodological contribution was the development of a spatial flexible 
parametric relative survival model in Chapter 7. Benefits over previous spatial 
relative survival models include the ability to predict smooth survival functions, the 
ease of including continuous independent variables, and the capacity to use 
individual-level data.  
 
The influence of tumour stage on small-area survival inequalities was demonstrated 
in Chapter 6, and further confirmed by Chapter 7. Much of the lower survival 
observed for breast cancer patients residing in more remote areas resulted from a 
greater proportion of advanced tumours diagnosed in these areas. Indeed, localised 
breast cancers had only slight differences in the predicted 5-year relative survival of 
60 year olds between SLAs, regardless of remoteness, in comparison to survival 
differences of up to 6% between SLAs for advanced breast cancers. In contrast, for 
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colorectal cancer these median posterior 5-year relative survival differences were 
over 4% between SLAs for localised colorectal cancer, and 14% for advanced 
colorectal cancer.  
 
9.1.5 Investigate changes in survival inequalities over time 
 
Improvements in survival at the small area level and the influence of tumour stage 
were investigated in Chapter 8. This pioneering spatio-temporal relative survival 
model was produced by extending the model introduced in Chapter 7 to include 
temporal components. This was an important methodological contribution. 
 
Between 1997-2001 and 2007-2011, all small areas showed improvements in 
survival, for both localised and advanced breast and colorectal cancers. Localised 
breast cancer had a median 5-year relative survival improvement across Queensland 
of 2.1%, with more than twice this improvement seen for advanced breast cancers 
(median 5-year improvement of 5.6%). Localised and advanced colorectal cancers 
had median 5-year relative survival improvements of 4.6% and 7.9%, respectively. 
Across time periods and the majority of areas, it appeared that survival 
improvements across Queensland were not due to earlier diagnosis, suggesting they 
resulted from improvements in non-diagnostic factors, such as patient management 
and treatment. 
 
9.2 Research Impact & Reflection 
 
This research placed variation in cancer outcomes within Queensland as an important 
health priority, catalysing government action for the benefit of cancer patients. 
 
Several practical benefits for cancer patients have already resulted from this project. 
Greater financial assistance for cancer patients required to travel for treatment was 
provided by the Queensland government in response to lobbying that used results 
from this research project. This increased the Patient Travel Subsidy Scheme from 
15c to 30c per kilometre, and from $30 to $60 per night for commercial 
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accommodation for patients required to access specialised medical services that are 
not locally available (Queensland Health, 2012). Other consequences of this research 
included additional staff positions created by Cancer Council Queensland to support 
cancer patients in regional locations. Results were used by Queensland Health to 
formulate cancer health service strategies for the next decade, with service direction 
objective 3.5 implemented in direct response to research findings, which states: 
“Reduce variations in cancer outcomes in Queensland between metro, regional and 
rural areas as well as between socio-economic groups” (Health Commissioning 
Queensland, 2014). 
 
Location information is increasingly being collected for health data, and demand for 
small-area analyses increasing. This project has demonstrated the feasibility of 
applying Bayesian hierarchical models in an environment of sparse data. These 
models are directly applicable to other non-infectious, relatively rare diseases also. 
Data availability is perhaps the greatest limitation in extending these models beyond 
cancer.   
 
When this project began, the use of Bayesian hierarchical models in spatial 
epidemiology was burgeoning. Yet within Australia, the only application of Bayesian 
hierarchical models to cancer data was in NSW (Bois et al., 2007), to produce maps 
of cancer incidence and mortality. Small area analyses of less common diseases in 
the Australian context poses challenges, and although Bayesian methods are well-
suited to address many of the issues resulting from sparse data, careful 
implementation is required. This includes considering the influence of prior and 
hyperprior distributions, confirming identifiability, and ensuring convergence.  
 
The use of the CAR prior on the spatial random effects term is not without 
controversy. This prior is computationally efficient, simple to implement, and has 
been widely applied in a range of contexts (Gelfand and Vounatsou, 2003; Assunção 
and Krainski, 2009). However, it is likely to result in some amount of 
oversmoothing, and may not be ideal when areas are of varying sizes and shapes, as 
in Queensland. The individual areas ranged in size from 0.3 to >100,000 km2, with 
one remote group of neighbouring areas occupying 422,000 square kilometres. 
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Alternative smoothing options include the use of two-dimensional P-splines, joint 
exponential distance decay, and modified weighted or mixture versions of the CAR 
prior that allow for disparate results between neighbours  (Lawson and Clark, 2002; 
Pettitt et al., 2002; Best et al., 2005; Sauleau et al., 2007a; MacNab et al., 2014). The 
use of the CAR prior minimised disparities in cancer incidence or survival between 
neighbouring regions.   
 
Constraints to this project resulted from the use of routinely collected data. Limited 
patient information is collected by cancer registries. Data linkage may be one option 
to obtain additional information from routine sources. Other projects have 
demonstrated the feasibility of applying similar models to linked BreastScreen 
Queensland and QCR data (see Appendix).  
 
The decision to use computationally intensive MCMC methods restrained model 
complexity and feasibility. The time required to compute estimates for models with 
additional numbers of areas, time periods, or more than five interior knots in the 
flexible parametric models may become impractical. Alternate computational 
methods such as R-INLA (Rue et al., 2009) would overcome this and are now widely 
available. 
 
From all the issues facing Australia’s heath care system in 2007, the leading issue 
identified was achieving health equity (Armstrong et al., 2007). At the conclusion of 
this project, this still remains a challenge. The difference is that now, evidence and 
quantification of small-area cancer inequalities are available for Queensland. Other 
studies can now use these results as a foundation for developing further 
investigations.  
 
9.3 Future Research  
 
Many aspects of this project could be extended. The application to Queensland data 
demonstrated the feasibility of the methods. Expanding this approach to the national 
level is likely to be beneficial, particularly as the health system is partially funded by 
the federal government. An increasing number of countries now produce national 
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cancer atlases, including Ireland (National Cancer Registry/Northern Ireland Cancer 
Registry, 2011), the United Kingdom (National Cancer Intelligence Network, 2009), 
Spain (Lopez-Abente et al., 2014), Saudi Arabia (Al-Ahmadi et al., 2013) and the 
United States of America (U.S. Cancer Statistics Working Group, 2014). 
 
Detailed analyses were only conducted on a limited range of cancers, and 
investigating others, as appropriate, could yield important insights. Extending the 
analyses to include second primary cancers, or alternatively to consider cancer 
relapses, within a spatial or spatio-temporal context could also be of benefit. 
 
Planned work includes investigating alternate structures for spatio-temporal 
interactions, as well as exploring model complexity and identifiability constraints.  
Work has also started on an incidence analysis examining tumour stage spatial 
patterns. 
 
There are many possible extensions and modifications to the introduced Bayesian 
flexible parametric spatial or spatio-temporal survival models. Options include 
incorporating time-varying covariates, alternate spatio-temporal interactions, or 
alternatives to the CAR prior for spatial structure. Investigating either cure models or 
competing risks within a spatial flexible parametric context could be a novel 
extension and provide additional insight to spatial inequalities.  
 
9.4 Conclusion 
 
This project has provided the most detailed and comprehensive analysis of small-area 
inequalities in cancer outcomes in Australia to date. All project objectives were met 
and findings have already had substantial impact. One key outcome from this 
research has been the raised awareness of the impact of cancer inequalities in 
Queensland. It was hoped that this study would influence government policy and 
bring practical benefits to cancer patients in Queensland, however the extent and 
speed of implementation have dramatically highlighted the benefits of these methods.  
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